Patent Application
20250115628
The presently-disclosed subject matter relates to fluorescent compounds. In particular, the presently-disclosed subject matter relates to polycyclic chemical fluorophores as well as method for making and using the same.
Fluorescence microscopy depends on the labeling of cellular components with fluorophores. Beginning with the development of fluorescein isocyanate (FIC) by Coons in the 1940s,1 followed by the shelf-stable analog fluorescein isothiocyanate (FITC) by Metcalf in the 1950s,2 small-molecule fluorophores have become ubiquitous labels for antibodies and other affinity reagents used in cellular imaging.3
Chemical dyes are also employed in self-labeling tag systems, such as the SNAP-tag®4,5 and HaloTag®,6,7 and in fluorogenic ligands that bind endogenous biomolecular targets.8,9 These strategies have expanded the utility of small-molecule fluorophores to label proteins inside living cells and animals, complementing genetically encoded labels such as green fluorescent protein (GFP).10
Of the extant classes of fluorophores, the rhodamine dyes remain in wide use as biomolecule labels, self-labeling tags ligands, and fluorogenic stains due to their excellent photophysical properties, tunable structures, and bioavailability.11-13 Elucidation of structure-activity relationships in rhodamines combined with new methods to synthesize functional dye derivatives leads to the creation of optimized reagents.
Accordingly, there remains a need in the art for unique functionalized rhodamine dyes and unique synthetic methods for preparing such dyes.
The presently-disclosed subject matter meets some or all of the above-identified needs, as will become evident to those of ordinary skill in the art after a study of information provided in this document.
This Summary describes several embodiments of the presently-disclosed subject matter, and in many cases lists variations and permutations of these embodiments. This Summary is merely exemplary of the numerous and varied embodiments. Mention of one or more representative features of a given embodiment is likewise exemplary. Such an embodiment can typically exist with or without the feature(s) mentioned; likewise, those features can be applied to other embodiments of the presently-disclosed subject matter, whether listed in this Summary or not. To avoid excessive repetition, this Summary does not list or suggest all possible combinations of such features.
The presently-disclosed subject matter includes polycyclic chemical fluorophores as well as method for making and using the same. In some embodiments the compound has the following formula:
and salts thereof.
In the compound, Q is selected from the group consisting of C(alkyl)2, NH, N(alkyl), O, S, SO2, Si(alkyl)2, P(O)(aryl), P(O)(alkyl), PO 2H, PO 2(alkyl), Se, and replaced with two H atoms.
R1 and R6 are independently selected from the group consisting of H, D, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), N3, NH2, NH(alkyl), N(alkyl)2, NH(aryl), N(aryl)2, NO2, CHO, C(O)(alkyl), C(O)(aryl), COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)NH(aryl), PO 3H2, SO3H, alkyl and substituted alkyl, aryl and substituted aryl, alkenyl and substituted alkenyl, alkynyl or substituted alkynyl, or wherein the R1 substituent and R2 substituent and/or the R6 substituent and R7 substituent, taken together with the carbon atoms to which they are bonded, independently form a substituted or unsubstituted ring containing 3, 4, 5, 6, 7, 8, or 9 atoms.
R2 and R7 are independently selected from the group consisting of H, alkyl, deuterated alkyl, and aryl so long as when Q=C(CH3)2, R1 and R2 form a 6-membered ring, and R1, R9, and R10 are methyl, then R7 cannot be methyl.
Each R3, R4, R5, R8, R9, R10 is independently selected from the group consisting of H and alkyl, so long as when R1 and R6 are H, and R3, R4, R5, R8, R9, and R10 are methyl, then Q cannot be O.
Z is selected from the group consisting of C(O), COOH, COO−, SO3−, PO 32−, or CR3 where each R is independently selected from the group consisting of H, OH, alkyl, and substituted alkyl.
X is selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, CN, COOH, COO−, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)N(alkyl)2, C(O)NH(aryl), C(O)N(aryl)2, PO 3H2, and SO3H.
The presently-disclosed subject matter further includes a method for detecting a target substance as disclosed herein. In some embodiments, the method includes contacting a sample with a compound as disclosed herein.
In some embodiments of the detection method, the target substance is selected from a protein, a carbohydrate, a polysaccharide, a glycoprotein, a hormone, a receptor, an antigen, an antibody, a virus, a substrate, a metabolite, an inhibitor, a drug, a nutrient, a growth factor, a liprotein, and a combination thereof.
In some embodiments of the method, the detecting step is performed with a microscope. In some embodiments, the contact step and the detecting step are performed in a live cell.
Some embodiments of the method include contacting the sample with a first compound as disclosed herein and a second compound as disclosed herein, wherein the first compound is selective for a first target substance and capable of emitting a first emission light, the second compound is selective for a second target substance and capable of emitting a second emission light, and the detecting step includes detecting the first emission light that indicates the presence of the first target substance and the second emission light that indicates the presence of the second target substance.
The presently-disclosed subject matter further includes a method of making a compound, including an intermediate compound, as disclosed herein.
In some embodiments, the method of making a compound comprises preparation of diarylether and diarylsilane intermediates, as disclosed herein.
In some embodiments, the method of making a compound comprises rhodamine synthesis via lactol (phthalaldehydic acid) condensation, as disclosed herein.
In some embodiments, the method of making a compound comprises preparation of 2,2-diarylpropane intermediates, as disclosed herein.
In some embodiments, the method of making a compound comprises preparation of anthrone intermediates, as disclosed herein.
In some embodiments, the method of making a compound comprises xanthene synthesis via lithiation of tetrafluorobenzoic acid, as disclosed herein.
In some embodiments, the method of making a compound comprises synthesis of carborhodamines via AlCl3 Condensation, as disclosed herein.
In some embodiments, the method of making a compound comprises rhodamine 110 and N-aryl rhodamine synthesis via cross-coupling, as disclosed herein.
In some embodiments, the method of making a compound comprises MAC substitution of 4,5,6,7-tetrafluoroxanthenes, as disclosed herein.
In some embodiments, the method of making a compound comprises conversion of MAC xanthenes to HaloTag® ligands, as disclosed herein.
In some embodiments, the method of making a compound comprises synthesis of HaloTag® and SNAP-tag® Ligands, as disclosed herein.
The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are used, and the accompanying drawings of which:
The details of one or more embodiments of the presently-disclosed subject matter are set forth in this document. Modifications to embodiments described in this document, and other embodiments, will be evident to those of ordinary skill in the art after a study of the information provided in this document. The information provided in this document, and particularly the specific details of the described exemplary embodiments, is provided primarily for clearness of understanding and no unnecessary limitations are to be understood therefrom. In case of conflict, the specification of this document, including definitions, will control.
Fluorescent dyes are important tools for biological research. A key challenge in the field of fluorescent dyes is the creation of derivatives with reactive groups for conjugation. It was previously discovered that masked acyl cyanide (MAC) reagents could efficiently react with rhodamine dyes that bear a fluorinated pendant phenyl ring, providing a facile strategy for regioselective installation of an amine-reactive moiety. As disclosed herein, the scope of this late-stage functionalization chemistry is expanded to more fluorophores. Using both established and unique chemistry, an array of fluorinated triarylmethane dyes are prepared, including variants of rhodamines, fluoresceins, and Malachite Green. The generality of the MAC chemistry is also demonstrated, which provides a variety of self-labeling protein tag (e.g., HaloTag®) ligands for use in imaging and sensing applications. This efficient umpolung synthetic method will enable the facile construction of new molecular tools for biological studies.
The presently-disclosed subject matter includes polycyclic chemical fluorophores as well as method for making and using the same. In some embodiments the compound has the following formula:
and salts thereof.
In the compound, Q is selected from the group consisting of C(alkyl)2, NH, N(alkyl), O, S, SO2, Si(alkyl)2, P(O)(aryl), P(O)(alkyl), PO 2H, PO 2(alkyl), Se, and replaced with two H atoms.
R1 and R6 are independently selected from the group consisting of H, D, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), N3, NH2, NH(alkyl), N(alkyl)2, NH(aryl), N(aryl)2, NO2, CHO, C(O)(alkyl), C(O)(aryl), COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)NH(aryl), PO 3H2, SO3H, alkyl and substituted alkyl, aryl and substituted aryl, alkenyl and substituted alkenyl, alkynyl or substituted alkynyl, or wherein the R1 substituent and R2 substituent and/or the R6 substituent and R7 substituent, taken together with the carbon atoms to which they are bonded, independently form a substituted or unsubstituted ring containing 3, 4, 5, 6, 7, 8, or 9 atoms.
R2 and R7 are independently selected from the group consisting of H, alkyl, deuterated alkyl, and aryl so long as when Q=C(CH3)2, R1 and R2 form a 6-membered ring, and R1, R9, and R10 are methyl, then R7 cannot be methyl.
Each R3, R4, R5, R1, R9, R10 is independently selected from the group consisting of H and alkyl, so long as when R1 and R6 are H, and R3, R4, R5, R8, R9, and R10 are methyl, then Q cannot be O.
Z is selected from the group consisting of C(O), COOH, COO−, SO3−, PO32−, or CR3 where each R is independently selected from the group consisting of H, OH, alkyl, and substituted alkyl.
X is selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, CN, COOH, COO−, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)N(alkyl)2, C(O)NH(aryl), C(O)N(aryl)2, PO 3H2, and SO3H.
In some embodiments of the compound, X is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, CN, COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)N(alkyl)2, C(O)NH(aryl), C(O)N(aryl)2.
In some embodiments of the compound, X is selected from the group consisting of
In some embodiments of the compound, Q is selected from selected from the group consisting of
and replaced with two H atoms. In some embodiments of the compound, Q is selected from selected from the group consisting of
In some embodiments of the compound, R2 and R7 are independently selected from the group consisting of H and alkyl.
In some embodiments of the compound, the R1 substituent and R2 substituent and/or the R6 substituent and R7 substituent, taken together with the carbon atoms to which they are bonded, independently form a substituted or unsubstituted ring containing 3, 4, 5, 6, 7, 8, or 9 atoms.
In some embodiments of the compound, the R1 substituent and R2 substituent and/or the R6 substituent and R7 substituent, taken together with the carbon atoms to which they are bonded, independently form a substituted or unsubstituted ring containing 6 atoms.
In some embodiments of the compound, each R3, R4, R5, R1, R9, and R10 is independently selected from the group consisting of H and methyl.
In some embodiments the compound has the following formula:
In some embodiments of the compound, Q is selected from the group consisting of C(alkyl)2, NH, N(alkyl), O, S, SO2, Si(alkyl)2, P(O)(aryl), P(O)(alkyl), PO 2H, PO 2(alkyl), Se, and replaced with two H atoms.
In some embodiments of the compound, R6 is selected from the group consisting of H, D, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), N3, NH2, NH(alkyl), N(alkyl)2, NH(aryl), N(aryl)2, NO2, CHO, C(O)(alkyl), C(O)(aryl), COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)NH(aryl), PO 3H2, SO3H, alkyl and substituted alkyl, aryl and substituted aryl, alkenyl and substituted alkenyl, alkynyl or substituted alkynyl, or where the R6 substituent and R7 substituent, taken together with the carbon atoms to which they are bonded, independently form a substituted or unsubstituted ring containing 3, 4, 5, 6, 7, 8, or 9 atoms.
In some embodiments of the compound, R7 is selected from the group consisting of H, alkyl, deuterated alkyl, and aryl, so long as when Q=C(CH3)2 and R8, R9, and R10 are methyl, then R7 cannot be methyl.
In some embodiments of the compound, each R1, R9, and R10 is independently selected from the group consisting of H and alkyl.
In some embodiments of the compound, Z is selected from the group consisting of C(O), COOH, COO−, SO3−, PO 32−, or CR3 where each R is independently selected from the group consisting of H, OH, alkyl, and substituted alkyl.
In some embodiments of the compound, X is selected from the group consisting of H, alkyl, substituted alkyl, aryl, substituted aryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, CN, COOH, COO−, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)N(alkyl)2, C(O)NH(aryl), C(O)N(aryl)2, PO 3H2, and SO3H.
In some embodiments the compound has a structure selected from the following:
In some embodiments of the compound, X is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, CN, COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)N(alkyl)2, C(O)NH(aryl), C(O)N(aryl)2.
In some embodiments of the compound, X is selected from the group consisting of
The presently-disclosed subject matter further includes a method for detecting a target substance as disclosed herein. In some embodiments, the method includes contacting a sample with a compound as disclosed herein.
In some embodiments of the detection method, the target substance is selected from a protein, a carbohydrate, a polysaccharide, a glycoprotein, a hormone, a receptor, an antigen, an antibody, a virus, a substrate, a metabolite, an inhibitor, a drug, a nutrient, a growth factor, a liprotein, and a combination thereof.
In some embodiments of the method, the detecting step is performed with a microscope. In some embodiments, the contact step and the detecting step are performed in a live cell.
Some embodiments of the method include contacting the sample with a first compound as disclosed herein and a second compound as disclosed herein, wherein the first compound is selective for a first target substance and capable of emitting a first emission light, the second compound is selective for a second target substance and capable of emitting a second emission light, and the detecting step includes detecting the first emission light that indicates the presence of the first target substance and the second emission light that indicates the presence of the second target substance.
The presently-disclosed subject matter further includes a method of making a compound, including an intermediate compound, as disclosed herein.
In some embodiments, the method of making a compound comprises preparation of diarylether and diarylsilane intermediates, as disclosed herein.
In some embodiments, the method of making a compound comprises rhodamine synthesis via lactol (phthalaldehydic acid) condensation, as disclosed herein.
In some embodiments, the method of making a compound comprises preparation of 2,2−diarylpropane intermediates, as disclosed herein.
In some embodiments, the method of making a compound comprises preparation of anthrone intermediates, as disclosed herein.
In some embodiments, the method of making a compound comprises xanthene synthesis via lithiation of tetrafluorobenzoic acid, as disclosed herein.
In some embodiments, the method of making a compound comprises synthesis of carborhodamines via AlCl3 Condensation, as disclosed herein.
In some embodiments, the method of making a compound comprises rhodamine 110 and N-aryl rhodamine synthesis via cross-coupling, as disclosed herein.
In some embodiments, the method of making a compound comprises MAC substitution of 4,5,6,7−tetrafluoroxanthenes, as disclosed herein.
In some embodiments, the method of making a compound comprises conversion of MAC xanthenes to HaloTag® ligands, as disclosed herein.
In some embodiments, the method of making a compound comprises synthesis of HaloTag® and SNAP-tag® Ligands, as disclosed herein.
While the terms used herein are believed to be well understood by those of ordinary skill in the art, certain definitions are set forth to facilitate explanation of the presently-disclosed subject matter.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as is commonly understood by one of skill in the art to which the invention(s) belong.
All patents, patent applications, published applications and publications, GenBank sequences, databases, websites and other published materials referred to throughout the entire disclosure herein, unless noted otherwise, are incorporated by reference in their entirety.
Where reference is made to a URL or other such identifier or address, it understood that such identifiers can change and particular information on the internet can come and go, but equivalent information can be found by searching the internet. Reference thereto evidences the availability and public dissemination of such information.
As used herein, the abbreviations for any protective groups, amino acids and other compounds, are, unless indicated otherwise, in accord with their common usage, recognized abbreviations, or the IUPAC-IUB Commission on Biochemical Nomenclature (see, Biochem. (1972) 11(9):1726-1732).
Although any methods, devices, and materials similar or equivalent to those described herein can be used in the practice or testing of the presently-disclosed subject matter, representative methods, devices, and materials are described herein.
Following long-standing patent law convention, the terms “a”, “an”, and “the” refer to “one or more” when used in this application, including the claims. Thus, for example, reference to “a cell” includes a plurality of such cells, and so forth.
Unless otherwise indicated, all numbers expressing quantities of ingredients, properties such as reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about”. Accordingly, unless indicated to the contrary, the numerical parameters set forth in this specification and claims are approximations that can vary depending upon the desired properties sought to be obtained by the presently-disclosed subject matter.
As used herein, the term “about,” when referring to a value or to an amount of mass, weight, time, volume, concentration or percentage is meant to encompass variations of in some embodiments ±20%, in some embodiments ±10%, in some embodiments ±5%, in some embodiments ±1%, in some embodiments ±0.5%, in some embodiments ±0.1%, in some embodiments ±0.01%, and in some embodiments ±0.001% from the specified amount, as such variations are appropriate to perform the disclosed method.
As used herein, ranges can be expressed as from “about” one particular value, and/or to “about” another particular value. It is also understood that there are a number of values disclosed herein, and that each value is also herein disclosed as “about” that particular value in addition to the value itself. For example, if the value “10” is disclosed, then “about 10” is also disclosed. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.
The term “absorption wavelength” as used herein refers to the wavelength of light capable of being absorbed by a compound in order to excite the compound to emit a light. The light emitted from a compound that has been excited with an absorption light will have an “emission wavelength.”
The present application can “comprise” (open ended) or “consist essentially of” the components of the present invention as well as other ingredients or elements described herein. As used herein, “comprising” is open ended and means the elements recited, or their equivalent in structure or function, plus any other element or elements which are not recited. The terms “having” and “including” are also to be construed as open ended unless the context suggests otherwise.
As used herein, the term “derivative” refers to a compound having a structure derived from the structure of a parent compound (e.g., a compounds disclosed herein) and whose structure is sufficiently similar to those disclosed herein and based upon that similarity, would be expected by one skilled in the art to exhibit the same or similar activities and utilities as the claimed compounds, or to induce, as a precursor, the same or similar activities and utilities as the claimed compounds.
The term “detect” is used herein to refer to the act of viewing, imagining, indicating the presence of, measuring, and the like a target substance based on the light emitted from the present compounds. More specifically, in some instances the present compounds can be bound to a target substance, and, upon being exposed to an absorption light, will emit an emission light. The presence of an emission light can indicate the presence of a target substance, whereas the quantification of the light intensity can be used to measure the concentration of a target substance.
As used herein, the term “protein” means any polymer comprising any of the 20 protein amino acids, regardless of its size. Although “polypeptide” is often used in reference to relatively large proteins, and “peptide” is often used in reference to small proteins, usage of these terms in the art overlaps and varies. The term “protein” as used herein refers to peptides, polypeptides and proteins, unless otherwise noted.
With regard to the term “salt,” as used herein, as will be appreciated by one of ordinary skill in the art, a compound disclosed herein can be provided as an inner salt, where the multi-ring system is positively charged and the substituted pendant phenyl ring has a negative charge. Alternatively, a compound disclosed herein can be provided where the multi-ring system is positively charged, the pendant phenyl ring is not charged, and a counter ion is provided making the compound a salt. Accordingly, unless otherwise apparent, structures as provided herein are inclusive of inner salts and salts of the compound/counter ion. Placing either the inner salt or compound/counter ion salt in water will cause any ions to dissociate yielding the same inner salt species in solution.
The term “selectively bind” is used herein to refer to the property of an atom, moiety, and/or molecule preferentially being drawn to or binding a particular compound. In some instances the atom, moiety, and/or molecule selectively binds to a particular site on a compound, such as an active site on a protein molecule.
As used herein, the term “substituted” is contemplated to include all permissible substituents of organic compounds. In a broad aspect, the permissible substituents include acyclic and cyclic, branched and unbranched, carbocyclic and heterocyclic, and aromatic and nonaromatic substituents of organic compounds. Illustrative substituents include, for example, those described below. The permissible substituents can be one or more and the same or different for appropriate organic compounds. For purposes of this disclosure, the heteroatoms, such as nitrogen, can have hydrogen substituents and/or any permissible substituents of organic compounds described herein which satisfy the valences of the heteroatoms. This disclosure is not intended to be limited in any manner by the permissible substituents of organic compounds.
Also, the terms “substitution” or “substituted with” include the implicit proviso that such substitution is in accordance with permitted valence of the substituted atom and the substituent, and that the substitution results in a stable compound, e.g., a compound that does not spontaneously undergo transformation such as by rearrangement, cyclization, elimination, etc. Unless stated otherwise, all chemical groups described herein include both unsubstituted and substituted varieties.
Where substituent groups are specified by their conventional chemical formula written from left to right, they equally encompass the chemically identical substituents that would result from writing the structure from right to left. For instance, —CH2O— also encompasses recite —OCH2—.
It should be understood that the bond types and locations in the chemical structures provided herein may adapt depending on the substituents in the compound, even if not specifically recited. For instance, —X— where X can be either C or N can refer to, respectively, —CH2— or —NH—, where the lone pair of electrons on N is not illustrated. Thus, even if not specifically illustrated, the chemical compounds described herein include any hydrogen atoms, lone pair of electrons, and the like necessary for completing a chemical structure.
The term “target substance” refers to a substance that is selectively bound directly by the presently-disclosed compounds and/or indirectly by a molecule that is bound to the present compound. A target substances can include, but is not limited to, a protein, carbohydrates, polysaccharide, glycoprotein, hormone, receptor, antigen, antibody, virus, substrate, metabolite, inhibitor, drug, nutrient, growth factor, and the like. In some embodiments the target substance refers to an entire molecule, and in other embodiments the target substances refers to a site on a molecule, such as a binding site on a particular protein.
The term “alkyl” as used herein is a branched or unbranched saturated hydrocarbon group of 1 to 24 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, n-pentyl, isopentyl, s-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, eicosyl, tetracosyl, and the like. The alkyl group can be cyclic or acyclic. The alkyl group can be branched or unbranched. The alkyl group can also refer to both substituted or unsubstituted alkyls. For example, the alkyl group can be substituted with one or more groups including, but not limited to, optionally substituted alkyl, cycloalkyl, alkoxy, amino, ether, halide, hydroxy, nitro, silyl, sulfo-oxo, or thiol, as described herein. A “lower alkyl” group is an alkyl group containing from one to six (e.g., from one to four) carbon atoms.
Throughout the specification “alkyl” is generally used to refer to both unsubstituted alkyl groups and substituted alkyl groups; however, substituted alkyl groups are also specifically referred to herein by identifying the specific substituent(s) on the alkyl group. For example, the term “halogenated alkyl” specifically refers to an alkyl group that is substituted with one or more halide, e.g., fluorine, chlorine, bromine, or iodine. The term “alkoxyalkyl” specifically refers to an alkyl group that is substituted with one or more alkoxy groups, as described below. The term “alkylamino” specifically refers to an alkyl group that is substituted with one or more amino groups, as described below, and the like. When “alkyl” is used in one instance and a specific term such as “alkylalcohol” is used in another, it is not meant to imply that the term “alkyl” does not also refer to specific terms such as “alkylalcohol” and the like.
This practice is also used for other groups described herein. That is, while a term such as “cycloalkyl” refers to both unsubstituted and substituted cycloalkyl moieties, the substituted moieties can, in addition, be specifically identified herein; for example, a particular substituted cycloalkyl can be referred to as, e.g., an “alkylcycloalkyl.” Similarly, a substituted alkoxy can be specifically referred to as, e.g., a “halogenated alkoxy,” a particular substituted alkenyl can be, e.g., an “alkenylalcohol,” and the like. Again, the practice of using a general term, such as “cycloalkyl,” and a specific term, such as “alkylcycloalkyl,” is not meant to imply that the general term does not also include the specific term. The term “alkyl” is inclusive of “cycloalkyl.”
The term “cycloalkyl” as used herein is a non-aromatic carbon-based ring composed of at least three carbon atoms. Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, norbornyl, and the like. The term “heterocycloalkyl” is a type of cycloalkyl group as defined above, and is included within the meaning of the term “cycloalkyl,” where at least one of the carbon atoms of the ring is replaced with a heteroatom such as, but not limited to, nitrogen, oxygen, sulfur, or phosphorus. The cycloalkyl group and heterocycloalkyl group can be substituted or unsubstituted. The cycloalkyl group and heterocycloalkyl group can be substituted with one or more groups including, but not limited to, optionally substituted alkyl, cycloalkyl, alkoxy, amino, ether, halide, hydroxy, nitro, silyl, sulfo-oxo, or thiol as described herein.
In this regard, the term “heterocycle,” as used herein refers to single and multi-cyclic aromatic or non-aromatic ring systems in which at least one of the ring members is other than carbon. Heterocycle includes pyridinde, pyrimidine, furan, thiophene, pyrrole, isoxazole, isothiazole, pyrazole, oxazole, thiazole, imidazole, oxazole, including, 1,2,3−oxadiazole, 1,2,5-oxadiazole and 1,3,4−oxadiazole, thiadiazole, including, 1,2,3−thiadiazole, 1,2,5−thiadiazole, and 1,3,4−thiadiazole, triazole, including, 1,2,3−triazole, 1,3,4−triazole, tetrazole, including 1,2,3,4-tetrazole and 1,2,4,5−tetrazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, including 1,2,4−triazine and 1,3,5−triazine, tetrazine, including 1,2,4,5−tetrazine, pyrrolidine, piperidine, piperazine, morpholine, azetidine, tetrahydropyran, tetrahydrofuran, dioxane, and the like.
The terms “alkoxy” and “alkoxyl” as used herein to refer to an alkyl or cycloalkyl group bonded through an ether linkage; that is, an “alkoxy” group can be defined as —OA1 where A1 is alkyl or cycloalkyl as defined above. “Alkoxy” also includes polymers of alkoxy groups as just described; that is, an alkoxy can be a polyether such as —OA1−OA2 or —OA1-(OA2)a—OA3, where “a” is an integer of from 1 to 200 and A1, A2, and A3 are alkyl and/or cycloalkyl groups.
The term “alkenyl” as used herein is a hydrocarbon group of from 2 to 24 carbon atoms with a structural formula containing at least one carbon-carbon double bond. The term is include of linear and ring-forming (i.e., cycloakenyl) groups. Asymmetric structures such as (A1A2)C═C(A3A4) are intended to include both the E and Z isomers. This can be presumed in structural formulae herein wherein an asymmetric alkene is present, or it can be explicitly indicated by the bond symbol C═C. The alkenyl group can be substituted with one or more groups including, but not limited to, optionally substituted alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, aldehyde, amino, carboxylic acid, ester, ether, haide, hydroxy, ketone, azide, nitro, silyl, sulfo-oxo, or thiol, as described herein.
The term “aryl” as used herein is a group that contains any carbon-based aromatic group including, but not limited to, benzene, naphthalene, phenyl, biphenyl, phenoxybenzene, and the like. The term “aryl” also includes “heteroaryl,” which is defined as a group that contains an aromatic group that has at least one heteroatom incorporated within the ring of the aromatic group. Examples of heteroatoms include, but are not limited to, nitrogen, oxygen, sulfur, and phosphorus. Likewise, the term “non-heteroaryl,” which is also included in the term “aryl,” defines a group that contains an aromatic group that does not contain a heteroatom. The aryl group can be substituted or unsubstituted. The aryl group can be substituted with one or more groups including, but not limited to, optionally substituted alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, aldehyde, amino, carboxylic acid, ester, ether, halide, hydroxy, ketone, azide, nitro, silyl, sulfo-oxo, or thiol as described herein. The term “biaryl” is a specific type of aryl group and is included in the definition of “aryl.” Biaryl refers to two aryl groups that are bound together via a fused ring structure, as in naphthalene, or are attached via one or more carbon-carbon bonds, as in biphenyl.
The term “ring” as used herein refers to a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl. A ring includes fused ring moieties, referred to as a fused ring system wherein a ring may be fused to one or more rings selected from a substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl in any combination. The number of atoms in a ring is typically defined by the number of members in the ring. For example, a “5- to 8-membered ring” means there are 5 to 8 atoms in the encircling arrangement. A ring can optionally include a heteroatom. The term “ring” further includes a ring system comprising more than one “ring”, wherein each “ring” is independently defined as above.
Some of the unsaturated structures described herein, such as ring structures including cycloalkyl and aryl, are illustrated with dashed bonds to signify the potential existence of a resonance structure. Structures having dashed bonds are intended to reflect every possible configuration of the structure, but does not necessarily imply that all possible structures are in existence. It should be understood that the types of bonds (e.g., single bond, double bond) in such structures will vary depending on the atoms in the structure as well as whether the structures are substituted with one or more additional atoms or moieties.
The term “aldehyde” as used herein is represented by a formula C(O)H. Throughout this specification “C(O)” is a short hand notation for a carbonyl group, i.e., C═O.
The terms “amine” or “amino” as used herein are represented by a formula NA1A2A3, where A1, A2, and A3 can be, independently, hydrogen or optionally substituted alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein. In specific embodiments amine refers to any of NH2, NH(alkyl), NH(aryl), N(alkyl)2, and N(aryl)2.
The term “carboxylic acid” as used herein is represented by a formula C(O)OH.
The term “halide” or “halogen” refers to at least one of the halogens selected from fluorine, chlorine, bromine, and iodine.
As used herein, “optional” or “optionally” means that the subsequently described event or circumstance does or does not occur and that the description includes instances where said event or circumstance occurs and instances where it does not. For example, an optionally variant portion means that the portion is variant or non-variant.
The presently-disclosed subject matter is further illustrated by the following specific but non-limiting examples. The following examples may include compilations of data that are representative of data gathered at various times during the course of development and experimentation related to the present invention.
Rhodamine dyes bearing an ortho-carboxyl substituent on the pendant phenyl ring exist in equilibrium between a lipophilic lactone (L) and fluorescent zwitterion (Z). The lactone-zwitterion equilibrium constant (KL-Z) can be used to rationalize the performance of rhodamine dyes in biological systems (
Four different classes of dyes were categorized based on KL-Z. First, rhodamines with very low KL-Z values are colorless and not useful for biological imaging. Second, rhodamines with slightly higher KL-Z values also preferentially lactonize in aqueous solution but have some propensity to adopt the zwitterionic form. Such dyes can be used to fashion chromogenic compounds; the change in environment that accompanies dye ligand binding shifts the equilibrium to the zwitterionic form.15, 16 Third, dyes with modestly higher KL-Z values mostly adopt the zwitterionic form in aqueous solution but can lactonize in hydrophobic environments; ligands based on these fluorophores often show improved membrane permeability making them more bioavailable.16 Finally, fluorophores with large KL-Z values exhibit high absorptivity, making them bright, environmentally insensitive labels.14 Understanding the KLZ trends of a particular dye scaffold and tuning this property through structural modifications can allow optimization of fluorescent labels for biological imaging experiments.
Fluorination of the pendant phenyl ring increases the KL-Z of azetidine-containing rhodamine dyes. For example, Janelia Fluor 646 (JF646, 1;
Fluorinated phenyl rings also enable facile derivatization of rhodamine dyes using Yamamoto's masked acyl cyanide (MAC) reagent concept.22 In this umpolung approach a 2-hydroxymalononitrile MAC reagent is used with a methoxymethyl ether (MOM) protecting group (3;
In previous work, the structure-activity relationships governing KL-Z, the effect of fluorination, and the generality of the MAC chemistry were investigated for a limited set of rhodamine dyes containing four-membered azetidine substituents.16 As disclosed herein, thinking outside the azetidine “box” and dyes containing different auxochromes are explored. Different synthetic methods were investigated to prepare rhodamine and related dyes, expanding several known routes and developing a new, succinct strategy for preparing fluorinated dyes using Li/H exchange. This suite of methods was used to synthesize a comprehensive collection of fluorinated and nonfluorinated rhodamine dyes with different nitrogen substituents. Evaluation of the properties of these known and unique molecules reveal that the range of accessible KL-Z values within a given rhodamine scaffold is strongly dependent on the identity of the auxochrome group. Despite these large differences in lactone-zwitterion equilibrium, fluorination universally increases KL-Z regardless of dye structure. For rhodamines bearing electron-donating julolidine substituents, which exhibit high KL-Z values, incorporation of fluorine substituents results in a bathochromic shift and increased absorptivity, yielding bright, red-shifted fluorophores useful for multicolor imaging and live-cell single-particle tracking (SPT). For dyes containing electron-withdrawing aniline substituents, fluorination improves chromogenicity, giving a live-cell compatible Forster resonance energy transfer (FRET) quencher dye that is useful for fluorescence lifetime imaging microscopy (FLIM). Together, this work expands the synthetic methods available for rhodamine synthesis, demonstrates the practicability of KL-Z tuning beyond azetidine-containing dyes, and yields new probes with improved properties for advanced fluorescence imaging experiments such as SPT and FLIM.
Different methods were considered for constructing rhodamine dyes, focusing on the synthesis of the less-explored fluorinated derivatives. In prior work16 fluorinated rhodamines were made using a synthetic approach14, 35-37 where a di(bromoarene) undergoes metal/Br exchange and addition to tetrafluorophthalic anhydride (4) to yield fluorinated rhodamine dyes (Scheme 1A: metal/Br exchange). This complements the standard method of fluorinated rhodamine synthesis involving protic or Lewis acid-catalyzed condensation of 3−aminophenols and 4 (Scheme 1B: acid-catalyzed condensation).38, 39
In addition to these established methods to construct dyes with fluorinated phenyl systems, consideration was given to repurposing other strategies for fluorinated rhodamine synthesis. These include the Pd-catalyzed cross-coupling using fluorescein ditriflates40, 41 (Scheme 1C: Pd-catalyzed cross-coupling) and the oxidative condensation of phthalaldehydic acids with 3−aminophenols or diphenyl ethers42 (Scheme 1D: lactol condensation and oxidation). Neither method has been used to make fluorinated rhodamines, but it was surmised that use of fluorinated fluorescein ditriflates or tetrafluorophthalaldehydic acid (5), respectively, could allow synthesis of the desired compounds. A unique strategy was also considered to prepare fluorinated dyes by lithiation of 2,3,4,5−tetrafluorobenzoic acid43 (6) and addition to substituted xanthone derivatives and their congeners (Scheme 1E: Li/H exchange). The scope of each synthetic method was set out to be explored, evaluating of the utility of these strategies to prepare standard oxygen-containing rhodamines, Si-rhodamines, and carborhodamines along with related dyes based on fluoresceins and Malachite Green.
The reaction of aminophenols with partially reduced phthalic anhydrides (phthalaldehydic acids) in the presence of O2 was considered first (Scheme 1D). This recently described strategy42 is an efficient and versatile method for the regioselective synthesis of rhodamine dyes including carboxy derivatives but has not been applied to fluorinated dyes. The shorthand term “lactol condensation” is used to refer to this approach, as phthalaldehydic acids mostly adopt the closed, 3−hydroxyphthalide (lactol) form in solution.44 This strategy was compared with previously described methods of rhodamine synthesis. Metal/bromide exchange of the dibromide 7 (Scheme 2) and addition to tetrafluorophthalic anhydride (4) afforded the unique deuterated dye 8 in 34% yield (Scheme 3); this fluorophore was named “JFX576” due to the deuterium substitution45 and its absorption maximum in aqueous solution. Reaction of diphenyl ether 9 (Scheme 2a) with tetrafluorolactol 5 in 2,2,2−trifluoroethanol (TFE) allowed convenient access to 8 in higher yield (85%), demonstrating the utility of this lactol chemistry in making fluorinated rhodamines.
This lactol condensation strategy was then compared with the classic acid-catalyzed reaction method, which remains the most common protocol for rhodamine synthesis but shows variable results when preparing fluorinated rhodamines.38, 39 Reaction of dihydro-quinoline 10 with 4 in refluxing propionic acid gave rhodamine 11 in low yield (8%; Scheme 3); other condensation reaction conditions were unsuccessful (Table 1). This is consistent with previous reports of the synthesis of 11,38′39 where the dye was prepared in low yield using standard acid-mediated chemistry. The lactol strategy proved superior, with diphenyl ether 12 (Scheme 2b) reacting with 5 to give 11 in 66% yield (Scheme 3).
a11 slowly decomposes with extended reaction time under these conditions to afford a mixture of several other products, most notably the analog resulting from protodecarboxylation of the ortho-carboxyl group.
The generality of the lactol synthesis was then explored for other fluorinated rhodamine dyes (Scheme 4). In addition to diphenyl ethers such as 12, 3−aminophenol derivatives were also accommodated by this chemistry. Reaction of 7-hydroxytetrahydroquinoline (13) with 5 afforded the 4,5,6,7−tetrafluoro-Q-rhodamine (FRhQ, 14). 8-Hydroxyjulolidine (15) reacted with 5 to give the fluorinated derivative of rhodamine 101 (FRh101, 16).46, 47 Diphenyl ether 17 (Scheme 2b) produced 18, a fluorinated analog of ATTO 550 that was called “Janelia Fluor” 563 (JF563). Finally, reaction of 5 and ether 19 (Scheme 2b) gave 20, the des-methyl analog of compound 11.38 Reactions using the secondary amine reactants 13, 17, and 19 afforded lower yields (27-57%) than those using the fully substituted anilines 9, 12, and 15 (66-85%; Scheme 3, Scheme 4), likely due to side reactions involving the secondary amine and the aldehyde tautomer of 5. Several nonfluorinated analogs of these dyes were also prepared using the lactol condensation (Scheme 5).
Substitution of the xanthene oxygen in rhodamines for a silicon moiety causes a substantial bathchromic shift of ˜100 nm, making Si-rhodamines useful fluorophores that are excited by long-wavelength light.21, 29, 31-34, 48-50 This substitution also decreases the KL-Z compared to standard oxygen-containing rhodamine dyes. As mentioned above, some Si-rhodamines such as JF646 (1;
Given the utility of JF669, the condensation of fluorinated lactol 5 was investigated to synthesize fluorinated Si-rhodamine dyes, again comparing this chemistry to the bis(arylmetal) addition strategy (Scheme 6). This lactol condensation approach has not been used to make any Si-rhodamines, fluorinated or otherwise. As described previously, metal/bromide-exchange of dibromide 21 and addition to anhydride 4 gives the fluorinated derivative of Si-tetramethylrhodamine29 (SiRF667; 22) in moderate yield (52%).
Application of the published protocol42 for the lactol condensation using 2,2,2-trifluoroethanol (TFE) at 80° C. and a concentration of 0.05 M (Scheme 3, Scheme 4) gave poor yields of the silicon-containing variants. To remedy this problem, different reaction conditions were explored using diarylsilane 23 as a model reactant (Table 2). Replacing TFE with the higher-boiling solvent 2,2,3,3,4,4,4−heptafluoro-1−butanol (HFB) allowed reaction at elevated temperature (95° C.).
This solvent change, combined with performing the condensation at higher concentration (0.2-0.3 M), afforded Si-rhodamine 22 in a similar yield (58%) to the more operationally complex reaction involving the bis(arylmetal) species (Scheme 6). Reaction of the pyrrolidine-d8−containing dibromide 24 (Scheme 2a) with 4 produced fluorophore 25 (JFX673) in 50% yield; synthesis of the same dye via the straightforward condensation of silane 26 (Scheme 2a) and lactol 5 gave a higher yield (64%).
aTFE = 2,2,2-trifluoroethanol;
The investigation of the lactol condensation chemistry was expanded to synthesize other fluorinated Si-rhodamines (Scheme 7). As with oxygen-containing rhodamines (Scheme 4), the use of secondary amine reactants gave lower yields of fluorophore products. This problem prompted protection of the aniline nitrogens in some cases to mitigate side reactions driven by the higher reaction temperature.
N-Benzyl-protected silane 27 (Scheme 2c) gave Si-rhodamine 28 in 42% yield; hydrogenation of 28 yielded the fluorinated Si-Q-rhodamine (FSiRhQ, 29). Compound 30 (Scheme 2c) combined with 5 to furnish dye 31, which was called “JF698”, albeit in very low yield (2%) due to competing protodesilylation of 30. These conditions were also used to prepare the silicon analogs of rhodamines 11, 18, and 20 (Scheme 3, Scheme 4). Condensation of 32 (Scheme 2c) with 5 afforded dibenzyl dye 33 in 41% yield, which was deprotected to give Si-rhodamine 34. Direct reaction of 35 (Scheme 2c) provided a 15% yield of dye 36; here, the dihydroquinoline moieties precluded use of N-benzyl protecting groups, which resulted in the relatively low yield. Reaction of silane 37 (Scheme 2c) and phthalaldehydic acid 5 formed Si-rhodamine 38 (47% yield). Attempts to synthesize dihydroquinoline dyes such as 38 via the dibromide/bis(arylmetal) route failed. The yields for some of these reactions were modest and, in a few cases-most notably JF698 (31) the dibromide strategy gave better results (Scheme 8). Nonetheless, these optimized, simple conditions using HFB and elevated temperature were general for the synthesis of fluorinated dyes and also useful for expediently accessing various nonfluorinated Si-rhodamines (Scheme 5).
The synthesis of a unique class of fluorophore were then explored: carbon-containing analogs of rhodamines and fluoresceins bearing a fluorinated pendant phenyl ring. Relative to the standard oxygen-bridged rhodamine dyes, the gem-dimethyl carbon substituent elicits a ˜60 nm bathochromic shift in absorption and emission wavelengths and a shift towards lower KL-Z values.41, 51, 52 As with other rhodamines, fluorination of carborhodamines should elicit a further bathochromic shift in λabs and λem and increase KL-Z, leading to higher absorptivity. An initial attempt was made to access fluorinated carborhodamines using dibromide starting materials (Scheme 1A) or using the lactol condensation chemistry (Scheme 1D, Scheme 9)
Li/Br-exchange of deuterated dibromide 39 (Scheme 10a) and addition to tetrafluorophthalic anhydride 4 gave carborhodamine 40 (JFX637) in modest yield (39%). This route was complicated by the longer, lower-yielding, and relatively complex synthesis of 39 compared to those of the oxygen and silicon dibromides (e.g., 7 and 24; Scheme 3, Scheme 6). Use of the lactol condensation conditions to react 41 (Scheme 10a) with 5 was unsuccessful, yielding only a small amount (<2%) of dye 40 even after extended reaction time (>72 h).
These issues with existing synthetic methods prompted consideration of a unique method to prepare carborhodamine dyes. In previous work, carbofluoresceins were synthesized by reacting aryl Grignards with dihydroxyanthrones; these could be converted to carborhodamines using Pd-catalyzed cross-coupling.41 The use of a Grignard was necessary to accommodate t-butyl-protected carboxyl groups, but this arylmagnesium species was not reactive enough to add to more electron-rich diaminoanthrones and directly generate rhodamine dyes.32 Aryllithium reagents are more commonly used for addition to diaminoanthrones due to their increased nucleophilicity, which limits functional group compatibility. Aside from one recent example,53 all existing syntheses of carboxy-substituted carbo- and Si-rhodamines involve lithium/bromide exchange on a rigorously protected phthalic acid equivalent and addition of the resulting aryllithium species to a diaminoanthrone.29-34 It was surmised that later-stage incorporation of the 6−carboxyl group using the MAC chemistry approach would minimize protecting group issues and simplify the use of the more reactive aryllithium reagents; the bespoke fluorinated phenyl ring could also facilitate the exchange, transmetalation, or deprotonation needed to form the desired organometallic species. Nonetheless, previous attempts to generate tetrafluoroaryllithium reagents containing protected 2−carboxyl groups via metal/halide exchange have proven unsuccessful.21 Direct metalation (i.e, deprotonation or Li/H-exchange) of unprotected 2,3,4,5−tetrafluorobenzoic acid (6) with 2 equivalents of n-butyllithium43 (SCHEME 1E) generated a dianionic aryllithium species that underwent facile addition to anthrone 42 (Scheme 11a), affording deuterated rhodamine JFX637 (40) in higher yield (57%) compared to the other two synthetic methods (Scheme 9).
This new Li/H exchange approach was then applied to prepare other fluorinated dyes. Use of anthrone 43 (Scheme 11a) gave the unique azetidinyl dye 44 (JF632; Scheme 12) in reasonable yield (53%). The dibenzyl anthrone 45 (Scheme 11b) afforded compound 46, which could be deprotected to yield 4,5,6,7−tetrafluoro-carbo-Q-rhodamine (FCRhQ, 47). Similarly, reaction of Michler's ketone (48) with the dianion of 6 furnished the fluorinated analog of Malachite Green lactone (FMGL; 49) in excellent yield (80%).
This chemistry could also be used to synthesize fluorescein analogs though a two-step, high-yielding protocol (77-94%; Scheme 13). Addition of lithiated 6 to di(silyloxy)anthrone 50 yielded the fluorinated carbofluorescein 51 after TBS deprotection with TBAF. Use of anthrone 52 in this sequence gave highly fluorinated 53, an analog of Virginia Orange.54 This method could be extended to Si-anthrone 54 to provide the known, 14 pH-sensitive, fluorinated Si-fluorescein 55 in high yield. These examples demonstrate the broad scope of 2,3,4,5−tetrafluorobenzoic acid (6) lithiation/addition in the synthesis of both rhodamine and fluorescein dyes (Scheme 14).
The collection of fluorinated carborhodamines was further expanded. Although the dibromide and site-selective lithiation routes (Scheme 1A,E) give good yields of carborhodamine dyes with compact substituents such as pyrrolidine and azetidine (Scheme 9, Scheme 12), this chemistry proved ineffective for dyes with highly substituted, fused-ring auxochromes such as those derived from reduced quinolines or julolidine.34, 55 Inspired by a brief report in the patent literature,56 a different approach was explored, returning to classic acid-catalyzed chemistry but using the Lewis acid AlCl3 (Scheme 15).
Reaction of bis-julolidine 56 (Scheme 10a) with tetrafluorophthalic anhydride (4) in the presence of AlCl3 afforded a 68% yield of the fluorinated carbon-containing analog of rhodamine 101 (JF660, 57). Likewise, AlCl3−mediated condensation of 58 (Scheme 10b) and 4 gave 59, a fluorinated analog of ATTO 647N, in excellent yield (80%). High-yielding syntheses of the des-fluoro analogs of rhodamines 57 and 59 was also achieved using this chemistry (Scheme 16). In contrast, all attempts to synthesize 57 or 59 through addition of lithiated 6 to anthrones containing a julolidine motif57 or via dibromination of 56 or 58 failed to provide appreciable amounts of the desired carborhodamine products.
As will be appreciated upon study of this document, in Scheme 16 and in other Schemes set forth herein, X is defined as F, H, or a combination thereof. As is apparent from consideration to the disclosure as a whole, the compounds and methods of making such compounds are inclusive of those in which each X is independently selected from F and H.
In a prior report cross-coupling of fluorescein ditriflates with amines was demonstrated as an efficient method to synthesize rhodamine dyes.40 Nevertheless, use of the known19 4,5,6,7−tetrafluorofluorescein (60) or analogs such as 51, 53, and 55 (Scheme 13) requires special considerations due to the electrophilicity of the perfluorinated arene. Cross-coupling reactions using primary or secondary aliphatic amine partners were unsuccessful due to facile substitution reactions by these nucleophilic species on the tetrafluoroaryl moiety16, 58, 59 under the requisite reaction conditions (Cs2CO3, 80-100° C.). Less nucleophilic aromatic amines or N-acyl derivatives are compatible with these conditions, however, allowing the synthesis of unique dyes (Scheme 17).
Reaction of 60, the carbon-containing analog 51, and Si-fluorescein 55 with triflic anhydride yielded ditriflates 61-63. Cross-coupling with N-methylaniline provided the N-arylrhodamines 64-66. Likewise, diacylrhodamines 67-69 were accessed in nearly quantitative yield through cross-coupling of the fluorescein ditriflates with t-butyl carbamate. Deprotection of the t-Boc groups with TFA gave rhodamine 110 derivatives 70 (FRh110), 71 (FCRh110), and 72 (FSiRh110). Fluorinated rhodamine 110 variants are largely unknown, with only a brief report in the patent literature38 detailing the synthesis of 4,5,6,7−tetrafluoro-Rh110 (70) in low yield (˜5%) through an acid-catalyzed synthesis. These results demonstrate that fluorinated fluorescein ditriflates can be used in cross-coupling reactions, albeit with a reduced scope limited to less nucleophilic nitrogen reactants.
Combined with previous investigations,14, 16-18, 32, 40, 41, 45 the work described herein (Schemes 1, 3, 4, 6, 8, 9, 12, 13, 15, and 17 and Schemes 5, 14, and 16) represents a comprehensive collection of fluoresceins and rhodamines containing 0, C, or Si bridging substituents, fluorinated or nonfluorinated pendant phenyl rings, and different auxochrome groups. The investigation of their spectral properties was initiated by examining the fluorescein variants, measuring λabs, λem, extinction coefficient (ε), and fluorescence quantum yield (Φf) of each dye (Table 3 and
Consistent with previous work describing 4,5,6,7−tetrafluorofluorescein (60)19 and 4,5,6,7−tetrafluoro-Si-fluorescein (55),14 the tetrafluorophenyl ring system in dyes 51 and 53 elicited a >15 nm bathochromic shift in λabs and λem and a lower pKa relative to the parent carbofluorescein (74) and Virginia Orange (78) dyes. Fluorophores 51 and 53 showed a noncooperative pH-driven transition with ηH≈1. This is in contrast to the behavior of carbofluoresceins 74 and 78, which do not contain the perfluorinated ring system and show cooperative transitions (ηH>1) from a colored to colorless species as pH decreases.41, 54 The Si-fluoresceins 55 and 80 maintain a cooperative pH titration even with the fluorinated ring system installed. These data reveal a subtle interplay between the nucleophilicity of the ortho-carboxyl group and the propensity of the dye to lactonize that controls the cooperative quinoid→lactone transition upon protonation. This understanding will help guide the future development of pH sensors based on red-shifted fluorescein analogs.41, 54, 60
The rhodamines (Table 4,
This modification also modestly increases e and decreases Of. The lower quantum yields could be caused by the energy gap law61 or photoinduced electron transfer (PeT) from the xanthene system to the electron-deficient pendant ring;62 plotting Φf vs. λabs showed no substantial difference in trends between fluorinated and nonfluorinated dyes (
The lactone-zwitterion equilibrium was then examined across the different dye series (Table 4); KL-Z was measured in 1:1 (v/v) dioxane:water mixtures. These conditions provide the broad range of values necessary for identifying structure-activity relationships.18 Plotting auxochrome structure vs. KL-Z (
Although the Hammett constants64 for most of these functionalities are unknown, the electron-donating capability of the auxochrome groups can be ranked as: NH2<azetidine<pyrrolidine<tetrahydroquinoline<julolidine based on data from substituted azobenzene dyes.65, 66 The KL-Z values follow this trend with Si-rhodamines SiRh110 (83) and JF646 (1) showing KL-Z≈10−3, JFX650 (89) and SiRhQ (95) exhibiting KL-Z≈10−2 and the julolidine-containing JF698 (31) giving KL-Z≈1. The correlation between the electron-donating character of the auxochrome and KL-Z is also observed for the carborhodamines and rhodamine dyes at commensurately higher KL-Z values (
Overall, these data show that rhodamines that typically favor the lactone form, such as SiRh110 (83; ε=2,200 M−1 cm−1, KL-Z, =0.0011) can be tuned through cooperative structural modifications-introduction of electron-donating auxochromes and fluorine substituents to yield JF698 (31), a dye that exhibits high absorptivity in aqueous solution (ε=147,000 M−1 cm−1, KL-Z, =4.57).
It is also noted that dyes containing electron-donating substituents, such as julolidine, exhibit higher and more compressed KL-Z ranges. This makes such scaffolds attractive for constructing bright, highly absorbing labels-8 is correlated with KL-Z (
Finally, the oxygen- and silicon-containing rhodamines were compared with more complicated auxochrome substituents (Table 5,
With this expanded collection of fluorinated dyes in hand the MAC chemistry derivatization strategy was tested, preparing the HaloTag® ligands of 8 (JFX576), 11, 18 (JF563), 25 (JFX673), 29 (FSiRhQ), 31 (JF698), 36, 38, 40 (JFX637), 44 (JF632), 49 (FMGL), 51, 55, 57 (JF660), 59 (JF657), 60, 64-66, and 70-72; the benzylguanine SNAP-tag® ligands of 11, 18, 25, 31, 40, 44, 49, 55, 59, 64, 65; and the chloropyrimidine SNAP-tag® ligands of 8, 11, 18, 25, 31, 40, 44, 49, 59, 64, 65, 85. The MAC chemistry proceeded in good to excellent yield regardless of dye reactant structure (Scheme 18 and Scheme 19). This approach was successful even with carbofluoresceins 51 and 55, which bear nucleophilic phenolic substituents that could react with the electrophilic ring system or the acyl cyanide intermediate.
The HaloTag® labeling rates of the matched pairs of nonfluorinated/fluorinated dye ligands were evaluated: 84HTL/85HTL, 81HTL/70HTL, 86HTL/44HTL, 87HTL/8HTL, and 88HTL/40HTL where a modest decrease in rate of 4-14-fold was observed for the fluorinated compounds (
Three unique fluorinated dye compounds were selected to examine more closely for biological imaging applications. The unique carborhodamine 59 (Scheme 15) was the first compound focused upon, which is a fluorine-containing analog of ATTO 647N (105;
A key design principle used in many ATTO dyes involves amidation of the ortho-carboxyl group on the pendant ring with 4−(methylamino)butanoic acid. This conjugation strategy does three things: (i) elicits a bathochromic shift in spectral properties to give λabs>640 nm, longer than the parent, unmodified dye (λabs=632 nm;
The approach of fluorinating fluorophores mirrors the spectral and structural advantages of using the ortho-carboxyl group for bioconjugation but does not produce a cationic species. The fluorine substitution confers a bathochromic shift in λabs/λem and works in concert with the julolidine and tetrahydroquinoline auxochromes to increase absorptivity and brightness by shifting the lactone-zwitterion equilibrium towards the zwitterionic form. Introduction of a reactive handle via the straightforward MAC chemistry approach preserves the zwitterionic character of the dye, which should minimize unwanted mitochondrial accumulation. Both diastereomers of 59 displayed identical spectral properties: λabs=657 nm, ε=137,000 M−1 cm−1, λem=672 nm, Of=0.50, and KL-Z=4.97 (
The NIR region is an attractive window for biological imaging with low autofluorescence, less scattering and relatively deep tissue penetration. Dyes that exhibit labs z 700-750 nm were considered and with particular interest in the unique fluorinated analog of Si-rhodamine 101 (JF698; 31); its ε=147,000 M−1 cm−1 and Φf=0.28 (Table 4) makes it similar in brightness to Alexa Fluor 700 and Cy770 but with the potential for live-cell labeling applications. The JF698-HaloTag® ligand (31HTL) was compared to other NIR-excited labels (
The utility of these NIR-excited HaloTag® ligands was tested in living cells. All the compounds labeled live cells expressing HaloTag® fused to histone H2B with similar kinetics but varying intensity. Consistent with the superior brightness of 31 in vitro, the HaloTag® ligand derivative 31HTL gave >3-fold higher nuclear intensity compared to the other ligands when excited at λabs (
Finally, the nonfluorescent N,N′-diaryl-carborhodamine 91 and its fluorinated analog (65; Scheme 17) were evaluated. Introduction of N-aryl groups into rhodamine dyes severely decreases fluorescence quantum yield due to increased twisted internal charge transfer (TICT),72, 73 making N-arylrhodamines and N-aryl-Si-rhodamines useful nonfluorescent acceptor dyes for Forster resonance energy transfer (FRET).26, 74, 75 These nonfluorescent rhodamine systems have not been used for intracellular labeling, however, and N-aryl-carborhodamines remain untested as FRET quenchers. Introduction of an N-aryl group into rhodamine dyes also shifts the lactone-zwitterion equilibrium toward the colorless lactone form (Table 4); commercial N-arylrhodamine quenchers typically have the ortho-carboxyl group blocked or removed, presumably to prevent unwanted lactonization.26, 74 The N-aryl-carborhodamine compound 91 shows extremely low visible absorption in aqueous solution (ε<200 M−1 cm−1) and a vanishingly small KL-Z.41 Incorporation of fluorine atoms into the pendant phenyl ring system, as in compound 65, shifts the lactone-zwitterion equilibrium toward the zwitterionic form, giving a dye with a measurable absorptivity (ε=2,700 M−1 cm−1), KL-Z=0.344, and far-red absorption (λabs=645 nm; Table 4).
It was surmised that the properties of 65 could translate into a highly chromogenic HaloTag® ligand. Incubation of 65HTL (
This unique, chromogenic, far-red quencher dye was employed in a semisynthetic sensor for the cyclic adenosine monophosphate (cAMP). The genes encoding the SNAP-tag® and HaloTag® proteins were linked via the sequence for the exchange protein directly activated by cAMP (Epac1),76 basing this design on an established cAMP sensor construct that incorporates fluorescent proteins.77 Binding of cAMP causes a conformational change that decreases FRET and increases the fluorescence lifetime (τ) of the donor (
Rhodamines remain the most important fluorophores for live-cell imaging and are increasingly used in more complex systems such as intact animals. Optimizing these fluorophores for specific applications requires the synthetic chemistry methods needed to make new rhodamines and an understanding of the structure-activity relationships that govern the spectral and chemical properties of dyes. Here, the synthesis of rhodamine dyes was thoroughly surveyed, with investigation of five different methods (Scheme 1). New and improved chemistry was developed, expanding the scope of the oxidative phthalaldehydic acid (“lactol”) condensation42 to synthesize fluorinated and nonfluorinated Si-rhodamines (Schemes 6, 7) and establishing a unique route to fluorinated dyes using the straightforward Li/H exchange of 2,3,4,5−tetrafluorobenzoic acid (6; Schemes 9, 12, 13). This vetted portfolio of organic chemistry strategies will enable the synthesis of a wide range of rhodamines, particularly fluorinated derivatives.
These methods were to assemble a systematic set of rhodamine dyes and measured their properties (Tables 3-5). These data revealed structure-activity relationships governing the lactone-zwitterion equilibrium (KL−z;
The unique molecules disclosed herein will immediately enable new biological imaging experiments in living cells. Prior to the synthesis of this comprehensive collection of dyes and exhaustive measurement of their chemical properties, the structure-activity relationships governing absorptivity and KL-Z in different classes of rhodamines appeared idiosyncratic. For example, the high Φf of julolidine-containing dyes has been appreciated for decades78 but julolidine's effect on ε was largely unrecognized. Trends in absorptivity and KL-Z can be rationalized by the electron-donating capability of the auxochrome group (
Commercial reagents were obtained from reputable suppliers and used as received. All solvents were purchased in septum-sealed bottles stored under an inert atmosphere. All reactions were sealed with septa through which a nitrogen atmosphere was introduced unless otherwise noted. Reactions were conducted in round-bottomed flasks or septum-capped crimp-top vials containing Teflon-coated magnetic stir bars. Heating of reactions was accomplished with a silicon oil bath or an aluminum reaction block on top of a stirring hotplate equipped with an electronic contact thermometer to maintain the indicated temperatures.
Reactions were monitored by thin layer chromatography (TLC) on precoated TLC glass plates (silica gel 60 F254, 250 μm thickness) or by LC/MS (Phenomenex Kinetex 2.1 mm×30 mm 2.6 μm C18 column; 5 μL injection; 5-98% MeCN/H2O, linear gradient, with constant 0.1% v/v HCO2H additive; 6 min run; 0.5 mL/min flow; ESI; positive ion mode). TLC chromatograms were visualized by UV illumination or developed with p-anisaldehyde, ceric ammonium molybdate, or KMnO4 stain. Reaction products were purified by flash chromatography on an automated purification system using pre-packed silica gel columns or by preparative HPLC (Phenomenex Gemini-NX 30×150 mm 5 m C18 column). Analytical HPLC analysis was performed with an Agilent Eclipse XDB 4.6×150 mm 5 m C18 column under the indicated conditions. High-resolution mass spectrometry was performed by the High Resolution Mass Spectrometry Facility at the University of Iowa.
NMR spectra were recorded on a 400 MHz spectrometer. 1H and 13C chemical shifts were referenced to TMS or residual solvent peaks, and 19F chemical shifts were referenced to CFCl3. Data for 1H NMR spectra are reported as follows: chemical shift (6 ppm), multiplicity (s=singlet, d=doublet, t=triplet, q=quartet, dd=doublet of doublets, m=multiplet), coupling constant (Hz), integration. Data for 13C NMR spectra are reported by chemical shift (δ ppm) with hydrogen multiplicity (C, CH, CH2, CH3) information obtained from DEPT spectra. The 13C NMR spectra are not reported for compounds containing trifluoro- or tetrafluoro-substituted aryl rings, as the 3-4 distinct fluorine couplings to each of the six different carbons of the bottom ring confounded any useful interpretation of the spectra.
A vial was charged with 3,3′-oxybis(bromobenzene)14 (S1; 1.00 g, 3.05 mmol), Pd2dba3 (279 mg, 0.305 mmol, 0.1 eq), XPhos (436 mg, 0.915 mmol, 0.3 eq), and Cs2CO3 (2.78 g, 8.54 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (12 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of pyrrolidine-2,2,3,3,4,4,5,5−d8 (612 μL, 7.32 mmol, 2.4 eq), the reaction was stirred at 100° C. for 18 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and concentrated to dryness. The crude product was purified by flash chromatography (0-20% Et2O/hexanes, linear gradient) to yield 936 mg (95%) of 9 as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.16-7.10 (m, 2H), 6.35-6.24 (m, 6H); 13C NMR (CDCl3, 101 MHz) δ 158.6 (C), 149.6 (C), 129.9 (CH), 106.7 (CH), 105.9 (CH), 102.5 (CH); HRMS (ESI) calcd for C20H9D16N2O [M+H]+ 325.2966, found 325.2957.
A vial was charged with bis(3−bromophenyl)dimethylsilane79 (S2; 300 mg, 0.810 mmol), Pd2dba3 (74.2 mg, 81.0 μmol, 0.1 eq), XPhos (116 mg, 0.243 mmol, 0.3 eq), and Cs2CO3 (739 mg, 2.27 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (3.5 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of pyrrolidine-2,2,3,3,4,4,5,5−d8 (163 μL, 1.95 mmol, 2.4 eq), the reaction was stirred at 100° C. for 18 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and concentrated to dryness. The resulting residue was purified by flash chromatography (0-10% Et2O/hexanes, linear gradient, with constant 0.1% v/v Et3N additive) to provide 261 mg (88%) of 26 as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.21 (dd, J=8.2, 7.1 Hz, 2H), 6.84 (dt, J=7.1, 1.1 Hz, 2H), 6.75 (dd, J=2.6, 1.0 Hz, 2H), 6.57 (ddd, J=8.2, 2.7, 1.1 Hz, 2H), 0.52 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 147.5 (C), 139.2 (C), 128.6 (CH), 121.5 (CH), 117.3 (CH), 112.5 (CH), −2.0 (CH3); HRMS (ESI) calcd for C22H15D16N2Si [M+H]+ 367.3255, found 367.3259.
1,1′-(Oxybis(3,1−phenylene))bis-(pyrrolidine-2,2,3,3,4,4,5,5−d8) (9; 850 mg, 2.62 mmol) was taken up in DMF (20 mL). N-Bromosuccinimide (932 mg, 5.24 mmol, 2 eq) was added portion-wise over 5 min, and the reaction was then stirred at room temperature for 4 h. The reaction mixture was concentrated in vacuo; the resulting residue was diluted with water and extracted with CH2Cl2 (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Silica gel chromatography (10-75% CH2Cl2/hexanes, linear gradient) afforded 1.04 g (82%) of 7 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.36 (d, J=8.7 Hz, 2H), 6.21 (dd, J=8.8, 2.8 Hz, 2H), 6.07 (d, J=2.7 Hz, 2H); 13C NMR (CDCl3, 101 MHz) δ 153.9 (C), 148.6 (C), 133.5 (CH), 108.6 (CH), 103.0 (CH), 98.7 (C); HRMS (ESI) calcd for C20H7D16Br2N2O [M+H]+ 481.1176, found 483.1149.
Silane 26 (1.95 g, 5.32 mmol) was taken up in DMF (60 mL). N-Bromosuccinimide (1.89 g, 10.64 mmol, 2 eq) was added portion-wise over 2-3 min, and the reaction was then stirred at room temperature for 1 h. The reaction mixture was concentrated to remove DMF, diluted with water, and extracted with CH2Cl2 (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude was dissolved in a minimum amount of CH2Cl2, diluted with an equivalent volume of hexanes, and gently concentrated until a white solid precipitated. The resulting suspension was filtered; the filter cake was washed with Et2O and dried to yield 2.32 g (83%) of dibromide 24 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.32 (d, J=8.7 Hz, 2H), 6.66 (d, J=3.1 Hz, 2H), 6.42 (dd, J=8.7, 3.1 Hz, 2H), 0.74 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 146.5 (C), 139.0 (C), 133.1 (CH), 120.7 (CH), 115.4 (C), 114.3 (CH), −0.8 (CH3); HRMS (ESI) calcd for C22H13D16Br2N2Si [M+H]+ 523.1466, found 523.1466.
To a solution of 3,3′-oxydianiline (S3; 1.00 g, 4.99 mmol) in acetone (30 mL) was added Yb(OTf)3 (465 mg, 0.749 mmol, 0.15 eq). After stirring the reaction at room temperature for 72 h, it was concentrated in vacuo, diluted with saturated NaHCO3, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated to dryness. Flash chromatography on silica gel (0-25% EtOAc/hexanes, linear gradient) yielded 1.27 g (71%) of 19 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 6.98 (d, J=8.3 Hz, 2H), 6.29 (dd, J=8.3, 2.4 Hz, 2H), 6.09 (d, J=2.4 Hz, 2H), 5.23 (q, J=1.3 Hz, 2H), 3.66 (s, 2H), 1.97 (d, J=1.4 Hz, 6H), 1.26 (s, 12H); 13C NMR (CDCl3, 101 MHz) δ 157.8 (C), 144.7 (C), 128.2 (C), 127.0 (CH), 124.8 (CH), 117.2 (C), 107.7 (CH), 103.3 (CH), 52.1 (C), 31.3 (CH3), 18.8 (CH3); HRMS (ESI) calcd for C24H29N2O [M+H]+ 361.2274, found 361.2267.
7,7′—Oxybis(2,2,4−trimethyl-1,2−dihydroquinoline) (19; 2.00 g, 5.55 mmol) was taken up in DMF (16 mL); K2CO3 (2.30 g, 16.64 mmol, 3 eq) and iodomethane (829 μL, 13.31 mmol, 2.4 eq) were added, and the reaction was stirred at 50° C. for 18 h. It was subsequently cooled to room temperature, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated to dryness. Silica gel chromatography (0-20% EtOAc/hexanes, linear gradient) afforded 12 as a white solid (2.10 g, 97%). 1H NMR (CDCl3, 400 MHz) δ 7.00-6.93 (m, 2H), 6.31-6.23 (m, 4H), 5.22 (q, J=1.4 Hz, 2H), 2.74 (s, 6H), 1.97 (d, J=1.4 Hz, 6H), 1.30 (s, 12H); 13C NMR (CDCl3, 101 MHz) δ 158.2 (C), 146.9 (C), 128.5 (CH), 128.0 (C), 124.2 (CH), 118.9 (C), 105.9 (CH), 102.1 (CH), 56.5 (C), 30.9 (CH3), 27.4 (CH3), 18.8 (CH3); HRMS (ESI) calcd for C26H33N2O [M+H]+389.2587, found 389.2579.
7,7′—Oxybis(2,2,4−trimethyl-1,2−dihydroquinoline) (19; 4.50 g, 12.48 mmol) was dissolved in EtOH (300 mL) in a round-bottom flask under nitrogen, and Pd/C (10%, 2.66 g, 2.50 mmol, 0.2 eq) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 18 h. The reaction mixture was filtered through Celite with EtOH and concentrated in vacuo. Silica gel chromatography (0-15% EtOAc/hexanes, linear gradient) yielded 4.47 g (98%) of 17 as a white solid (mixture of diastereomers). 1H NMR (CDCl3, 400 MHz) δ 7.09-7.02 (m, 2H), 6.36-6.28 (m, 2H), 6.10-6.05 (m, 2H), 3.54 (s, 2H), 2.94-2.80 (m, 2H), 1.72 (dd, J=12.9, 5.5 Hz, 2H), 1.42 (t, J=12.5 Hz, 2H), 1.31 (d, J=6.7 Hz, 6H), 1.21 (s, 6H), 1.17 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 156.6 (C), 144.9 (C), 127.91/127.86 (CH), 120.17/120.15 (C), 107.76/107.67 (CH), 104.13/104.10 (CH), 49.5 (C), 44.7 (CH2), 31.6 (CH), 28.04/27.96 (CH3), 27.4 (CH3), 20.57/20.54 (CH3); HRMS (ESI) calcd for C24H33N2O [M+H]+ 365.2587, found 365.2580.
7−Bromo-1,2,3,4−tetrahydroquinoline (1.00 g, 4.71 mmol), benzyl bromide (1.61 g, 9.43 mmol, 2 eq), K2CO3 (1.56 g, 11.3 mmol, 2.4 eq), and KI (157 mg, 0.943 mmol, 0.2 eq) were combined in DMF (15 mL) and stirred at 60° C. for 1 h. The reaction was subsequently diluted with water and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried (MgSO4), filtered, and concentrated in vacuo. Silica gel chromatography (0-15% Et2O/hexanes, linear gradient) yielded S4 (1.35 g, 95%) as a gum that crystallized into a colorless, low-melting solid upon standing. 1H NMR (CDCl3, 400 MHz) δ 7.36-7.29 (m, 2H), 7.28-7.20 (m, 3H), 6.80 (d, J=7.9 Hz, 1H), 6.66 (dd, J=7.9, 1.9 Hz, 1H), 6.62 (d, J=1.8 Hz, 1H), 4.45 (s, 2H), 3.36-3.28 (m, 2H), 2.73 (t, J=6.3 Hz, 2H), 2.02-1.91 (m, 2H); 13C NMR (CDCl3, 101 MHz) δ 146.9 (C), 138.1 (C), 130.2 (CH), 128.8 (CH), 127.1 (CH), 126.7 (CH), 121.2 (C), 120.9 (C), 118.5 (CH), 113.4 (CH), 55.0 (CH2), 49.6 (CH2), 27.9 (CH2), 22.1 (CH2); HRMS (ESI) calcd for C16H16BrNNa [M+Na]+324.0358, found 324.0360.
A solution of 1−benzyl-7−bromo-1,2,3,4−tetrahydroquinoline (S4; 4.00 g, 13.24 mmol, 2.4 eq) in THE (50 mL) was cooled to −78° C. under nitrogen. n-Butyllithium (2.5 M in hexanes, 5.29 mL, 13.24 mmol, 2.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. Dichlorodimethylsilane (665 μL, 5.51 mmol) was then added. The dry ice bath was removed, and the reaction was stirred at room temperature for 2 h. It was subsequently quenched with saturated NH4Cl, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-40% CH2Cl2/hexanes, linear gradient, with constant 1% v/v Et3N additive) afforded 2.58 g (93%) of 27 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.30-7.24 (m, 4H), 7.23-7.18 (m, 6H), 6.90 (dt, J=7.4, 1.0 Hz, 2H), 6.67-6.62 (m, 4H), 4.38 (s, 4H), 3.37-3.31 (m, 4H), 2.78 (t, J=6.4 Hz, 4H), 2.02-1.94 (m, 4H), 0.24 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 145.0 (C), 139.3 (C), 136.8 (C), 128.66 (CH), 128.60 (CH), 127.0 (CH), 126.8 (CH), 123.4 (C), 122.0 (CH), 116.9 (CH), 55.6 (CH2), 50.3 (CH2), 28.3 (CH2), 22.5 (CH2), −2.3 (CH3); HRMS (ESI) calcd for C34H39N2Si [M+H]+ 503.2877, found 503.2873.
A solution of 8-bromojulolidine (S5; 3.00 g, 11.90 mmol, 2.4 eq) in THE (50 mL) was cooled to −78° C. under nitrogen. n-Butyllithium (2.5 M in hexanes, 4.76 mL, 11.90 mmol, 2.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. Dichlorodimethylsilane (598 μL, 4.96 mmol) was then added. The dry ice bath was removed, and the reaction was stirred at room temperature for 2 h. It was subsequently quenched with saturated NH4Cl, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-20% Et2O/hexanes, linear gradient) afforded 1.54 g (77%) of 30 as a white foam. 1H NMR (CDCl3, 400 MHz) δ 6.77 (d, J=7.4 Hz, 2H), 6.69 (d, J=7.4 Hz, 2H), 3.16-3.10 (m, 4H), 3.10-3.04 (m, 4H), 2.76 (t, J=6.5 Hz, 4H), 2.67 (t, J=6.5 Hz, 4H), 1.96 (p, J=6.3 Hz, 4H), 1.85 (p, J=6.3 Hz, 4H), 0.51 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 142.8 (C), 135.3 (C), 127.7 (C), 126.7 (CH), 123.3 (C), 122.9 (CH), 50.7 (CH2), 50.2 (CH2), 28.7 (CH2), 28.2 (CH2), 22.5 (CH2), 22.2 (CH2), 0.2 (CH3); HRMS (ESI) calcd for C26H35N2Si [M+H]+ 403.2564, found 403.2563.
Dimethylbis(2,3,6,7−tetrahydro-1H,5H-pyrido[3,2,1−ij]quinolin-8-yl)silane (30; 980 mg, 2.43 mmol) was taken up in DMF (12 mL), and N-bromosuccinimide (866 mg, 4.87 mmol, 2 eq) was added portion-wise over 5 min. The reaction was stirred at room temperature for 2 h. It was subsequently diluted with water and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel chromatography (0-20% Et2O/hexanes, linear gradient) afforded 690 mg (51%) of dibromide S6 as a white solid. 1H NMR (DMSO-d6, 400 MHz, 350 K) δ6.87 (s, 2H), 3.10 (t, J=6.1 Hz, 4H), 3.03 (t, J=6.0 Hz, 4H), 2.66 (t, J=6.4 Hz, 4H), 2.63 (t, J=6.4 Hz, 4H), 1.83 (p, J=6.3 Hz, 4H), 1.72 (p, J=6.2 Hz, 4H), 0.71 (s, 6H); 13C NMR (DMSO-d6, 101 MHz, 350 K) δ 141.4 (C), 136.4 (C), 130.8 (CH), 128.6 (C), 124.1 (C), 113.9 (C), 49.4 (CH2), 48.6 (CH2), 28.2 (CH2), 26.7 (CH2), 21.4 (CH2), 20.8 (CH2), 7.1 (CH3); HRMS (ESI) calcd for C26H33Br2N2Si [M+H]+ 561.0754, found 561.0751.
A solution of 6−bromo-1−methylindoline (S7; 3.30 g, 15.56 mmol, 2.4 eq) in THE (40 mL) was cooled to −78° C. under nitrogen. n-Butyllithium (2.5 M in hexanes, 6.22 mL, 15.56 mmol, 2.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. Dichlorodimethylsilane (782 μL, 6.48 mmol) was then added. The dry ice bath was removed, and the reaction was stirred at room temperature for 2 h. It was subsequently quenched with saturated NH4Cl, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-25% EtOAc/hexanes, linear gradient) afforded 2.03 g (97%) of S8 as a colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.08 (dq, J=7.2, 1.0 Hz, 2H), 6.86 (dd, J=7.1, 0.9 Hz, 2H), 6.65 (bs, 2H), 3.27 (t, J=8.1 Hz, 4H), 2.93 (td, J=8.1, 1.1 Hz, 4H), 2.74 (s, 6H), 0.50 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 152.9 (C), 137.4 (C), 131.8 (C), 124.4 (CH), 124.0 (CH), 112.4 (CH), 56.1 (CH2), 36.4 (CH3), 28.9 (CH2), −1.7 (CH3); HRMS (ESI) calcd for C20H27N2Si [M+H]+ 323.1938, found 323.1946.
A solution of dimethylbis(1−methylindolin-6−yl)silane (S8; 1.90 g, 5.89 mmol) in DMF (30 mL) was cooled to 0° C., and N-bromosuccinimide (2.10 g, 11.78 mmol, 2 eq) was added portion-wise over 15 min. The reaction was warmed to room temperature and stirred 2 h. It was subsequently diluted with water and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel chromatography (0-25% EtOAc/hexanes, linear gradient) afforded 2.46 g (87%) of dibromide S9 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.20 (t, J=1.0 Hz, 2H), 6.56 (s, 2H), 3.29 (t, J=8.2 Hz, 4H), 2.92 (td, J=8.1, 1.2 Hz, 4H), 2.70 (s, 6H), 0.71 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 152.1 (C), 137.0 (C), 134.2 (C), 128.8 (CH), 117.9 (C), 115.2 (CH), 56.2 (CH2), 36.3 (CH3), 28.5 (CH2), −0.6 (CH3); HRMS (ESI) calcd for C20H25Br2N2Si [M+H]+ 481.0128, found 481.0120.
A solution of N,N-diallyl-3−bromoaniline (S10; 35.00 g, 138.8 mmol, 2.4 eq) in THF (300 mL) was cooled to −78° C. under nitrogen. n-Butyllithium (2.5 M in hexanes, 55.52 mL, 138.8 mmol, 2.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. Dichlorodimethylsilane (6.98 mL, 57.83 mmol) was then added. The dry ice bath was removed, and the reaction was stirred at room temperature for 2 h. It was subsequently quenched with saturated NH4Cl, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-5% Et2O/hexanes, linear gradient) afforded 22.92 g (98%) of S11 as a colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.18 (dd, J=8.3, 7.1 Hz, 2H), 6.89-6.87 (m, 2H), 6.85 (dt, J=7.1, 1.0 Hz, 2H), 6.70 (ddd, J=8.3, 2.8, 1.0 Hz, 2H), 5.83 (ddt, J=17.1, 10.1, 5.0 Hz, 4H), 5.14 (dq, J=17.4, 1.8 Hz, 4H), 5.12 (dq, J=10.4, 1.7 Hz, 4H), 3.89 (dt, J=4.9, 1.7 Hz, 8H), 0.48 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 148.1 (C), 139.0 (C), 134.3 (CH), 128.6 (CH), 122.4 (CH), 118.3 (CH), 116.2 (CH2), 113.3 (CH), 53.0 (CH2), −2.2 (CH3); HRMS (ESI) calcd for C26H35N2Si [M+H]+ 403.2564, found 403.2565.
A round-bottom flask equipped with a reflux condenser was charged with Pd(PPh3)4(5.74 g, 4.97 mmol, 0.1 eq) and 1,3−dimethylbarbituric acid (62.04 g, 397.4 mmol, 8 eq). The flask was sealed and evacuated/backfilled with nitrogen (3×). A solution of 3,3′-(dimethylsilanediyl)bis(N,N-diallylaniline) (511; 20.00 g, 49.67 mmol) in CH2Cl2 (500 mL) was added via cannula, and the resulting mixture was stirred at reflux for 18 h. The reaction was cooled to room temperature and slowly diluted with saturated NaHCO3 (400 mL) while stirring vigorously. The layers were separated, and the aqueous layer was extracted again with CH2Cl2. The combined organic extracts were dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The residue was purified twice by silica gel chromatography (10-100% EtOAc/hexanes, linear gradient) to afford 10.34 g (86%) of S12 as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.15 (ddd, J=7.8, 7.1, 0.5 Hz, 2H), 6.92 (dt, J=7.2, 1.1 Hz, 2H), 6.83-6.79 (m, 2H), 6.68 (ddd, J=7.9, 2.5, 1.1 Hz, 2H), 3.58 (s, 4H), 0.48 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 145.8 (C), 139.5 (C), 128.9 (CH), 124.6 (CH), 120.9 (CH), 116.1 (CH), −2.3 (CH3); HRMS (ESI) calcd for C14H19N2Si [M+H]+ 243.1312, found 243.1315.
3,3′-(Dimethylsilanediyl)dianiline (512; 10.00 g, 41.25 mmol) and iodine (4.19 g, 16.50 mmol, 0.4 eq) were combined in acetone (250 mL) and stirred at reflux for 48 h. The reaction was then cooled to room temperature, concentrated to dryness, and purified by silica gel chromatography (0-30% Et2O/hexanes, linear gradient) to afford 5.05 g (30%) of 35 as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.03 (d, J=7.5 Hz, 2H), 6.80 (dd, J=7.5, 1.1 Hz, 2H), 6.54 (d, J=1.1 Hz, 2H), 5.30 (q, J=1.5 Hz, 2H), 3.64 (s, 2H), 1.97 (d, J=1.4 Hz, 6H), 1.26 (s, 12H), 0.44 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 142.5 (C), 138.6 (C), 128.9 (CH), 128.6 (C), 123.2 (CH), 123.0 (CH), 122.2 (C), 118.7 (CH), 52.0 (C), 31.4 (CH3), 18.7 (CH3),-2.2 (CH3); HRMS (ESI) calcd for C26H35N2Si [M+H]+ 403.2564, found 403.2562.
Dimethylbis(2,2,4−trimethyl-1,2−dihydroquinolin-7−yl)silane (35; 1.48 g, 3.68 mmol) was dissolved in THE (35 mL) in a round-bottom flask under nitrogen, and Pd/C (10%, 782 mg, 0.735 mmol, 0.2 eq) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 18 h. The reaction mixture was filtered through Celite with EtOAc and concentrated in vacuo. Silica gel chromatography (0-25% Et2O/hexanes, linear gradient) yielded 1.25 g (84%) of S13 as a white foam (mixture of diastereomers). 1H NMR (CDCl3, 400 MHz) δ 7.14 (d, J=7.6 Hz, 2H), 6.83 (d, J=7.5 Hz, 2H), 6.61-6.57 (m, 2H), 3.57 (s, 2H), 2.96-2.84 (m, 2H), 1.72 (dd, J=12.9, 5.5 Hz, 2H), 1.43 (t, J=12.6 Hz, 2H), 1.32 (d, J=6.7 Hz, 6H), 1.22 (s, 6H), 1.17 (s, 6H), 0.44 (s, 6H); Analytical HPLC: tR=10.0 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 230 nm); HRMS (ESI) calcd for C26H39N2Si [M+H]+ 407.2877, found 407.2873.
Dimethylbis(2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7−yl)silane (S13; 1.15 g, 2.83 mmol), K2CO3 (2.34 g, 16.97 mmol, 6 eq), and KI (188 mg, 1.13 mmol, 0.4 eq) were combined in DMF (30 mL) in a round-bottom flask. Benzyl bromide (2.90 g, 16.97 mmol, 6 eq) was added, the flask was sealed, and the contents were stirred at 100° C. for 18 h. The reaction was cooled to room temperature, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Silica gel chromatography (0-10% Et2O/hexanes, linear gradient) yielded 1.59 g (96%) of 32 as a white foam (mixture of diastereomers). 1H NMR (CDCl3, 400 MHz) δ 7.28-7.15 (m, 10H), 7.03 (d, J=7.4 Hz, 2H), 6.57 (d, J=7.4 Hz, 2H), 6.42-6.37 (m, 2H), 4.62 (d, J=17.5 Hz, 2H), 4.13 (d, J=17.6 Hz, 2H), 3.04-2.92 (m, 2H), 1.80 (dd, J=13.0, 5.0 Hz, 2H), 1.72 (td, J=12.7, 2.0 Hz, 2H), 1.34 (d, J=6.6 Hz, 6H), 1.27 (s, 6H), 1.24 (s, 6H), 0.04 (s, 1.5H), 0.00 (s, 3H), −0.04 (s, 1.5H); Analytical HPLC: tR=13.9 min, >99% purity (65-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C40H51N2Si [M+H]+ 587.3816, found 587.3808.
A solution of 7−bromo-1,2,2,4−tetramethyl-1,2−dihydroquinoline (S14; 10.26 g, 38.55 mmol, 2.5 eq) in THE (75 mL) was cooled to −78° C. under nitrogen. n-Butyllithium (2.5 M in hexanes, 15.42 mL, 38.55 mmol, 2.5 eq) was added, and the reaction was stirred at −78° C. for 30 min. Dichlorodimethylsilane (1.86 mL, 15.42 mmol) was then added. The dry ice bath was removed, and the reaction was stirred at room temperature for 2 h. It was subsequently quenched with saturated NH4Cl, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-5% Et2O/hexanes, linear gradient) afforded 6.00 g (90%) of 37 as a colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.03 (d, J=7.4 Hz, 2H), 6.84 (dd, J=7.3, 1.1 Hz, 2H), 6.68 (d, J=1.0 Hz, 2H), 5.28 (q, J=1.5 Hz, 2H), 2.76 (s, 6H), 1.96 (d, J=1.4 Hz, 6H), 1.28 (s, 12H), 0.50 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 144.4 (C), 138.8 (C), 130.6 (CH), 128.3 (C), 124.0 (C), 122.59 (CH), 122.57 (CH), 116.1 (CH), 56.3 (C), 30.6 (CH3), 27.4 (CH3), 18.7 (CH3), −2.0 (CH3); HRMS (ESI) calcd for C28H39N2Si [M+H]+ 431.2877, found 431.2874.
A solution of 2,3,4,5−tetrafluorobenzoic acid (2.00 g, 10.31 mmol) in THE (30 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 9.89 mL, 24.73 mmol, 2.4 eq) was added, and the reaction was stirred at −78° C. for 3 h. Methyl formate (3.18 mL, 51.53 mmol, 5 eq) was added in one portion; the reaction was then stirred at −78° C. for 30 min, warmed to room temperature, and stirred for 2 h. Following the addition of water (75 mL) and CH2Cl2 (75 mL), the pH was adjusted to 10-11 with 2 M NaOH. The aqueous layer was washed again with CH2Cl2, acidified to pH ˜2 with 2 M HCl, and extracted with EtOAc (2×). The combined EtOAc layers were dried over anhydrous MgSO4, filtered, and evaporated. Purification by silica gel chromatography (5-100% EtOAc/hexanes, linear gradient, with constant 1% v/v AcOH additive) afforded 5 as a white solid (1.58 g, 69%). 1H NMR (DMSO-d6, 400 MHz) δ 8.77 (s, 1H), 6.88 (s, 1H); 19F NMR (DMSO-d6, 376 MHz) δ−140.20 (td, J=20.6, 8.4 Hz, 1F), −142.72 (t, J=20.1 Hz, 1F), −143.93-−144.25 (m, 1F), −150.36 (t, J=20.5 Hz, 1F); Analytical HPLC: tR=9.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 230 nm); HRMS (ESI) calcd for C8HF4O3[M−H]220.9867, found 220.9861.
1,2,3,4−Tetrahydroquinolin-7−ol (13; 141 mg, 0.946 mmol, 2.1 eq), tetrafluorophthalaldehydic acid (5; 100 mg, 0.450 mmol), 2,2,2−trifluoroethanol (8 mL), and water (2 mL) were combined in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was then cooled to room temperature, diluted with MeOH, deposited onto Celite, and concentrated to dryness. Purification by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient; dry load with Celite) followed by reverse phase HPLC (20-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) provided 14 as a dark red solid (152 mg, 57%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 6.98 (s, 2H), 6.64 (s, 2H), 3.51-3.44 (m, 4H), 2.78 (t, J=6.2 Hz, 4H), 1.93 (p, J=6.3 Hz, 4H); 19F NMR (CD3OD, 376 MHz) δ−75.53 (s, 3F), −136.17-−136.31 (m, 1F), −137.42-−137.56 (m, 1F), −151.06-−151.23 (m, 1F), −152.47-−152.64 (m, 1F); Analytical HPLC: tR=11.7 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C26H19F4N2O3[M+H]+ 483.1326, found 483.1321.
1,2,3,4−Tetrahydroquinolin-7−ol (13; 78.3 mg, 0.525 mmol, 2.1 eq), 4-carboxyphthalaldehydic acid42 (109; 48.6 mg, 0.250 mmol), 2,2,2−trifluoroethanol (4 mL), and water (1 mL) were combined in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was then cooled to room temperature, and concentrated to dryness. Purification by reverse phase HPLC (20-40% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) provided S17 as a rust red solid (74.1 mg, 52%, TFA salt). 1H NMR (DMSO-d6, 400 MHz) δ 13.61 (s, 1H), 13.35 (s, 1H), 8.80 (s, 2H), 8.31 (d, J=8.1 Hz, 1H), 8.27 (dd, J=8.2, 1.6 Hz, 1H), 7.83 (d, J=1.5 Hz, 1H), 6.69 (s, 2H), 6.68 (s, 2H), 3.42-3.34 (m, 4H), 2.64 (t, J=6.4 Hz, 4H), 1.84-1.70 (m, 4H); 13C NMR (DMSO-d6, 101 MHz) δ 166.1 (C), 165.7 (C), 155.7 (C), 155.4 (C), 154.8 (C), 134.5 (C), 134.2 (C), 133.8 (C), 131.4 (CH), 130.7 (CH), 130.7 (CH), 128.3 (CH), 123.4 (C), 112.8 (C), 96.4 (CH), 40.9 (CH2), 26.1 (CH2), 19.8 (CH2); Analytical HPLC: tR=9.4 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C27H23N2O5 [M+H]+ 455.1601, found 455.1598.
8−Hydroxyjulolidine (15; 358 mg, 1.89 mmol, 2.1 eq) and tetrafluorophthalaldehydic acid (5; 200 mg, 0.901 mmol) were combined in 2,2,2-trifluoroethanol (18 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) to provide 16 as a dark purple solid (385 mg, 76%). 1H NMR (CD3OD, 400 MHz) δ 6.87 (s, 2H), 3.59-3.48 (m, 8H), 3.05 (t, J=6.4 Hz, 4H), 2.86-2.70 (m, 4H), 2.09 (p, J=6.3 Hz, 4H), 1.97 (p, J=6.3 Hz, 4H); 19F NMR (CD3OD, 376 MHz) δ-139.20 (ddd, J=21.3, 12.6, 3.4 Hz, 1F), −141.27 (ddd, J=22.5, 12.6, 3.5 Hz, 1F), −154.15 (ddd, J=22.7, 18.8, 3.8 Hz, 1F), −158.00 (ddd, J=22.4, 19.0, 3.5 Hz, 1F); Analytical HPLC: tR=13.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C32H27F4N2O3[M+H]+ 563.1952, found 563.1943.
7,7′—Oxybis(2,2,4−trimethyl-1,2,3,4−tetrahydroquinoline) (17; 200 mg, 0.549 mmol) and tetrafluorophthalaldehydic acid (5; 183 mg, 0.823 mmol, 1.5 eq) were combined in 2,2,2−trifluoroethanol (11 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) to provide 84.2 mg (27%) of 18 as a dark red-purple solid (mixture of diastereomers). 1H NMR (CD3OD, 400 MHz) δ 7.15-7.10 (m, 2H), 6.63-6.58 (m, 2H), 2.99-2.86 (m, 2H), 1.93-1.82 (m, 2H), 1.48-1.22 (m, 20H); 19F NMR (CD3OD, 376 MHz) δ−138.47-−139.23 (m, 1F), −139.52-−140.42 (m, 1F), −152.78-−153.26 (m, 1F), −156.57-−158.07 (m, 1F); Analytical HPLC: tR (three isomers)=13.7 min, 14.0 min, 14.2 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C32H31F4N2O3[M+H]+ 567.2265, found 567.2264.
7,7′—Oxybis(2,2,4−trimethyl-1,2,3,4−tetrahydroquinoline) (17; 400 mg, 1.10 mmol) and phthalaldehydic acid (S16; 165 mg, 1.10 mmol, 1 eq) were combined in 2,2,2-trifluoroethanol (22 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 18 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) to provide 151 mg (28%) of 99 as a red solid (mixture of diastereomers). An analytically pure sample for spectral characterization was obtained by reverse phase HPLC (10-95% MeCN/H2O, linear gradient, with constant 0.1% TFA). 1H NMR (CD3OD, 400 MHz, TFA salt) δ 8.35-8.29 (m, 1H), 7.88-7.77 (m, 2H), 7.43-7.38 (m, 1H), 6.98-6.95 (m, 1H), 6.94-6.91 (m, 1H), 6.67-6.62 (m, 2H), 2.94-2.81 (m, 2H), 1.90-1.81 (m, 2H), 1.43-1.33 (m, 8H), 1.32-1.26 (m, 6H), 1.16-1.09 (m, 6H); Analytical HPLC: tR (three isomers)=13.4 min, 13.6 min, 13.8 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C32H35N2O3 [M+H]+ 495.2642, found 495.2634.
7,7′—Oxybis(2,2,4−trimethyl-1,2,3,4−tetrahydroquinoline) (17; 300 mg, 0.823 mmol) and 4−carboxyphthalaldehydic acid (109; 160 mg, 0.823 mmol, 1 eq) were combined in 2,2,2−trifluoroethanol (15 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 18 h. The reaction was cooled to room temperature, diluted with MeOH, deposited onto Celite, and concentrated in vacuo. Silica gel chromatography (0-40% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive; dry load with Celite) produced a broad elution profile for the desired product, so the numerous fractions containing S18 were concentrated to dryness, suspended in water (50 mL), sonicated (5 min), and filtered. The resulting filter cake was washed (water, MeCN, EtOAc, Et2O) and dried to afford 229 mg (46%, acetate salt) of S18 as a dark red-brown solid (mixture of diastereomers). 1H NMR (CD3OD with 1% TFA, 400 MHz) δ 8.42-8.35 (m, 2H), 8.00-7.95 (m, 1H), 6.96-6.92 (m, 1H), 6.92-6.89 (m, 1H), 6.68-6.63 (m, 2H), 2.94-2.83 (m, 2H), 1.90-1.82 (m, 2H), 1.45-1.35 (m, 8H), 1.32-1.28 (m, 6H), 1.17-1.09 (m, 6H); Analytical HPLC: tR (three isomers)=12.2 min, 12.5 min, 12.8 min; >99% total purity (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C33H35N2O5 [M+H]+ 539.2540, found 539.2543.
7,7′—Oxybis(2,2,4−trimethyl-1,2−dihydroquinoline) (19; 180 mg, 0.500 mmol) and tetrafluoro-phthalaldehydic acid (5; 111 mg, 0.500 mmol, 1 eq), 2,2,2−trifluoroethanol (8 mL), and water (2 mL) were combined in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) to provide 20 as a dark purple solid (82.6 mg, 29%). 1H NMR (CD3OD, 400 MHz) δ 6.90 (s, 2H), 6.54 (s, 2H), 5.65 (q, J=1.5 Hz, 2H), 1.91 (d, J=1.4 Hz, 6H), 1.41 (s, 6H), 1.39 (s, 6H); 19F NMR (CD3OD, 376 MHz) δ-138.77 (ddd, J=21.2, 12.5, 4.0 Hz, 1F), −139.93-−140.09 (m, 1F), −152.85 (ddd, J=22.6, 19.1, 4.0 Hz, 1F), −157.01-−157.25 (m, 1F); Analytical HPLC: tR=13.8 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C32H27F4N2O3[M+H]+ 563.1952, found 563.1942.
7,7′—Oxybis(2,2,4−trimethyl-1,2−dihydroquinoline) (19; 180 mg, 0.500 mmol), phthalaldehydic acid (S16; 75.1 mg, 0.500 mmol, 1 eq), 2,2,2−trifluoroethanol (8 mL), and water (2 mL) were combined in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) to provide 101 as a dark purple solid (68.4 mg, 28%).
1H NMR (CD3OD, 400 MHz) δ 8.15-8.10 (m, 1H), 7.70-7.62 (m, 2H), 7.30-7.24 (m, 1H), 6.88 (s, 2H), 6.53 (s, 2H), 5.58 (q, J=1.4 Hz, 2H), 1.76 (d, J=1.4 Hz, 6H), 1.38 (s, 6H), 1.37 (s, 6H); 13C NMR (CD3OD, 101 MHz) δ 171.3 (C), 160.1 (C), 159.0 (C), 154.8 (C), 134.4 (C), 132.5 (CH), 131.97 (CH), 131.94 (C), 131.6 (CH), 131.01 (CH), 130.98 (CH), 127.4 (C), 124.6 (CH), 122.5 (C), 115.4 (C), 97.0 (CH), 55.1 (C), 31.97 (CH3), 31.94 (CH3), 18.1 (CH3); Analytical HPLC: tR=13.6 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C32H31N2O3 [M+H]+ 491.2329, found 491.2325.
7,7′—Oxybis(2,2,4−trimethyl-1,2−dihydroquinoline) (19; 300 mg, 0.832 mmol) and 4−carboxyphthalaldehydic acid (109; 162 mg, 0.832 mmol, 1 eq) were combined in 2,2,2-trifluoroethanol (15 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 18 h. The reaction was cooled to room temperature, diluted with MeOH, deposited onto Celite, and concentrated in vacuo. Purification by silica gel chromatography (0-20% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive; dry load with Celite) afforded S19 as a dark red solid (197 mg, 40%, acetate salt). An analytically pure sample for spectral characterization was obtained by reverse phase HPLC (20-50% MeCN/H2O, linear gradient, with constant 0.1% TFA). 1H NMR (CD3OD, 400 MHz, TFA salt) δ 8.39 (dd, J=8.2, 1.5 Hz, 1H), 8.36 (dd, J=8.2, 0.7 Hz, 1H), 8.01 (dd, J=1.6, 0.7 Hz, 1H), 6.71 (s, 2H), 6.59 (s, 2H), 5.64 (q, J=1.5 Hz, 2H), 1.74 (d, J=1.3 Hz, 6H), 1.41 (s, 12H); 13C NMR (CD3OD, 101 MHz, TFA salt) δ 168.0 (C), 167.8 (C), 159.0 (C), 156.7 (C), 155.0 (C), 136.9 (C), 135.9 (C), 135.1 (C), 133.0 (CH), 132.51 (CH), 132.48 (CH), 132.3 (CH), 127.1 (C), 123.6 (CH), 123.0 (C), 115.1 (C), 97.3 (CH), 55.3 (C), 31.91 (CH3), 31.89 (CH3), 18.1 (CH3); Analytical HPLC: tR=11.3 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C33H31N2O5 [M+H]+ 535.2227, found 535.2231.
7,7′—Oxybis(1,2,2,4−tetramethyl-1,2−dihydroquinoline) (12; 1.00 g, 2.57 mmol) and tetrafluorophthalaldehydic acid (5; 572 mg, 2.57 mmol, 1 eq) were combined in 2,2,2-trifluoroethanol (50 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) to provide 11 as a dark blue-purple solid (1.00 g, 66%). 1H NMR (CD3OD, 400 MHz) δ 6.93 (s, 2H), 6.81 (s, 2H), 5.68 (q, J=1.5 Hz, 2H), 3.19 (s, 6H), 1.93 (d, J=1.4 Hz, 6H), 1.51 (s, 6H), 1.50 (s, 6H); 19F NMR (CD3OD, 376 MHz) δ-138.84 (ddd, J=21.1, 12.6, 4.0 Hz, 1F), −140.19 (ddd, J=22.4, 12.6, 3.7 Hz, 1F), −152.79 (ddd, J=23.0, 19.2, 4.1 Hz, 1F), −157.56 (ddd, J=21.4, 19.4, 3.8 Hz, 1F); Analytical HPLC: tR=14.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C34H31F4N2O3[M+H]+ 591.2265, found 591.2258.
7,7′—Oxybis(1,2,2,4−tetramethyl-1,2−dihydroquinoline) (12; 200 mg, 0.515 mmol) and phthalaldehydic acid (S16; 77.3 mg, 0.515 mmol, 1 eq) were combined in 2,2,2-trifluoroethanol (10 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) to provide 103 as a dark purple solid (185 mg, 69%). 1H NMR (CD3OD, 400 MHz) δ 8.13-8.08 (m, 1H), 7.65 (td, J=7.4, 1.6 Hz, 1H), 7.62 (td, J=7.4, 1.6 Hz, 1H), 7.27-7.22 (m, 1H), 6.94 (s, 2H), 6.76 (s, 2H), 5.62-5.57 (m, 2H), 3.16 (s, 6H), 1.78 (d, J=1.4 Hz, 6H), 1.49 (s, 6H), 1.48 (s, 6H); 13C NMR (CD3OD, 101 MHz) δ 173.3 (C), 161.5 (C), 159.6 (C), 154.5 (C), 141.9 (C), 133.6 (C), 133.4 (CH), 131.1 (CH), 130.8 (CH), 130.5 (CH), 130.4 (CH), 126.9 (C), 124.2 (C), 123.8 (CH), 115.4 (C), 96.0 (CH), 60.9 (C), 33.2 (CH3), 29.2 (CH3), 29.1 (CH3), 18.3 (CH3); Analytical HPLC: tR=13.9 min, 98.5% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C34H35N2O3 [M+H]+ 519.2642, found 519.2652.
7,7′—Oxybis(1,2,2,4−tetramethyl-1,2−dihydroquinoline) (12; 300 mg, 0.772 mmol) and 4−carboxyphthalaldehydic acid (109; 150 mg, 0.772 mmol, 1 eq) were combined in 2,2,2-trifluoroethanol (15 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 18 h. The reaction was cooled to room temperature, deposited onto Celite, and concentrated in vacuo. Purification by silica gel chromatography (0-20% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive; dry load with Celite) afforded S20 as a dark red-purple solid (387 mg, 80%, acetate salt). An analytically pure sample for spectral characterization was obtained by reverse phase HPLC (20-60% MeCN/H2O, linear gradient, with constant 0.1% TFA). 1H NMR (CD3OD, 400 MHz, TFA salt) δ 8.40 (dd, J=8.2, 1.5 Hz, 1H), 8.38 (d, J=8.0 Hz, 1H), 8.04-8.02 (m, 1H), 6.84 (s, 2H), 6.73 (s, 2H), 5.67 (q, J=1.4 Hz, 2H), 3.20 (s, 6H), 1.75 (d, J=1.3 Hz, 6H), 1.51 (s, 12H); 13C NMR (CD3OD, 101 MHz, TFA salt) δ 167.9 (C), 167.7 (C), 159.6 (C), 156.7 (C), 154.8 (C), 136.9 (C), 135.9 (C), 134.9 (C), 134.2 (CH), 132.54 (CH), 132.47 (CH), 132.42 (CH), 126.5 (C), 124.8 (C), 122.2 (CH), 115.1 (C), 96.4 (CH), 61.2 (C), 33.4 (CH3), 29.14 (CH3), 29.12 (CH3), 18.1 (CH3); Analytical HPLC: tR=11.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C35H35N2O5 [M+H]+ 563.2540, found 563.2543.
Via lactol condensation route: Bis(1−benzyl-1,2,3,4−tetrahydroquinolin-7-yl)dimethylsilane (27; 400 mg, 0.796 mmol) and tetrafluorophthalaldehydic acid (5; 265 mg, 1.19 mmol, 1.5 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (4 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) to provide 236 mg (42%) of 28 as a pale yellow-green solid.
Via tetrafluorobenzoic acid route: A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 275 mg, 1.42 mmol, 2.5 eq) in THE (5 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 1.02 mL, 2.55 mmol, 4.5 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of 1,11−dibenzyl-13,13−dimethyl-1,2,3,4,8,9,10,11-octahydrosilino[3,2−g:5,6−g′]diquinolin-6(13H)-one32 (S56; 300 mg, 0.567 mmol) in THF (5 mL) was added; the reaction was warmed to room temperature and stirred for 72 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The residue was purified twice by silica gel chromatography (10-100% EtOAc/hexanes, linear gradient; then, 0-20% EtOAc/toluene, linear gradient) yielded 110 mg (28%) of 28 as a pale yellow-green solid.
1H NMR (CDCl3, 400 MHz) δ 7.34-7.28 (m, 4H), 7.26-7.21 (m, 6H), 6.64 (s, 2H), 6.47 (s, 2H), 4.51 (AB quartet, vA=1811.4 Hz, vB=1795.4 Hz, JAB=16.7 Hz, 4H), 3.40-3.32 (m, 4H), 2.73-2.58 (m, 4H), 1.94 (p, J=6.1 Hz, 4H), 0.18 (s, 3H), 0.17 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−139.43 (td, J=20.0, 8.2 Hz, 1F), −139.85 (td, J=20.4, 3.5 Hz, 1F), −143.88 (ddd, J=21.1, 18.6, 8.1 Hz, 1F), −152.53 (ddd, J=21.1, 17.9, 3.4 Hz, 1F); Analytical HPLC: tR=15.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 700 nm); HRMS (ESI) calcd for C42H37F4N2O2Si [M+H]+ 705.2555, found 705.2547.
A round-bottom flask was charged with Pd/C (10%, 69.2 mg, 65.0 mol, 0.2 eq) under nitrogen, and 2−(1,11−dibenzyl-13,13−dimethyl-2,3,4,8,9,10,11,13−octahydrosilino[3,2-g:5,6−g′]diquinolin-6−ylium-6(1H)-yl)-3,4,5,6−tetrafluorobenzoate (28; 229 mg, 0.325 mmol) in THF (10 mL) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 24 h. The reaction mixture was filtered through Celite with MeOH, and the filtrate was concentrated in vacuo. The pale blue residue was resuspended in 3:1 CH2Cl2/MeOH (8 mL), and p-chloranil (160 mg, 0.650 mmol, 2 eq) was added. After stirring the mixture at room temperature for 2 h, it was deposited onto Celite and concentrated to dryness. Silica gel chromatography (20-100% EtOAc/toluene, linear gradient; dry load with Celite) yielded 133 mg (78%) of 29 as a blue solid. 1H NMR (CD3OD, 400 MHz) δ 6.93 (s, 2H), 6.80 (s, 2H), 3.50-3.42 (m, 4H), 2.67 (dt, J=16.0, 6.1 Hz, 2H), 2.57 (dt, J=16.1, 6.2 Hz, 2H), 1.88 (p, J=6.2 Hz, 4H), 0.45 (s, 3H), 0.44 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−140.13 (ddd, J=21.6, 13.2, 3.2 Hz, 1F), −141.67 (ddd, J=22.3, 13.1, 3.7 Hz, 1F), −155.20-−155.37 (m, 1F), −157.47-−157.65 (m, 1F); Analytical HPLC: tR=12.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C28H2 5F4N2O2Si [M+H]+ 525.1616, found 525.1613.
Step 1: Bis(1−benzyl-1,2,3,4−tetrahydroquinolin-7−yl)dimethylsilane (27; 400 mg, 0.796 mmol) and 4−carboxyphthalaldehydic acid (109; 232 mg, 1.19 mmol, 1.5 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (4 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (5-100% EtOAc/hexanes, linear gradient, with constant 1% v/v AcOH additive) to provide 102 mg (19%) of 4−carboxy-2−(1,11−dibenzyl-13,13−dimethyl-2,3,4,8,9,10,11,13-octahydrosilino[3,2−g:5,6−g′]diquinolin-6−ylium-6(1H)-yl)benzoate (S21) as a green solid.
Step 2: A round-bottom flask was charged with Pd/C (10%, 55.0 mg, 51.7 mol, 0.2 eq) under nitrogen, and the product from the first step (S21; 175 mg, 0.259 mmol) in 1:1 THF/MeOH (20 mL) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 24 h. The reaction mixture was filtered through Celite with MeOH and EtOAc, and the filtrate was concentrated in vacuo. The pale blue residue was resuspended in 3:1 CH2Cl2/MeOH (8 mL), and p-chloranil (127 mg, 0.517 mmol, 2 eq) was added. After stirring the mixture at room temperature for 1 h, it was deposited onto Celite and concentrated to dryness. Silica gel chromatography (50-100% EtOAc/hexanes, linear gradient, with constant 1% v/v AcOH additive; dry load with Celite) yielded 98 mg (76%) of S22 as a blue solid. 1H NMR (CD3OD with 1% TFA, 400 MHz) δ 8.31 (d, J=8.1 Hz, 1H), 8.28 (dd, J=8.2, 1.6 Hz, 1H), 7.79 (d, J=1.5 Hz, 1H), 6.99 (s, 2H), 6.57 (s, 2H), 3.51-3.42 (m, 4H), 2.49 (t, J=6.3 Hz, 4H), 1.86 (p, J=6.2 Hz, 4H), 0.52 (s, 3H), 0.47 (s, 3H); 13C NMR (CD3OD with 1% TFA, 101 MHz) δ 168.1 (C), 167.7 (C), 154.0 (C), 146.8 (C), 142.7 (C), 140.2 (CH), 136.1 (C), 135.1 (C), 132.5 (CH), 132.3 (CH), 130.9 (CH), 129.1 (C), 124.0 (C), 123.8 (CH), 43.1 (CH2), 27.6 (CH2), 21.5 (CH2), −1.0 (CH3), −2.1 (CH3); Analytical HPLC: tR=9.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C29H29N2O4Si [M+H]+ 497.1891, found 497.1887.
Via lactol condensation route: Reaction of 30 and 5 according to the method described for 28 (the typical Si-rhodamine lactol protocol) afforded only a very low yield (2%) of 31 as a dark green solid.
Via dibromide route: A solution of bis(9−bromo-2,3,6,7−tetrahydro-1H,5H-pyrido[3,2,1−ij]quinolin-8-yl)dimethylsilane (S6; 400 mg, 0.714 mmol) in THF (15 mL) was cooled to −78° C. under nitrogen. tert-Butyllithium (1.7 M in pentane, 1.85 mL, 3.14 mmol, 4.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. It was then warmed to −10° C. before adding a solution of MgBr2·OEt2 (405 mg, 1.57 mmol, 2.2 eq) in THE (10 mL). After an additional 30 min at −10° C., a solution of tetrafluorophthalic anhydride (4; 346 mg, 1.57 mmol, 2.2 eq) in THE (10 mL) was added dropwise over 30 min via addition funnel. The reaction was then allowed to warm to room temperature overnight (18 h). It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Silica gel chromatography (0-15% MeOH (2 M NH3)/CH2Cl2, linear gradient) afforded 192 mg (44%) of 31 as a dark green solid.
1H NMR (CDCl3, 400 MHz) δ 6.42 (s, 2H), 3.22 (t, J=6.0 Hz, 4H), 3.20-3.15 (m, 4H), 2.95-2.82 (m, 4H), 2.68-2.51 (m, 4H), 2.00 (p, J=6.1 Hz, 4H), 1.89 (p, J=6.3 Hz, 4H), 0.67-0.63 (m, 3H), 0.59 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−139.72 (td, J=20.1, 8.2 Hz, 1F), −142.18 (td, J=20.2, 3.3 Hz, 1F), −143.85 (ddd, J=20.4, 18.3, 8.3 Hz, 1F), −153.92 (ddd, J=21.1, 18.3, 3.3 Hz, 1F); Analytical HPLC: tR=13.3 min, 98.4% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 700 nm); HRMS (ESI) calcd for C34H33F4N2O2Si [M+H]+ 605.2242, found 605.2249.
Step 1: Bis(1−benzyl-2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7-yl)dimethylsilane (32; 175 mg, 0.298 mmol) and tetrafluorophthalaldehydic acid (5; 99.3 mg, 0.447 mmol, 1.5 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (1.5 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-30% EtOAc/hexanes, linear gradient) to provide 97.5 mg (41%) of 2−(1,11−dibenzyl-2,2,4,8,10,10,13,13−octamethyl-2,3,4,8,9,10,11,13-octahydrosilino[3,2−g:5,6−g′]diquinolin-6−ylium-6(1H)-yl)-3,4,5,6−tetrafluorobenzoate as an off-white solid (33; mixture of diastereomers).
Step 2: A round-bottom flask was charged with Pd/C (10%, 93.6 mg, 88.0 mol, 0.2 eq) under nitrogen, and a solution of the intermediate from Step 1 (33; 347 mg, 0.440 mmol) in THE (10 mL) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 24 h. A second portion of Pd/C (10%, 93.6 mg, 88.0 mol, 0.2 eq) was added, and stirring was continued for an additional 24 h (H2, room temperature). The reaction mixture was filtered through Celite with MeOH and THF, and the filtrate was concentrated in vacuo. The pale blue residue was resuspended in 3:1 CH2Cl2/MeOH (8 mL), and p-chloranil (216 mg, 0.880 mmol, 2 eq) was added. After stirring the mixture at room temperature for 1 h, it was deposited onto Celite and concentrated to dryness. Silica gel chromatography (0-50% EtOAc/toluene, linear gradient; dry load with Celite) yielded 228 mg (85%) of 34 as a blue solid (mixture of diastereomers).
1H NMR (CD3OD, 400 MHz) δ 7.05-7.00 (m, 2H), 6.96-6.92 (m, 2H), 2.90-2.73 (m, 2H), 1.87-1.77 (m, 2H), 1.44-1.36 (m, 2H), 1.36-1.32 (m, 6H), 1.30-1.25 (m, 6H), 1.18-1.13 (m, 3H), 1.12-1.07 (m, 3H), 0.49-0.43 (m, 6H); 19F NMR (CD3OD, 376 MHz) δ-139.92-−140.13 (m, 1F), −140.97-−141.27 (m, 1F), −154.89-−155.43 (m, 1F), −157.23-−159.17 (m, 1F); Analytical HPLC: tR (three isomers)=14.1 min, 14.4 min, 14.7 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C34H37F4N2O2Si [M+H]+ 609.2555, found 609.2546.
Step 1: Bis(1−benzyl-2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7-yl)dimethylsilane (32; 400 mg, 0.682 mmol) and phthalaldehydic acid (S16; 128 mg, 0.852 mmol, 1.25 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (3 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-25% EtOAc/hexanes, linear gradient) to provide 190 mg (39%) of 2−(1,11−dibenzyl-2,2,4,8,10,10,13,13−octamethyl-2,3,4,8,9,10,11,13-octahydrosilino[3,2−g:5,6−g′]diquinolin-6−ylium-6(1H)-yl)benzoate as an off-white solid (S23; mixture of diastereomers).
Step 2: A round-bottom flask was charged with Pd/C (10%, 56.4 mg, 53.0 mol, 0.2 eq) under nitrogen, and a solution of the intermediate from Step 1 (S23; 190 mg, 0.265 mmol) in THE (10 mL) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 24 h. A second portion of Pd/C (10%, 56.4 mg, 53.0 mol, 0.2 eq) was added, and stirring was continued for an additional 24 h (H2, room temperature). The reaction mixture was filtered through Celite with MeOH, and the filtrate was concentrated in vacuo. The residue was resuspended in 3:1 CH2Cl2/MeOH (8 mL), and p-chloranil (130 mg, 0.530 mmol, 2 eq) was added. After stirring the mixture at room temperature for 2 h, it was deposited onto Celite and concentrated to dryness. Silica gel chromatography (0-40% EtOAc/hexanes, linear gradient; dry load with Celite) yielded 108 mg (76%) of 100 as a blue solid (mixture of diastereomers).
1H NMR (CD3OD, 400 MHz) δ 8.00-7.94 (m, 1H), 7.82-7.72 (m, 1H), 7.70-7.61 (m, 1H), 7.40-7.28 (m, 1H), 6.86-6.81 (m, 2H), 6.67-6.62 (m, 2H), 2.79-2.63 (m, 2H), 1.74-1.63 (m, 2H), 1.33-1.23 (m, 2H), 1.23-1.18 (m, 6H), 1.16-1.09 (m, 6H), 1.03-0.94 (m, 6H), 0.55-0.51 (m, 3H), 0.49-0.45 (m, 3H); Analytical HPLC: tR (three isomers)=14.2 min, 14.4 min, 14.5 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C34H41N2O2Si [M+H]+ 537.2932, found 537.2927.
Dimethylbis(2,2,4−trimethyl-1,2−dihydroquinolin-7−yl)silane (35; 200 mg, 0.497 mmol) and tetrafluorophthalaldehydic acid (5; 331 mg, 1.49 mmol, 3 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (2.5 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) to provide 36 as a blue-green solid (44.7 mg, 15%). 1H NMR (CDCl3, 400 MHz) δ 6.64 (s, 2H), 6.53 (s, 2H), 5.29 (q, J=1.5 Hz, 2H), 3.87 (s, 2H), 1.77 (d, J=1.4 Hz, 6H), 1.274 (s, 6H), 1.272 (s, 6H), 0.48 (s, 3H), 0.48 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−139.01-−139.26 (m, 2F), −144.21-−144.35 (m, 1F), −151.82 (t, J=18.0 Hz, 1F); Analytical HPLC: tR=11.6 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 725 nm); HRMS (ESI) calcd for C34H33F4N2O2Si [M+H]+ 605.2242, found 605.2243.
Dimethylbis(2,2,4−trimethyl-1,2−dihydroquinolin-7−yl)silane (35; 200 mg, 0.497 mmol) and phthalaldehydic acid (S16; 224 mg, 1.49 mmol, 3 eq) were combined in 2,2,3,3,4,4,4-heptafluoro-1−butanol (2.5 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) to provide 102 as an off-white solid (18 mg, 7%). 1H NMR (CDCl3, 400 MHz) δ 7.97 (dt, J=7.6, 1.0 Hz, 1H), 7.66 (td, J=7.5, 1.2 Hz, 1H), 7.56 (td, J=7.5, 1.0 Hz, 1H), 7.36 (dt, J=7.7, 1.0 Hz, 1H), 6.66 (s, 2H), 6.53 (s, 2H), 5.23 (q, J=1.1 Hz, 2H), 3.81 (s, 2H), 1.63 (d, J=1.1 Hz, 6H), 1.25 (s, 12H), 0.54 (s, 3H), 0.53 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 170.8 (C), 154.2 (C), 142.5 (C), 136.8 (C), 133.4 (CH), 133.0 (C), 129.1 (CH), 128.9 (CH), 128.2 (C), 127.4 (C), 125.8 (CH), 124.9 (CH), 122.5 (CH), 121.9 (C), 117.5 (CH), 92.6 (C), 52.1 (C), 31.7 (CH3), 31.6 (CH3), 18.1 (CH3), 0.6 (CH3), −1.8 (CH3); Analytical HPLC: tR=11.9 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 700 nm); HRMS (ESI) calcd for C34H37N2O2Si [M+H]+ 533.2619, found 533.2616.
Dimethylbis(1,2,2,4−tetramethyl-1,2−dihydroquinolin-7−yl)silane (37; 300 mg, 0.697 mmol) and tetrafluorophthalaldehydic acid (5; 309 mg, 1.39 mmol, 2 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (2.3 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, diluted with saturated NaHCO3, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) provided 38 as a pale yellow-green solid (206 mg, 47%). 1H NMR (CDCl3, 400 MHz) δ 6.66 (s, 2H), 6.53 (s, 2H), 5.28 (q, J=1.4 Hz, 2H), 2.86 (s, 6H), 1.76 (d, J=1.4 Hz, 6H), 1.31 (s, 6H), 1.30 (s, 6H), 0.55 (s, 3H), 0.52 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−139.29 (td, J=20.0, 8.2 Hz, 1F), −140.03 (td, J=20.0, 3.5 Hz, 1F), −144.18 (ddd, J=20.7, 18.5, 8.3 Hz, 1F), −152.19 (ddd, J=21.1, 18.3, 3.6 Hz, 1F); Analytical HPLC: tR=12.6 min, 98.9% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 750 nm); HRMS (ESI) calcd for C36H37F4N2O2Si [M+H]+ 633.2555, found 633.2549.
Dimethylbis(1,2,2,4−tetramethyl-1,2−dihydroquinolin-7−yl)silane (37; 300 mg, 0.697 mmol) and phthalaldehydic acid (S16; 157 mg, 1.04 mmol, 1.5 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (2.3 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 18 h. The reaction was cooled to room temperature, diluted with saturated NaHCO3, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude material was purified twice by silica gel chromatography (0-25% EtOAc/toluene, linear gradient; then, 0-50% EtOAc/hexanes, linear gradient) to provide 104 as an off-white solid (41.8 mg, 11%). 1H NMR (CDCl3, 400 MHz) δ 7.96 (dt, J=7.6, 1.0 Hz, 1H), 7.61 (td, J=7.5, 1.2 Hz, 1H), 7.52 (td, J=7.5, 1.0 Hz, 1H), 7.28 (d, J=7.7 Hz, 1H), 6.69 (s, 2H), 6.53 (s, 2H), 5.21 (t, J=1.5 Hz, 2H), 2.85 (s, 6H), 1.63 (d, J=1.4 Hz, 6H), 1.29 (s, 6H), 1.27 (s, 6H), 0.61 (s, 3H), 0.57 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 171.1 (C), 155.1 (C), 144.2 (C), 136.6 (C), 133.6 (CH), 131.9 (C), 130.8 (CH), 128.7 (CH), 127.8 (C), 127.0 (C), 125.6 (CH), 124.5 (CH), 123.8 (C), 122.2 (CH), 114.4 (CH), 92.3 (C), 56.6 (C), 30.8 (CH3), 28.2 (CH3), 27.6 (CH3), 18.2 (CH3), 0.5 (CH3), −1.2 (CH3); Analytical HPLC: tR=12.2 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 725 nm); HRMS (ESI) calcd for C36H41N2O2Si [M+H]+ 561.2932, found 561.2921.
Dimethylbis(1,2,2,4−tetramethyl-1,2−dihydroquinolin-7−yl)silane (37; 300 mg, 0.697 mmol) and 4−carboxyphthalaldehydic acid (109; 203 mg, 1.04 mmol, 1.5 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (3.5 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified twice by silica gel chromatography (10-100% EtOAc/hexanes, linear gradient with constant 0.1% v/v AcOH additive) to provide 110 as a green solid (63.4 mg, 15%). An analytically pure sample for spectral characterization was obtained by reverse phase HPLC (30-70% MeCN/H2O, linear gradient, with constant 0.1% TFA). 1H NMR (CD3OD, 400 MHz, TFA salt) δ 8.23 (dd, J=8.0, 1.3 Hz, 1H), 8.06 (dd, J=8.0, 0.7 Hz, 1H), 7.87 (dd, J=1.3, 0.7 Hz, 1H), 6.84 (s, 2H), 6.54 (s, 2H), 5.31 (q, J=1.5 Hz, 2H), 2.91 (s, 6H), 1.61 (d, J=1.4 Hz, 6H), 1.29 (s, 6H), 1.27 (s, 6H), 0.65 (s, 3H), 0.56 (s, 3H); 13C NMR (CD3OD, 101 MHz, TFA salt) δ 171.7 (C), 168.5 (C), 154.9 (C), 146.7 (C), 139.3 (C), 138.0 (C), 132.4 (CH), 131.8 (C), 131.25 (C), 131.21 (CH), 128.2 (C), 127.26 (CH), 127.21 (CH), 125.1 (C), 123.8 (CH), 116.4 (CH), 58.2 (C), 31.4 (CH3), 27.9 (CH3), 18.1 (CH3), 0.0 (CH3), −1.1 (CH3); Analytical HPLC: tR=12.7 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 725 nm); HRMS (ESI) calcd for C37H41N2O4Si [M+H]+ 605.2830, found 605.2816.
3,3′-(Dimethylsilanediyl)bis(N,N-dimethylaniline)1 (23; 200 mg, 0.670 mmol) and tetrafluoro-phthalaldehydic acid (5; 446 mg, 2.01 mmol, 3 eq) were combined in 2,2,3,3,4,4,4-heptafluoro-1−butanol (2.2 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 72 h. The reaction was cooled to room temperature, diluted with saturated NaHCO3, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) provided 22 as a blue-green solid (194 mg, 58%). The characterization data for 22 matched the previously reported spectra.1
Via lactol condensation route: 1,1′-(Oxybis(3,1−phenylene))bis(pyrrolidine-2,2,3,3,4,4,5,5−d8) (9; 248 mg, 0.764 mmol) and tetrafluorophthalaldehydic acid (5; 170 mg, 0.764 mmol, 1 eq) were combined in 2,2,2−trifluoroethanol (15 mL) in a round-bottom flask. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-10% MeOH (2 M NH3)/CH2Cl2, linear gradient) to provide 8 as a dark purple solid (343 mg, 85%).
Via dibromide route: A solution of 1,1′-(oxybis(4−bromo-3,1-phenylene))bis(pyrrolidine-2,2,3,3,4,4,5,5−d8) (7; 300 mg, 0.622 mmol) in THE (15 mL) was cooled to −78° C. under nitrogen. tert-Butyllithium (1.7 M in pentane, 1.61 mL, 2.74 mmol, 4.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. It was then warmed to −10° C. before adding a solution of MgBr2 OEt2 (353 mg, 1.37 mmol, 2.2 eq) in THE (10 mL). After an additional 30 min at −10° C., a solution of tetrafluorophthalic anhydride (4; 301 mg, 1.37 mmol, 2.2 eq) in THE (10 mL) was added dropwise over 30 min via addition funnel. The reaction was then allowed to warm to room temperature overnight (18 h). Following the addition of AcOH (500 L), the mixture was diluted with MeOH, deposited onto Celite, and concentrated to dryness. Silica gel chromatography (0-10% MeOH (2 M NH3)/CH2Cl2, linear gradient; dry load with Celite) afforded 113 mg (34%) of 8 as a dark purple solid.
1H NMR (CD3OD, 400 MHz) δ 7.34 (dd, J=9.3, 0.9 Hz, 1H), 6.93 (dd, J=9.4, 2.3 Hz, 1H), 6.76 (d, J=2.3 Hz, 1H); 19F NMR (CD3OD, 376 MHz) δ−139.00 (ddd, J=21.1, 12.5, 4.1 Hz, 1F), −140.94 (ddd, J=22.4, 12.8, 3.7 Hz, 1F), −153.55 (ddd, J=22.7, 19.1, 4.1 Hz, 1F), −157.66-−157.87 (m, 1F); Analytical HPLC: tR=12.4 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C28H7D16F4N2O3[M+H]+ 527.2644, found 527.2640.
1,1′-(Oxybis(3,1−phenylene))bis(pyrrolidine-2,2,3,3,4,4,5,5−d8) (9; 45 mg, 0.139 mmol) and 4−carboxyphthalaldehydic acid (109; 40.4 mg, 0.208 mmol, 1.5 eq) were combined in 2,2,2−trifluoroethanol (3 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 80° C. under the O2 balloon for 24 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-20% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive) to provide S24 as a dark red solid (61.2 mg, 79%, acetate salt). The characterization data for S24 matched the previously reported spectra.45
Via lactol condensation route: Dimethylbis(3−(pyrrolidin-1−yl-d8)phenyl)silane (26; 250 mg, 0.682 mmol) and tetrafluorophthalaldehydic acid (5; 151 mg, 0.682 mmol, 1 eq) were combined in 2,2,3,3,4,4,4−heptafluoro-1−butanol (3 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 48 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (0-75% EtOAc/hexanes, linear gradient) to provide 25 as a blue solid (247 mg, 64%).
Via dibromide route: A solution of bis(2−bromo-5−(pyrrolidin-1−yl-d8)phenyl)dimethylsilane (24; 600 mg, 1.14 mmol) in THE (40 mL) was cooled to −78° C. under nitrogen. tert-Butyllithium (1.7 M in pentane, 2.96 mL, 5.03 mmol, 4.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. It was then warmed to −10° C. before adding a solution of MgBr2 OEt2 (650 mg, 2.52 mmol, 2.2 eq) in THF (10 mL). After an additional 30 min at −10° C., a solution of tetrafluorophthalic anhydride (4; 554 mg, 2.52 mmol, 2.2 eq) in THE (10 mL) was added dropwise over 30 min via addition funnel. The reaction was then allowed to warm to room temperature overnight (18 h). It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Silica gel chromatography (0-75% EtOAc/hexanes, linear gradient) afforded 326 mg (50%) of 25 as a blue solid.
1H NMR (CDCl3, 400 MHz) δ 6.78 (d, J=2.9 Hz, 2H), 6.77 (d, J=8.6 Hz, 2H), 6.45 (dd, J=8.8, 2.7 Hz, 2H), 0.58 (s, 3H), 0.55 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−139.43-−139.69 (m, 2F), −144.25-−144.45 (m, 1F), −152.39-−152.57 (m, 1F); Analytical HPLC: tR=13.4 min, 98.8% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C30H13D16F4N2O2Si [M+H]+ 569.2933, found 569.2943.
Dimethylbis(3−(pyrrolidin-1−yl-d8)phenyl)silane (26; 250 mg, 0.682 mmol) and 4-carboxyphthalaldehydic acid (109; 132 mg, 0.682 mmol, 1 eq) were combined in 2,2,3,3,4,4,4-heptafluoro-1−butanol (2.5 mL) in a crimp-top vial. The reaction mixture was sparged with O2 from a balloon for 10 min, then stirred at 95° C. under the O2 balloon for 72 h. The reaction was cooled to room temperature, concentrated in vacuo, and purified by silica gel chromatography (10-100% EtOAc/hexanes, linear gradient, with constant 0.1% v/v AcOH additive) to provide S25 as a blue solid (139 mg, 38%). The characterization data for S25 matched the previously reported spectra.45
A solution of 1,3−dibromobenzene (S27; 14.02 g, 59.45 mmol, 1.1 eq) in THE (100 mL) was cooled to −78° C. under nitrogen. n-Butyllithium (2.5 M in hexanes, 23.78 mL, 59.45 mmol, 1.1 eq) was added, and the reaction was stirred at −78° C. for 30 min. 3-Bromobenzaldehye (S28; 10.00 g, 54.05 mmol) was then added. The dry ice bath was removed, and the reaction was stirred at room temperature for 2 h. It was subsequently quenched with saturated NH4Cl, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-50% Et2O/hexanes, linear gradient) afforded 16.15 g (92%) of S29 as a colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.54 (t, J=1.9 Hz, 2H), 7.42 (ddd, J=7.8, 2.0, 1.2 Hz, 2H), 7.30-7.26 (m, 2H), 7.22 (t, J=7.7 Hz, 2H), 5.76 (s, 1H), 2.25 (s, 1H); 13C NMR (CDCl3, 101 MHz) δ 145.4 (C), 131.1 (CH), 130.4 (CH), 129.6 (CH), 125.3 (CH), 122.9 (C), 75.1 (CH); HRMS (EI) calcd for C13H10Br2O [M]+·339.9098, found 339.3088.
To a solution of bis(3−bromophenyl)methanol (S29; 11.80 g, 34.50 mmol) in CH2Cl2 (100 mL) was added MnO2 (50.00 g) in two portions. After stirring the reaction at room temperature for 18 h, it was filtered through Celite with CH2Cl2 and concentrated in vacuo. The resulting white solid was recrystallized from hot EtOAc to yield 11.20 g (95%) of S30 as white crystals. 1H NMR (CDCl3, 400 MHz) δ 7.93 (t, J=1.8 Hz, 2H), 7.74 (ddd, J=8.0, 2.1, 1.1 Hz, 2H), 7.71-7.67 (m, 2H), 7.38 (t, J=7.9 Hz, 2H); 13C NMR (CDCl3, 101 MHz) δ 193.8 (C), 138.9 (C), 135.9 (CH), 132.9 (CH), 130.2 (CH), 128.7 (CH), 123.0 (C); HRMS (EI) calcd for C13H8Br2O [M]+·337.8942, found 337.8947.
An oven-dried 500 mL 3−neck round-bottom flask equipped with two addition funnels was charged with CH2Cl2 (100 mL) under nitrogen and cooled to −40° C. Solutions of TiCl4 (1 M in CH2Cl2, 80.00 mL, 80.00 mmol, 4 eq) followed by Me2Zn (2 M in toluene, 40.00 mL, 80.00 mmol, 4 eq) were successively added dropwise via the addition funnels. The reaction was stirred at −40° C. to −30° C. for 20 min. A solution of bis(3−bromophenyl)methanone (S30; 6.80 g, 20.00 mmol) in CH2Cl2 (100 mL) was added via cannula; the resulting suspension was then warmed to room temperature and vigorously stirred for 3 h. The mixture was carefully diluted with water (˜200 mL) and extracted with CH2Cl2 (2×). The combined organic extracts were dried over anhydrous MgSO4, filtered through Celite, and concentrated in vacuo. Silica gel chromatography (100% hexanes, isocratic) afforded 6.83 g (96%) of S31 as a colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.37 (t, J=1.8 Hz, 2H), 7.33 (ddd, J=7.6, 2.0, 1.3 Hz, 2H), 7.14 (t, J=7.8 Hz, 2H), 7.11-7.08 (m, 2H), 1.64 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 152.4 (C), 129.90 (CH), 129.86 (CH), 129.2 (CH), 125.8 (CH), 122.6 (C), 43.3 (C), 30.6 (CH3); HRMS (EI) calcd for C15H14Br2 [M]+·351.9462, found 351.9480.
An oven-dried crimp-top vial was charged with CuI (108 mg, 0.565 mmol, 0.2 eq), L-proline (130 mg, 1.13 mmol, 0.4 eq), and K2CO3 (1.56 g, 11.30 mmol, 4 eq). The flask was sealed and evacuated/backfilled with nitrogen (3×). A solution of 3,3′-(propane-2,2-diyl)bis(bromobenzene) (S31; 1.00 g, 2.82 mmol) in DMSO (11 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of pyrrolidine-2,2,3,3,4,4,5,5−ds (1.42 mL, 16.94 mmol, 6 eq), the reaction was stirred at 100° C. for 18 h. It was then cooled to room temperature, diluted with saturated NH4Cl, and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-20% Et2O/hexanes, linear gradient) afforded 809 mg (82%) of 41 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.10 (t, J=7.9 Hz, 2H), 6.58-6.52 (m, 2H), 6.51 (t, J=2.1 Hz, 2H), 6.42-6.35 (m, 2H), 1.67 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 152.0 (C), 147.9 (C), 128.7 (CH), 114.9 (CH), 110.4 (CH), 109.0 (CH), 43.3 (C), 31.0 (CH3); HRMS (ESI) calcd for C23H15D16N2[M+H]+ 351.3486, found 351.3478.
1,1′-(Propane-2,2−diylbis(3,1−phenylene))bis(pyrrolidine-2,2,3,3,4,4,5,5−d8) (41; 1.19 g, 3.39 mmol) was taken up in DMF (30 mL) and cooled to 0° C. N-Bromosuccinimide (1.21 g, 6.79 mmol, 2 eq) was added portion-wise over 5 min, and the reaction was subsequently stirred at 0° C. for 2 h. After removing DMF by rotary evaporation, the resulting residue was diluted with water and extracted with CH2Cl2 (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel chromatography (0-100% CH2Cl2/hexanes, linear gradient) afforded 716 mg (41%) of 39 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.24 (d, J=8.7 Hz, 2H), 6.82 (d, J=2.9 Hz, 2H), 6.29 (dd, J=8.6, 2.9 Hz, 2H), 1.81 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 147.41 (C), 147.36 (C), 135.1 (CH), 112.5 (CH), 111.3 (CH), 108.1 (C), 46.2 (C), 29.5 (CH3); HRMS (ESI) calcd for C23H13D16Br2N2[M+H]+ 509.1676, found 509.1668.
Step 1: An oven-dried round-bottom flask was charged with tert-butyl carbamate (4.76 g, 40.67 mmol, 2.4 eq), CuI (3.23 g, 16.94 mmol, 1 eq), and K3PO 4 (10.79 g, 50.83 mmol, 3 eq). The flask was sealed and evacuated/backfilled with nitrogen (3×). A solution of 3,3′-(propane-2,2−diyl)bis(bromobenzene) (S31; 6.00 g, 16.94 mmol) in dioxane (60 mL) was added via cannula, and the reaction was flushed again with nitrogen (3×). Following the addition of N,N-dimethylethylenediamine (1.82 mL, 16.94 mmol, 1 eq), the reaction was stirred at 110° C. for 18 h. It was then cooled to room temperature, diluted with EtOAc (˜250 mL) and saturated NH4Cl (˜250 mL), and vigorously stirred for 15 min while open to air. The resulting suspension was filtered; the filter cake was washed (water, EtOAc) and dried to provide a large crop of white powder that was identified as the desired dicarbamate product by NMR and LC/MS analysis. The filtrate was partitioned, and the aqueous layer was extracted again with EtOAc (3×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and evaporated. The white residue was triturated with Et2O, filtered, washed with additional Et2O, and dried to afford a second, smaller crop of the product. The two batches were combined to yield a total of 6.39 g (88%) of di-tert-butyl (propane-2,2−diylbis(3,1-phenylene))dicarbamate (S32) as a white solid.
Step 2: The dicarbamate (S32; 6.39 g, 14.98 mmol) was suspended in CH2Cl2 (60 mL), and trifluoroacetic acid (12 mL) was added. The reaction was stirred at room temperature for 4 h. It was then diluted with toluene (60 mL) and concentrated to dryness. The residue was taken up in saturated NaHCO3 and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and evaporated. Flash chromatography (10-100% EtOAc/hexanes, linear gradient) afforded 2.34 g (69%) of S33 as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.06 (t, J=7.8 Hz, 2H), 6.68 (ddd, J=7.8, 1.8, 1.0 Hz, 2H), 6.54 (t, J=2.0 Hz, 2H), 6.51 (ddd, J=7.8, 2.3, 1.0 Hz, 2H), 3.56 (s, 4H), 1.60 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 152.2 (C), 146.1 (C), 128.9 (CH), 117.4 (CH), 114.3 (CH), 112.7 (CH), 42.9 (C), 30.7 (CH3); HRMS (ESI) calcd for C15H19N2[M+H]+ 227.1543, found 227.1544.
A mixture of 3,3′-(propane-2,2−diyl)dianiline (S33; 2.30 g, 10.16 mmol), Na2CO3 (8.62 g, 81.30 mmol, 8 eq), and 1−bromo-3−chloropropane (24.15 mL, 243.9 mmol, 24 eq) was stirred at 140° C. for 48 h. The gummy, heterogeneous mixture that resulted was cooled to room temperature, diluted with water, and extracted with EtOAc (2×). The organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The resulting red residue was taken back up in DMF (15 mL) and stirred at 160° C. for 18 h. The reaction was cooled to room temperature, diluted with saturated NaHCO3, and extracted with CH2Cl2 (2×). The CH2Cl2 extracts were dried over anhydrous MgSO4, filtered, and evaporated. Silica gel chromatography (0-20% Et2O/hexanes, linear gradient) yielded 2.04 g (52%) of 56 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 6.76 (AB quartet, vA=2710.7 Hz, vB=2693.5 Hz, JAB=8.0 Hz, 4H), 3.09 (t, J=5.7 Hz, 4H), 2.97 (t, J=6.3 Hz, 4H), 2.73 (t, J=6.5 Hz, 4H), 2.42-1.82 (m, 8H), 1.65-1.54 (m, 10H) 13C NMR (CDCl3, 101 MHz) δ 146.0 (C), 143.5 (C), 126.7 (CH), 121.7 (C), 119.7 (C), 113.1 (CH), 51.0 (CH2), 50.2 (CH2), 43.6 (C), 31.4 (CH3), 28.2 (CH2), 25.3 (CH2), 22.4 (CH2); HRMS (ESI) calcd for C27H35N2[M+H]+ 387.2795, found 387.2796.
A solution of 1,3−dibromobenzene (S27; 25.00 g, 106.0 mmol, 1.2 eq) in THE (200 mL) was cooled to −78° C. under nitrogen. n-Butyllithium (2.7 M in hexanes, 39.25 mL, 106.0 mmol, 1.2 eq) was added, and the reaction was stirred at −78° C. for 30 min. m-Anisaldehyde (S34; 10.76 mL, 88.31 mmol) was then added. The dry ice bath was removed, and the reaction was stirred at room temperature for 2 h. It was subsequently quenched with saturated NH4Cl, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-50% Et2O/hexanes, linear gradient) afforded 22.23 g (86%) of S35 as a pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ 7.56 (t, J=1.9 Hz, 1H), 7.39 (ddd, J=7.9, 2.1, 1.2 Hz, 1H), 7.31-7.27 (m, 1H), 7.26 (t, J=8.2 Hz, 1H), 7.19 (t, J=7.8 Hz, 1H), 6.95-6.90 (m, 2H), 6.82 (ddd, J=8.4, 2.5, 1.2 Hz, 1H), 5.77 (d, J=3.4 Hz, 1H), 3.79 (s, 3H), 2.22 (d, J=3.4 Hz, 1H); 13C NMR (CDCl3, 101 MHz) δ 160.0 (C), 146.0 (C), 145.0 (C), 130.8 (CH), 130.2 (CH), 129.9 (CH), 129.6 (CH), 125.2 (CH), 122.8 (C), 119.0 (CH), 113.4 (CH), 112.4 (CH), 75.7 (CH), 55.4 (CH3); HRMS (EI) calcd for C14H13BrO2 [M]+·292.0094, found 292.0088.
To a solution of (3−bromophenyl)(3−methoxyphenyl)-methanol (S35; 21.75 g, 74.19 mmol) in CH2Cl2 (400 mL) was added MnO2 (100 g, portion-wise over 10 min). After stirring the reaction at room temperature for 18 h, it was filtered through Celite with CH2Cl2 and concentrated in vacuo. Silica gel chromatography (0-40% Et2O/hexanes, linear gradient) yielded 20.34 g (94%) of S36 as a viscous, colorless oil that crystallized into a white solid upon standing.
1H NMR (CDCl3, 400 MHz) δ 7.94 (t, J=1.8 Hz, 1H), 7.74-7.69 (m, 2H), 7.40 (t, J=7.2 Hz, 1H), 7.38-7.33 (m, 2H), 7.31 (dt, J=7.6, 1.3 Hz, 1H), 7.16 (ddd, J=8.2, 2.7, 1.1 Hz, 1H), 3.87 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 195.1 (C), 159.9 (C), 139.7 (C), 138.4 (C), 135.4 (CH), 132.9 (CH), 130.0 (CH), 129.5 (CH), 128.7 (CH), 123.0 (CH), 122.7 (C), 119.5 (CH), 114.4 (CH), 55.6 (CH3); HRMS (ESI) calcd for C14H12BrO2 [M+H]+ 291.0015, found 291.0021.
An oven-dried 1 L 3−neck round-bottom flask equipped with two addition funnels was charged with CH2Cl2 (150 mL) under nitrogen and cooled to −30° C. Solutions of TiCl4 (1 M in CH2Cl2, 100.0 mL, 100.0 mmol, 4 eq) followed by Me2Zn (1.2 M in toluene, 83.33 mL, 100.0 mmol, 4 eq) were successively added dropwise via the addition funnels. The reaction was stirred at −30° C. for 20 min. A solution of (3−bromophenyl)(3−methoxyphenyl)methanone (S36; 7.28 g, 25.00 mmol) in CH2Cl2 (50 mL) was added dropwise via cannula; the resulting brown suspension was then warmed to room temperature and vigorously stirred for 3 h. The mixture was carefully diluted with water (˜400 mL) and extracted with CH2Cl2 (2×). The combined organic extracts were dried over anhydrous MgSO4, filtered through Celite, and concentrated in vacuo. Silica gel chromatography (0-10% Et2O/hexanes, linear gradient) afforded 7.23 g (95%) of S37 as a viscous, colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.41-7.37 (m, 1H), 7.33-7.27 (m, 1H), 7.23-7.17 (m, 1H), 7.14-7.09 (m, 2H), 6.81-6.76 (m, 2H), 6.75-6.71 (m, 1H), 3.77 (s, 3H), 1.65 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 159.5 (C), 153.1 (C), 151.7 (C), 129.9 (CH), 129.7 (CH), 129.2 (CH), 129.0 (CH), 125.8 (CH), 122.5 (C), 119.5 (CH), 113.6 (CH), 110.5 (CH), 55.3 (CH3), 43.2 (C), 30.7 (CH3); HRMS (EI) calcd for C16H17BrO [M]+·304.0458, found 304.0469.
An oven-dried round-bottom flask was charged with tert-butyl carbamate (4.61 g, 39.32 mmol, 1.2 eq), CuI (3.12 g, 16.38 mmol, 0.5 eq), and K3PO 4 (10.43 g, 49.14 mmol, 1.5 eq). The flask was sealed and evacuated/backfilled with nitrogen (3×). A solution of 1−bromo-3-(2−(3−methoxyphenyl)propan-2−yl)benzene (S37; 10.00 g, 32.76 mmol) in dioxane (100 mL) was added via cannula, and the reaction was flushed again with nitrogen (3×). Following the addition of N,N′-dimethylethylenediamine (1.76 mL, 16.38 mmol, 0.5 eq), the reaction was stirred at 110° C. for 18 h. It was then cooled to room temperature, stirred open to air for 3 h, filtered through Celite with EtOAc, and concentrated in vacuo. Purification of the crude residue by flash chromatography (0-25% EtOAc/hexanes, linear gradient) yielded 10.42 g (93%) of S38 as a viscous, colorless gum that crystallized into a white solid upon standing. 1H NMR (CDCl3, 400 MHz) δ 7.33 (d, J=8.0 Hz, 1H), 7.18 (td, J=8.1, 2.0 Hz, 2H), 7.05 (t, J=2.0 Hz, 1H), 6.90 (ddd, J=7.8, 1.9, 1.0 Hz, 1H), 6.83-6.77 (m, 2H), 6.71 (ddd, J=8.1, 2.4, 1.1 Hz, 1H), 6.40 (s, 1H), 3.75 (s, 3H), 1.64 (s, 6H), 1.49 (s, 9H); 13C NMR (CDCl3, 101 MHz) δ 159.4 (C), 152.9 (C), 152.4 (C), 151.6 (C), 138.2 (C), 129.0 (CH), 128.8 (CH), 121.8 (CH), 119.6 (CH), 117.3 (CH), 116.2 (CH), 113.5 (CH), 110.4 (CH), 80.5 (C), 55.3 (CH3), 43.1 (C), 30.8 (CH3), 28.5 (CH3); HRMS (ESI) calcd for C21H27NO3Na [M+Na]+364.1883, found 364.1884.
tert-Butyl (3−(2−(3−methoxyphenyl)propan-2−yl)phenyl)-carbamate (S38; 10.30 g, 30.17 mmol) was taken up in CH2Cl2 (200 mL), and trifluoroacetic acid (40 mL) was added. The reaction was stirred at room temperature for 2 h. It was then diluted with toluene (100 mL) and concentrated to dryness. The residue was taken up in saturated NaHCO3 and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography (0-40% EtOAc/hexanes, linear gradient) afforded 6.72 g (92%) of S39 as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.18 (t, J=8.2 Hz, 1H), 7.05 (t, J=7.8 Hz, 1H), 6.84-6.80 (m, 2H), 6.71 (ddd, J=8.2, 2.5, 1.0 Hz, 1H), 6.66 (ddd, J=7.8, 1.9, 1.0 Hz, 1H), 6.53 (t, J=2.1 Hz, 1H), 6.50 (ddd, J=7.8, 2.4, 1.0 Hz, 1H), 3.76 (s, 3H), 3.45 (s, 2H), 1.63 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 159.4 (C), 152.7 (C), 151.9 (C), 146.1 (C), 128.97 (CH), 128.96 (CH), 119.7 (CH), 117.4 (CH), 114.2 (CH), 113.5 (CH), 112.8 (CH), 110.3 (CH), 55.3 (CH3), 43.0 (C), 30.7 (CH3); HRMS (ESI) calcd for C16H20NO [M+H]+ 242.1539, found 242.1541.
3−(2−(3−Methoxyphenyl)-propan-2−yl)aniline (S39; 2.20 g, 9.12 mmol) and iodine (463 mg, 1.82 mmol, 0.2 eq) were combined in acetone (50 mL) and stirred at reflux for 18 h. The reaction was then cooled to room temperature, concentrated to dryness, and purified by silica gel chromatography (0-20% Et2O/hexanes, linear gradient) to afford 1.91 g (65%) of S40 as a colorless oil that crystallized into an off-white solid upon standing. 1H NMR (CDCl3, 400 MHz) δ 7.17 (t, J=8.2 Hz, 1H), 6.95 (d, J=8.0 Hz, 1H), 6.85-6.81 (m, 2H), 6.70 (ddd, J=8.1, 2.5, 1.0 Hz, 1H), 6.52 (dd, J=8.0, 1.9 Hz, 1H), 6.27 (d, J=1.9 Hz, 1H), 5.24 (q, J=1.5 Hz, 1H), 3.76 (s, 3H), 3.60 (s, 1H), 1.95 (d, J=1.4 Hz, 3H), 1.61 (s, 6H), 1.24 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 159.4 (C), 152.7 (C), 151.1 (C), 142.9 (C), 128.9 (CH), 128.5 (C), 127.8 (CH), 123.3 (CH), 119.7 (CH), 119.3 (C), 115.9 (CH), 113.5 (CH), 111.8 (CH), 110.3 (CH), 55.3 (CH3), 52.0 (C), 42.9 (C), 31.3 (CH3), 30.7 (CH3), 18.6 (CH3); HRMS (ESI) calcd for C22H28NO [M+H]+ 322.2165, found 322.2168.
7−(2−(3−Methoxy-phenyl)propan-2−yl)-2,2,4−trimethyl-1,2−dihydroquinoline (S40; 1.50 g, 4.67 mmol), K2CO3 (3.87 g, 28.00 mmol, 6 eq), and iodoethane (4.50 mL, 55.99 mmol, 12 eq) were combined in DMF (24 mL) in a heavy-wall pressure flask. The vessel was sealed (PTFE bushing, Viton O-ring) and stirred at 120° C. for 4 h. After cooling to room temperature, the mixture was diluted with water and extracted with EtOAc (2×). The organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-10% Et2O/hexanes, linear gradient) afforded 1.57 g (96%) of S41 as a colorless gum. 1H NMR (CDCl3, 400 MHz) δ 7.20-7.14 (m, 1H), 6.94 (d, J=7.9 Hz, 1H), 6.87 (d, J=1.7 Hz, 1H), 6.87-6.84 (m, 1H), 6.74-6.66 (m, 1H), 6.48 (dd, J=7.9, 1.8 Hz, 1H), 6.26 (d, J=1.8 Hz, 1H), 5.13 (q, J=1.5 Hz, 1H), 3.76 (s, 3H), 3.19 (q, J=7.0 Hz, 2H), 1.93 (d, J=1.4 Hz, 3H), 1.65 (s, 6H), 1.28 (s, 6H), 1.02 (t, J=7.0 Hz, 3H); 13C NMR (CDCl3, 101 MHz) δ 159.4 (C), 152.9 (C), 151.1 (C), 143.1 (C), 128.9 (CH), 128.7 (CH), 127.6 (C), 123.3 (CH), 120.3 (C), 119.8 (CH), 113.6 (CH), 113.5 (CH), 110.2 (CH), 109.7 (CH), 57.0 (C), 55.3 (CH3), 43.2 (C), 38.1 (CH2), 30.7 (CH3), 28.9 (CH3), 18.8 (CH3), 14.2 (CH3); HRMS (ESI) calcd for C24H32NO [M+H]+ 350.2478, found 350.2481.
A round-bottom flask was charged with Pd/C (10%, 1.52 g, 1.43 mmol, 0.2 eq) under nitrogen, and 1-ethyl-7−(2−(3−methoxyphenyl)propan-2−yl)-2,2,4−trimethyl-1,2-dihydroquinoline (S41; 2.50 g, 7.15 mmol) in THE (70 mL) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 4 h. The reaction mixture was filtered through Celite with EtOAc and concentrated in vacuo. Silica gel chromatography (0-10% Et2O/hexanes, linear gradient) yielded 2.46 g (98%) of S42 as a colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.18 (t, J=8.2 Hz, 1H), 7.01 (dd, J=7.9, 1.2 Hz, 1H), 6.90-6.85 (m, 2H), 6.70 (ddd, J=8.1, 2.4, 1.0 Hz, 1H), 6.49 (dd, J=7.9, 1.8 Hz, 1H), 6.35 (d, J=1.9 Hz, 1H), 3.77 (s, 3H), 3.33 (dq, J=14.2, 7.0 Hz, 1H), 3.04 (dq, J=13.9, 6.9 Hz, 1H), 2.90-2.78 (m, 1H), 1.67 (dd, J=12.9, 4.8 Hz, 1H), 1.66 (s, 6H), 1.54 (t, J=12.8 Hz, 1H), 1.29 (d, J=6.5 Hz, 3H), 1.28 (s, 3H), 1.14 (s, 3H), 1.02 (t, J=6.9 Hz, 3H); 13C NMR (CDCl3, 101 MHz) δ 159.4 (C), 153.0 (C), 149.0 (C), 144.2 (C), 128.8 (CH), 125.3 (CH), 125.0 (C), 119.9 (CH), 113.6 (CH), 113.5 (CH), 110.4 (CH), 110.1 (CH), 55.3 (CH3), 54.4 (C), 47.2 (CH2), 43.0 (C), 39.1 (CH2), 30.9 (CH3), 30.8 (CH3), 29.9 (CH3), 27.1 (CH), 25.4 (CH3), 20.0 (CH3), 15.0 (CH3); HRMS (ESI) calcd for C24H34NO [M+H]+ 352.2635, found 352.2636.
1−Ethyl-7−(2−(3−methoxyphenyl)propan-2−yl)-2,2,4−trimethyl-1,2,3,4-tetrahydroquinoline (S42; 2.00 g, 5.69 mmol) was dissolved in glacial AcOH (12 mL); 48% aqueous HBr (12 mL) was added, and the mixture was stirred at reflux for 4 h. After cooling to room temperature, the solution was carefully diluted into water (100 mL), adjusted to pH 5-6 with 25% w/w NaOH, and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (0-40% EtOAc/hexanes, linear gradient) afforded 1.83 g (95%) of S43 as a colorless gum. 1H NMR (CDCl3, 400 MHz) δ 7.13 (t, J=7.9 Hz, 1H), 7.02 (dd, J=7.9, 1.2 Hz, 1H), 6.92-6.87 (m, 1H), 6.73 (t, J=2.1 Hz, 1H), 6.65-6.61 (m, 1H), 6.50 (dd, J=7.9, 1.9 Hz, 1H), 6.34 (d, J=1.9 Hz, 1H), 4.52 (s, 1H), 3.33 (dq, J=14.2, 7.0 Hz, 1H), 3.05 (dq, J=14.1, 6.9 Hz, 1H), 2.90-2.79 (m, 1H), 1.67 (dd, J=12.9, 4.8 Hz, 1H), 1.64 (s, 6H), 1.54 (t, J=12.8 Hz, 1H), 1.29 (d, J=7.3 Hz, 3H), 1.28 (s, 3H), 1.15 (s, 3H), 1.02 (t, J=7.0 Hz, 3H); 13C NMR (CDCl3, 101 MHz) δ 155.2 (C), 153.4 (C), 149.0 (C), 144.2 (C), 129.1 (CH), 125.3 (CH), 125.0 (C), 119.5 (CH), 114.3 (CH), 113.4 (CH), 112.4 (CH), 110.5 (CH), 54.4 (C), 47.2 (CH2), 42.9 (C), 39.1 (CH2), 30.8 (CH3), 29.9 (CH3), 27.0 (CH), 25.4 (CH3), 20.0 (CH3), 15.0 (CH3); HRMS (ESI) calcd for C23H32NO [M+H]+ 338.2478, found 338.2478.
3−(2−(1−Ethyl-2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7−yl)propan-2−yl)phenol (S43; 1.70 g, 5.04 mmol) was taken up in CH2Cl2 (50 mL). DIEA (2.63 mL, 15.11 mmol, 3 eq) and N-phenyl-bis(trifluoromethanesulfonimide) (3.60 g, 10.07 mmol, 2 eq) were added, and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude residue was purified by silica gel chromatography (0-40% CH2Cl2/hexanes, linear gradient) to afford 2.24 g (95%) of S44 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.35-7.27 (m, 2H), 7.19 (t, J=2.0 Hz, 1H), 7.07 (dt, J=7.4, 2.2 Hz, 1H), 7.04 (d, J=7.9 Hz, 1H), 6.48 (dd, J=7.9, 1.9 Hz, 1H), 6.23 (d, J=1.9 Hz, 1H), 3.31 (dq, J=14.3, 7.1 Hz, 1H), 3.01 (dq, J=14.1, 6.9 Hz, 1H), 2.90-2.79 (m, 1H), 1.68 (dd, J=12.9, 4.7 Hz, 1H), 1.67 (s, 6H), 1.53 (t, J=12.8 Hz, 1H), 1.30 (d, J=6.6 Hz, 3H), 1.28 (s, 3H), 1.15 (s, 3H), 0.98 (t, J=7.0 Hz, 3H); 19F NMR (CDCl3, 376 MHz) δ−73.41 (s); 13C NMR (CDCl3, 101 MHz) δ 154.7 (C), 149.7 (C), 147.9 (C), 144.4 (C), 129.6 (CH), 127.4 (CH), 125.6 (CH), 119.9 (CH), 118.9 (q, 1JCF=320.8 Hz, CF3), 118.3 (CH), 113.1 (CH), 110.4 (CH), 54.5 (C), 47.1 (CH2), 43.2 (C), 39.0 (CH2), 30.64 (CH3), 30.63 (CH3), 29.8 (CH3), 27.1 (CH), 25.3 (CH3), 20.0 (CH3), 14.8 (CH3); HRMS (ESI) calcd for C24H31F3NO3S [M+H]+ 470.1971, found 470.1974.
An oven-dried crimp-top vial was charged with tert-butyl carbamate (299 mg, 2.56 mmol, 1.2 eq), Pd2dba3 (97.5 mg, 0.106 mmol, 0.05 eq), XPhos (152 mg, 0.319 mmol, 0.15 eq), and Cs2CO3 (971 mg, 2.98 mmol, 1.4 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). A solution of 3−(2−(1-ethyl-2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7-yl)propan-2−yl)phenyl trifluoromethanesulfonate (S44; 1.00 g, 2.13 mmol) in dioxane (10 mL) was added; after flushing the reaction again with nitrogen (3×), it was stirred at 100° C. for 4 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and evaporated. The residue was purified by silica gel chromatography (0-20% Et2O/hexanes, linear gradient) to afford S45 (906 mg, 97%) as pale yellow gum. 1H NMR (CDCl3, 400 MHz) δ 7.43-7.30 (m, 1H), 7.19 (t, J=7.9 Hz, 1H), 7.05 (t, J=2.0 Hz, 1H), 7.01 (dd, J=7.9, 1.2 Hz, 1H), 6.97 (ddd, J=7.8, 1.9, 1.0 Hz, 1H), 6.48 (dd, J=7.9, 1.9 Hz, 1H), 6.38 (s, 1H), 6.34 (d, J=1.9 Hz, 1H), 3.33 (dq, J=14.2, 7.0 Hz, 1H), 3.05 (dq, J=13.9, 6.9 Hz, 1H), 2.90-2.78 (m, 1H), 1.67 (dd, J=12.9, 4.7 Hz, 1H), 1.65 (s, 6H), 1.54 (t, J=12.9 Hz, 1H), 1.49 (s, 9H), 1.29 (d, J=7.0 Hz, 3H), 1.28 (s, 3H), 1.15 (s, 3H), 1.02 (t, J=7.0 Hz, 3H); 13C NMR (CDCl3, 101 MHz) δ 152.9 (C), 152.2 (C), 149.0 (C), 144.2 (C), 138.0 (C), 128.6 (CH), 125.3 (CH), 125.0 (C), 121.9 (CH), 117.5 (CH), 116.0 (CH), 113.5 (CH), 110.4 (CH), 80.4 (C), 54.4 (C), 47.2 (CH2), 43.0 (C), 39.0 (CH2), 30.9 (CH3), 29.9 (CH3), 28.5 (CH3), 27.1 (CH), 25.4 (CH3), 20.0 (CH3), 15.0 (CH3); HRMS (ESI) calcd for C28H41N2O2 [M+H]+ 437.3163, found 437.3163.
tert-Butyl (3−(2−(1-ethyl-2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7−yl)propan-2−yl)phenyl)carbamate (S45; 1.90 g, 4.35 mmol) was taken up in CH2Cl2 (35 mL), and trifluoroacetic acid (7 mL) was added. The reaction was stirred at room temperature for 2 h. It was then diluted with toluene (30 mL) and concentrated to dryness. The residue was taken up in saturated NaHCO3 and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, concentrated in vacuo. Flash chromatography (0-30% EtOAc/hexanes, linear gradient) afforded 1.29 g (88%) of S46 as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.05 (t, J=7.8 Hz, 1H), 7.01 (dd, J=7.9, 1.0 Hz, 1H), 6.73 (ddd, J=7.8, 1.7, 0.9 Hz, 1H), 6.61 (t, J=2.1 Hz, 1H), 6.53-6.47 (m, 2H), 6.38 (d, J=1.9 Hz, 1H), 3.53 (s, 2H), 3.33 (dq, J=14.2, 7.0 Hz, 1H), 3.06 (dq, J=14.2, 6.9 Hz, 1H), 2.90-2.78 (m, 1H), 1.67 (dd, J=12.9, 4.8 Hz, 1H), 1.63 (s, 6H), 1.54 (t, J=12.8 Hz, 1H), 1.29 (d, J=6.7 Hz, 3H), 1.28 (s, 3H), 1.15 (s, 3H), 1.04 (t, J=7.0 Hz, 3H); 13C NMR (CDCl3, 101 MHz) δ 152.5 (C), 149.3 (C), 146.0 (C), 144.1 (C), 128.8 (CH), 125.3 (CH), 124.9 (C), 117.5 (CH), 114.4 (CH), 113.5 (CH), 112.6 (CH), 110.5 (CH), 54.4 (C), 47.2 (CH2), 42.8 (C), 39.1 (CH2), 30.86 (CH3), 30.84 (CH3), 29.9 (CH3), 27.0 (CH), 25.4 (CH3), 20.0 (CH3), 15.0 (CH3); HRMS (ESI) calcd for C23H33N2[M+H]+ 337.2638, found 337.2637.
A mixture of 3−(2−(1-ethyl-2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7-yl)propan-2−yl)aniline (S46; 700 mg, 2.08 mmol), Na2CO3 (2.20 g, 20.80 mmol, 10 eq), and 1-bromo-3−chloropropane (15.44 mL, 156.0 mmol, 75 eq) was stirred at 140° C. for 18 h. The reaction was subsequently cooled to room temperature, diluted with water, and extracted with EtOAc (2×). The combined organic extracts were dried over anhydrous MgSO4, filtered, and evaporated. Silica gel chromatography (0-10% Et2O/hexanes, linear gradient) yielded 453 mg (52%) of 58 as a colorless gum. 1H NMR (CDCl3, 400 MHz) δ 6.95 (d, J=7.9 Hz, 1H), 6.79 (s, 2H), 6.40 (dd, J=7.9, 1.8 Hz, 1H), 6.36 (d, J=1.8 Hz, 1H), 3.32 (dq, J=14.2, 7.0 Hz, 1H), 3.13-3.08 (m, 2H), 3.04 (dq, J=15.0, 7.0 Hz, 1H), 2.99 (t, J=6.3 Hz, 2H), 2.89-2.77 (m, 1H), 2.74 (t, J=6.4 Hz, 2H), 2.25-2.12 (m, 2H), 1.97-1.88 (m, 2H), 1.67 (dd, J=12.9, 4.8 Hz, 1H), 1.614 (s, 3H), 1.607 (s, 3H), 1.57-1.48 (m, 3H), 1.272 (s, 3H), 1.271 (d, J=6.7 Hz, 3H), 1.14 (s, 3H), 1.01 (t, J=6.9 Hz, 3H); 13C NMR (CDCl3, 101 MHz) δ 150.3 (C), 145.3 (C), 144.3 (C), 143.7 (C), 125.9 (CH), 125.3 (CH), 124.6 (C), 122.4 (C), 120.4 (C), 114.3 (CH), 112.9 (CH), 109.3 (CH), 54.3 (C), 50.9 (CH2), 50.3 (CH2), 47.5 (CH2), 43.4 (C), 39.0 (CH2), 32.0 (CH3), 31.3 (CH3), 29.8 (CH3), 28.2 (CH2), 27.1 (CH), 26.2 (CH2), 25.2 (CH3), 22.4 (CH2), 22.1 (CH2), 20.2 (CH3), 15.0 (CH3); HRMS (ESI) calcd for C29H41N2[M+H]+ 417.3264, found 417.3264.
3,6−Dihydroxy-10,10−dimethylanthracen-9(10)-one41 (S47; 747 mg, 2.94 mmol) was taken up in CH2Cl2 (15 mL) and cooled to 0° C. Pyridine (1.90 mL, 23.50 mmol, 8 eq) and trifluoromethanesulfonic anhydride (1.98 mL, 11.75 mmol, 4 eq) were added, and the ice bath was removed. The reaction was stirred at room temperature for 2 h. It was subsequently diluted with water and extracted with CH2Cl2 (2×). The combined organic extracts were washed with saturated CuSO4 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-30% EtOAc/hexanes, linear gradient) afforded 1.46 g (96%) of S48 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 8.47 (d, J=8.7 Hz, 2H), 7.58 (d, J=2.4 Hz, 2H), 7.38 (dd, J=8.8, 2.4 Hz, 2H), 1.78 (s, 6H); 19F NMR (CDCl3, 376 MHz) δ−73.13 (s); 13C NMR (CDCl3, 101 MHz) δ 180.9 (C), 153.4 (C), 152.7 (C), 130.9 (CH), 129.4 (C), 120.5 (CH), 120.0 (CH), 118.9 (q, 1JCF=320.8 Hz, CF3) 38.8 (C), 33.0 (CH3); HRMS (ESI) calcd for C18H13F6O7S2[M+H]+ 519.0001, found 518.9993.
A vial was charged with 9,9−dimethyl-10−oxo-9,10−dihydroanthracene-2,7−diyl bis(trifluoromethanesulfonate) (S48; 1.00 g, 1.93 mmol), Pd2dba3 (177 mg, 0.193 mmol, 0.1 eq), XPhos (276 mg, 0.579 mmol, 0.3 eq), and Cs2CO3 (1.76 g, 5.40 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (10 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of pyrrolidine-2,2,3,3,4,4,5,5−d8(387 μL, 4.63 mmol, 2.4 eq), the reaction was stirred at 100° C. for 3 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and concentrated to dryness. Purification by silica gel chromatography (0-40% EtOAc/hexanes, linear gradient, with constant 40% v/v CH2Cl2 additive) afforded 42 (498 mg, 69%) as a yellow solid. 1H NMR (CDCl3, 400 MHz) δ 8.28-8.25 (m, 2H), 6.64-6.60 (m, 4H), 1.71 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 181.3 (C), 152.6 (C), 150.8 (C), 129.5 (CH), 119.6 (C), 111.0 (CH), 107.6 (CH), 38.2 (C), 33.9 (CH3); HRMS (ESI) calcd for C24H13D16N2O [M+H]+ 377.3279, found 377.3264.
A vial was charged with 9,9−dimethyl-10−oxo-9,10−dihydroanthracene-2,7−diyl bis(trifluoromethanesulfonate) (S48; 1.25 g, 2.41 mmol), Pd2dba3 (221 mg, 0.241 mmol, 0.1 eq), XPhos (345 mg, 0.723 mmol, 0.3 eq), and Cs2CO3 (2.20 g, 6.75 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (12 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of azetidine (390 μL, 5.79 mmol, 2.4 eq), the reaction was stirred at 100° C. for 4 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and concentrated to dryness. Purification by silica gel chromatography (0-40% EtOAc/hexanes, linear gradient, with constant 40% v/v CH2Cl2 additive) afforded 43 (645 mg, 80%) as a yellow solid. 1H NMR (CDCl3, 400 MHz) δ 8.26-8.21 (m, 2H), 6.46-6.40 (m, 4H), 4.03 (t, J=7.3 Hz, 8H), 2.43 (p, J=7.2 Hz, 4H), 1.66 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 181.4 (C), 154.3 (C), 152.4 (C), 129.3 (CH), 120.7 (C), 109.8 (CH), 106.5 (CH), 51.8 (CH2), 38.1 (C), 33.6 (CH3), 16.7 (CH2); HRMS (ESI) calcd for C22H2 5N2O [M+H]+ 333.1961, found 333.1959.
Methyl 1,2,3,4−tetrahydroquinoline-6−carboxylate (S49; 1.90 g, 9.94 mmol), benzyl bromide (4.25 g, 24.8 mmol, 2.5 eq), K2CO3 (4.12 g, 29.8 mmol, 3 eq), and KI (412 mg, 2.49 mmol, 0.25 eq) were combined in DMF (25 mL) and stirred at 60° C. for 4 h. The reaction was subsequently diluted with water and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried (MgSO4), filtered, and concentrated in vacuo. Silica gel chromatography (0-25% EtOAc/hexanes, linear gradient) afforded 2.60 g (93%) of S50 as a gum that crystallized into a colorless solid upon standing. 1H NMR (CDCl3, 400 MHz) δ 7.69-7.62 (m, 2H), 7.36-7.29 (m, 2H), 7.28-7.24 (m, 1H), 7.24-7.19 (m, 2H), 6.49-6.43 (m, 1H), 4.55 (s, 2H), 3.82 (s, 3H), 3.47-3.40 (m, 2H), 2.84 (t, J=6.2 Hz, 2H), 2.07-1.96 (m, 2H); 13C NMR (CDCl3, 101 MHz) δ 167.6 (C), 149.3 (C), 137.7 (C), 130.7 (CH), 129.8 (CH), 128.9 (CH), 127.2 (CH), 126.5 (CH), 121.3 (C), 116.8 (C), 109.8 (CH), 54.8 (CH2), 51.5 (CH3), 50.1 (CH2), 28.2 (CH2), 22.0 (CH2); HRMS (ESI) calcd for C18H20NO2 [M+H]+ 282.1489, found 282.1488.
A solution of methyl 1−benzyl-1,2,3,4−tetrahydroquinoline-6−carboxylate (S50; 4.25 g, 15.1 mmol) in THE (50 mL) was cooled to 0° C. under nitrogen, and LiAlH4 (1.0 M in THF, 30.2 mL, 30.2 mmol, 2 eq) was added. The reaction was stirred for 2 h at 0° C. The Fieser workup was performed by the sequential addition of (1) H2O (1.15 mL), (2) 15% NaOH (1.15 mL), and (3) H2O (3×1.15 mL). The resulting suspension was vigorously stirred for 10 min. It was then diluted with Et2O (100 mL), and MgSO4 (˜5 g) was added. After stirring for another 5 min, the mixture was filtered through Celite with Et2O and concentrated to dryness. Flash chromatography on silica gel (10-50% EtOAc/hexanes, linear gradient) provided S51 (3.43 g, 90%) as a colorless gum. Note: Alcohol S51 is photosensitive and decomposes rapidly in chlorinated solvents. 1H NMR (acetone-d6, 400 MHz) δ 7.34-7.25 (m, 4H), 7.25-7.19 (m, 1H), 6.93-6.90 (m, 1H), 6.90-6.85 (m, 1H), 6.45 (d, J=8.3 Hz, 1H), 4.49 (s, 2H), 4.41 (d, J=5.8 Hz, 2H), 3.71 (t, J=5.7 Hz, 1H), 3.41-3.35 (m, 2H), 2.77 (t, J=6.3 Hz, 2H), 2.02-1.93 (m, 2H); 13C NMR (acetone-d6, 101 MHz) δ 145.5 (C), 140.2 (C), 130.5 (C), 129.3 (CH), 129.0 (CH), 127.5 (CH), 127.4 (CH), 126.9 (CH), 122.6 (C), 111.6 (CH), 64.9 (CH2), 55.6 (CH2), 50.7 (CH2), 28.9 (CH2), 23.20 (CH2); HRMS (ESI) calcd for C17H19NONa [M+Na]+276.1359, found 276.1354.
1−Benzyl-7−bromo-1,2,3,4−tetrahydroquinoline (S4; 2.16 g, 7.15 mmol) and (1-benzyl-1,2,3,4−tetrahydroquinolin-6−yl)methanol (S51; 1.90 g, 7.50 mmol, 1.05 eq) were combined in CH2Cl2 (50 mL) and cooled to 0° C. under nitrogen. BCl3 (1 M in CH2Cl2, 21.4 mL, 21.4 mmol, 3 eq) was added over 5 min; the reaction was then allowed to warm to room temperature overnight while stirring (18 h). The reaction was carefully neutralized by the slow addition of saturated NaHCO3 with vigorous stirring. The mixture was then extracted with CH-2Cl2 (2×). The combined organics were dried (MgSO4), filtered, and evaporated. Flash chromatography (0-20% Et2O/hexanes, linear gradient) afforded 3.15 g (82%) of S52 as a colorless, gummy foam. 1H NMR (CDCl3, 400 MHz) δ 7.35-7.19 (m, 10H), 6.83 (d, J=2.0 Hz, 1H), 6.80 (dd, J=8.3, 2.2 Hz, 1H), 6.74 (s, 1H), 6.69 (s, 1H), 6.43 (d, J=8.3 Hz, 1H), 4.43 (s, 2H), 4.42 (s, 2H), 3.79 (s, 2H), 3.35-3.30 (m, 2H), 3.30-3.24 (m, 2H), 2.78 (t, J=6.4 Hz, 2H), 2.67 (t, J=6.3 Hz, 2H), 2.04-1.89 (m, 4H); 13C NMR (CDCl3, 101 MHz) δ 145.1 (C), 144.1 (C), 139.4 (C), 138.5 (C), 131.1 (CH), 129.6 (CH), 128.8 (CH), 128.7 (CH), 128.3 (C), 128.1 (C), 127.5 (CH), 127.1 (CH), 126.83 (CH), 126.81 (CH), 122.8 (C), 122.4 (C), 122.0 (C), 114.4 (CH), 111.2 (CH), 55.6 (CH2), 55.2 (CH2), 50.1 (CH2), 49.5 (CH2), 39.7 (CH2), 28.4 (CH2), 27.9 (CH2), 22.7 (CH2), 22.3 (CH2); HRMS (ESI) calcd for C33H34BrN2 [M+H]+ 537.1900, found 537.1914.
A solution of 1−benzyl-6−((1−benzyl-1,2,3,4−tetrahydroquinolin-6−yl)methyl)-7-bromo-1,2,3,4−tetrahydro-quinoline (S52; 2.35 g, 4.37 mmol) in THE (40 mL) was cooled to −78° C. under nitrogen. n-Butyllithium (2.5 M in hexanes, 4.37 mL, 10.9 mmol, 2.5 eq) was added, and the reaction was stirred for 15 min at −78° C. Acetone (3.21 mL, 43.7 mmol, 10 eq) was then added. The dry ice bath was removed, and the reaction was stirred at room temperature for 4 h. It was subsequently quenched with saturated NH4Cl and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried (MgSO4), filtered, and concentrated in vacuo. The residue was purified by silica gel chromatography (10-40% Et2O/hexanes, linear gradient) to provide S53 as a colorless gum that crystallized into a white solid upon standing (2.07 g, 92%). 1H NMR (CDCl3, 400 MHz) δ 7.34-7.18 (m, 10H), 6.77 (d, J=1.9 Hz, 1H), 6.75 (s, 1H), 6.69 (dd, J=8.4, 2.1 Hz, 1H), 6.59 (s, 1H), 6.41 (d, J=8.4 Hz, 1H), 4.44 (s, 2H), 4.42 (s, 2H), 4.07 (s, 2H), 3.37-3.27 (m, 4H), 2.79-2.68 (m, 4H), 2.03-1.93 (m, 4H), 1.63 (bs, 1H), 1.45 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 144.7 (C), 143.9 (C), 143.6 (C), 139.5 (C), 139.4 (C), 133.9 (CH), 130.5 (C), 129.4 (CH), 128.7 (CH), 128.6 (CH), 127.4 (CH), 126.96 (CH), 126.91 (CH), 126.85 (CH), 126.82 (CH), 126.0 (C), 122.5 (C), 121.3 (C), 111.3 (CH), 109.1 (CH), 74.2 (C), 56.0 (CH2), 55.7 (CH2), 50.4 (CH2), 50.1 (CH2), 38.0 (CH2), 31.9 (CH3), 28.4 (CH2), 27.6 (CH2), 22.7 (CH2); HRMS (ESI) calcd for C36H40N2ONa [M+Na]+539.3033, found 539.3024.
2−(1−Benzyl-6−((1−benzyl-1,2,3,4−tetrahydroquinolin-6−yl)methyl)-1,2,3,4-tetrahydroquinolin-7−yl)propan-2−ol (S53; 1.85 g, 3.58 mmol) was dissolved in CH2Cl2 (50 mL) and cooled to 0° C. under nitrogen. BBr3 (1.0 M in CH2Cl2, 14.3 mL, 14.3 mmol, 4 eq) was added dropwise; the reaction was then allowed to warm to room temperature overnight while stirring (18 h). It was carefully neutralized through the sequential addition of H2O (40 mL) and saturated NaHCO3. The mixture was diluted with CH2Cl2 (50 mL), filtered through a hydrophobic phase separator column, and concentrated to give a blue residue. The crude material was taken up in acetone (35 mL) and cooled to −15° C. KMnO4 (1.13 g, 7.16 mmol, 2 eq) was added in 4 equal portions 15 min apart (45 min total). After stirring for another 30 min at −15° C., the brown mixture was diluted with CH2Cl2, filtered through Celite, and concentrated in vacuo. Flash chromatography on silica gel (10-50% EtOAc/hexanes, linear gradient) provided 1.093 g (60%, 2 steps) of 45 as a photosensitive yellow solid. 1H NMR (CDCl3, 400 MHz) δ 7.96 (s, 2H), 7.34-7.29 (m, 4H), 7.27-7.21 (m, 6H), 6.48 (s, 2H), 4.57 (s, 4H), 3.52-3.43 (m, 4H), 2.89 (t, J=6.2 Hz, 4H), 2.10-1.97 (m, 4H), 1.27 (s, 6H); 13C NMR (CDCl3, 101 MHz) δ 181.1 (C), 150.9 (C), 148.9 (C), 138.1 (C), 128.9 (CH), 127.8 (CH), 127.2 (CH), 126.6 (CH), 121.3 (C), 119.9 (C), 107.4 (CH), 55.5 (CH2), 50.7 (CH2), 37.5 (C), 33.3 (CH3), 27.8 (CH2), 22.3 (CH2); HRMS (ESI) calcd for C36H37N2O [M+H]+ 513.2900, found 513.2894.
Step 1: A solution of 1−(2−bromophenyl)-4−methyl-2,6,7-trioxabicyclo[2.2.2]octane32 (S54; 556 mg, 1.95 mmol, 5 eq) in THE (30 mL) was cooled to −78° C. under nitrogen. tert-Butyllithium (1.7 M in pentane, 2.29 mL, 3.90 mmol, 10 eq) was added dropwise, and the reaction was stirred for 30 min at −78° C. A solution of 1,11−dibenzyl-13,13-dimethyl-1,2,3,4,8,9,10,11−octahydrobenzo[1,2−g:5,4−g′]diquinolin-6(13H)-one (45; 200 mg, 0.390 mmol) in THE (10 mL) was then added dropwise. The reaction was allowed to slowly warm to room temperature while stirring overnight (18 h). It was subsequently quenched with 1 N HCl (˜20 mL), stirred for 10 min, diluted with water, and extracted with 15% i-PrOH/CHCl3 (2×). The combined organic extracts were dried over anhydrous MgSO4, filtered, and evaporated. Silica gel chromatography (0-15% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive) afforded the 2,2−bis(hydroxymethyl)propyl ester intermediate as a dark blue solid (280 mg, 92%, acetate salt).
Step 2: The ester intermediate from Step 1 (280 mg, 0.359 mmol) was taken up in 2,2,2−trifluoroethanol (18 mL), and 25% w/w NaOH (6 mL) was added. The reaction was stirred at room temperature for 7 days. It was then diluted with water and extracted with CH2Cl2 (3×). The combined organic extracts were dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by flash chromatography on silica gel (5-75% EtOAc/toluene, linear gradient) afforded 175 mg (79%) of S55 as a pale blue solid. 1H NMR (CDCl3, 400 MHz) δ 7.99 (d, J=7.4 Hz, 1H), 7.58 (td, J=7.5, 1.4 Hz, 1H), 7.53 (td, J=7.2, 1.2 Hz, 1H), 7.35-7.29 (m, 4H), 7.28-7.20 (m, 6H), 7.07 (d, J=7.3 Hz, 1H), 6.53 (s, 2H), 6.23 (s, 2H), 4.49 (AB quartet, vA=1809.4 Hz, vB=1781.5 Hz, JAB=16.8 Hz, 4H), 3.42-3.30 (m, 4H), 2.65-2.47 (m, 4H), 1.98-1.86 (m, 4H), 1.41 (s, 3H), 1.31 (s, 3H); 13C NMR (CDCl3, 101 MHz) δ 171.2 (C), 155.8 (C), 145.9 (C), 144.9 (C), 138.8 (C), 134.5 (CH), 128.75 (CH), 128.70 (CH), 128.0 (CH), 127.3 (C), 127.0 (CH), 126.7 (CH), 124.8 (CH), 124.1 (CH), 121.6 (C), 118.6 (C), 108.2 (CH), 88.7 (C), 55.6 (CH2), 50.3 (CH2), 37.7 (C), 34.9 (CH3), 33.0 (CH3), 27.7 (CH2), 22.3 (CH2); Analytical HPLC: tR=12.0 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C43H41N2O2 [M+H]+ 617.3163, found 617.3156.
A round-bottom flask was charged with Pd/C (10%, 34.5 mg, 32.4 mol, 0.2 eq) under nitrogen, and a solution of carborhodamine S55 (100 mg, 0.162 mmol) in 1:1 THF/MeOH (15 mL) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 24 h. The reaction mixture was filtered through Celite with MeOH, and the filtrate was concentrated in vacuo. The blue residue was resuspended in 3:1 CH2Cl2/MeOH (8 mL), and p-chloranil (79.7 mg, 0.324 mmol, 2 eq) was added. After stirring the mixture at room temperature for 2 h, it was deposited onto Celite and concentrated to dryness. Silica gel chromatography (0-10% MeOH (2 M NH3)/CH2Cl2, linear gradient; dry load with Celite) yielded 49.5 mg (70%) of 94 as a blue-purple solid. 1H NMR (DMSO-d6, 400 MHz) δ 7.91 (d, J=7.6 Hz, 1H), 7.71 (td, J=7.4, 1.1 Hz, 1H), 7.62 (td, J=7.4, 1.0 Hz, 1H), 7.07 (d, J=7.6 Hz, 1H), 6.68 (s, 2H), 6.01 (s, 2H), 5.92 (s, 2H), 3.20-3.06 (m, 4H), 2.45 (dt, J=15.9, 5.9 Hz, 2H), 2.35 (dt, J=15.8, 6.1 Hz, 2H), 1.68 (p, J=6.1 Hz, 4H), 1.64 (s, 3H), 1.54 (s, 3H); 13C NMR (DMSO-d6, 101 MHz) δ 170.0 (C), 155.0 (C), 146.0 (C), 144.1 (C), 135.0 (CH), 129.1 (CH), 127.4 (CH), 126.3 (C), 124.4 (CH), 123.9 (CH), 119.1 (C), 117.9 (C), 109.7 (CH), 88.5 (C), 40.6 (CH2), 36.8 (C), 35.0 (CH3), 32.7 (CH3), 26.3 (CH2), 21.3 (CH2); Analytical HPLC: tR=11.8 min, 98.3% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C29H29N2O2 [M+H]+ 437.2224, found 437.2219.
A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 281 mg, 1.45 mmol, 2 eq) in THF (5 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 1.16 mL, 2.90 mmol, 4 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of 3,6-bis((tert-butyldimethylsilyl)oxy)-10,10−dimethylanthracen-9(10)-one41 (50; 350 mg, 0.725 mmol) in THE (4 mL) was added; the reaction was warmed to room temperature and stirred for 1 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and evaporated. The resulting yellow-orange residue was taken up in THE (10 mL) before adding TBAF (1.0 M in THF, 2.90 mL, 2.90 mmol, 4 eq). After stirring the reaction at room temperature for 30 min, it was acidified with 1 M HCl, diluted with water, and extracted with EtOAc (2×). The organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography (0-75% EtOAc/hexanes, linear gradient) afforded 51 (258 mg, 83%) as a pale yellow solid. 1H NMR (DMSO-d6, 400 MHz) δ 9.81 (s, 2H), 7.10 (d, J=2.4 Hz, 2H), 6.84 (d, J=8.6 Hz, 2H), 6.66 (dd, J=8.6, 2.4 Hz, 2H), 1.69 (s, 3H), 1.60 (s, 3H); 19F NMR (DMSO-d6, 376 MHz) δ−139.94-−140.16 (m, 1F), −143.10-−143.30 (m, 1F), −143.78 (td, J=21.4, 20.8, 8.4 Hz, 1F), −152.01-−152.23 (m, 1F); Analytical HPLC: tR=12.8 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C23H15F4O4 [M+H]+ 431.0901, found 431.0899.
A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 281 mg, 1.45 mmol, 1.5 eq) in THF (5 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 1.16 mL, 2.89 mmol, 3 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of 3,6-bis((tert-butyldimethylsilyl)oxy)-2,7−difluoro-10,10−dimethylanthracen-9(10H)-one54 (52; 500 mg, 0.964 mmol) in THF (5 mL) was added; the reaction was warmed to room temperature and stirred for 1 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and evaporated. The resulting yellow-orange residue was taken up in THE (10 mL) before adding TBAF (1.0 M in THF, 3.86 mL, 3.86 mmol, 4 eq). After stirring the reaction at room temperature for 30 min, it was acidified with 1 M HCl, diluted with water, and extracted with EtOAc (2×). The organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography (0-75% EtOAc/hexanes, linear gradient, with constant 0.1% v/v AcOH additive) afforded 53 (345 mg, 77%) as a pale yellow solid. 1H NMR (DMSO-d6, 400 MHz) δ 10.35 (s, 2H), 7.28 (d, 4JHF=8.7 Hz, 2H), 6.87 (d, 3JHF=12.0 Hz, 2H), 1.66 (s, 3H), 1.58 (s, 3H); 19F NMR (DMSO-d6, 376 MHz) δ−136.55-−136.80 (m, 2F), −139.04-−139.27 (m, 1F), −143.52-−143.86 (m, 2F), −152.25 (t, J=19.8 Hz, 1F); Analytical HPLC: tR=13.4 min, 98.9% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (ESI) calcd for C23H13F6O4 [M+H]+ 467.0713, found 467.0705.
A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 292 mg, 1.50 mmol, 1.5 eq) in THF (5 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 1.20 mL, 3.01 mmol, 3 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of 3,7-bis((tert-butyldimethylsilyl)oxy)-5,5−dimethyldibenzo[b,e]silin-10(5H)-one80 (54; 500 mg, 1.00 mmol) in THE (5 mL) was added; the reaction was warmed to room temperature and stirred for 1 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and evaporated. The resulting red-orange residue was taken up in THE (10 mL) before adding TBAF (1.0 M in THF, 4.00 mL, 4.00 mmol, 4 eq). After stirring the reaction at room temperature for 30 min, it was acidified with 1 M HCl, diluted with water, and extracted with EtOAc (2×). The organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography (10-100% EtOAc/hexanes, linear gradient) afforded 55 (422 mg, 94%) as an orange foam. The characterization data for 55 matched the previously reported spectra.1
A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 868 mg, 4.47 mmol, 6 eq) in THF (15 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 3.58 mL, 8.94 mmol, 12 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of Michler's ketone (48; 200 mg, 0.745 mmol) in THE (10 mL) was added; the reaction was warmed to room temperature and stirred for 18 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) yielded 266 mg (80%) of 49 as a blue-green foam. 1H NMR (CDCl3, 400 MHz) δ 7.15 (d, J=9.0 Hz, 4H), 6.64 (d, J=9.0 Hz, 4H), 2.96 (s, 12H); 19F NMR (CDCl3, 376 MHz) δ−137.82-−137.98 (m, 1F), −138.99 (td, J=20.0, 8.7 Hz, 1F), −143.58 (ddd, J=21.1, 18.2, 8.7 Hz, 1F), −152.13 (ddd, J=20.8, 18.3, 4.3 Hz, 1F); Analytical HPLC: tR=12.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (ESI) calcd for C24H21F4N2O2[M+H]+ 445.1534, found 445.1531.
A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 525 mg, 2.71 mmol, 6 eq) in THF (9 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 2.17 mL, 5.41 mmol, 12 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of 3,6-di(azetidin-1−yl)-10,10−dimethylanthracen-9(10H)-one (43; 150 mg, 0.451 mmol) in THF (40 mL) was added; the reaction was warmed to room temperature and stirred for 18 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel chromatography (0-10% MeOH (2 M NH3)/CH2Cl2, linear gradient) yielded 121 mg (53%) of 44 as a deep blue solid. 1H NMR (CDCl3, 400 MHz) δ 6.66 (d, J=8.6 Hz, 2H), 6.54 (d, J=2.4 Hz, 2H), 6.27 (dd, J=8.6, 2.3 Hz, 2H), 3.93 (t, J=7.4 Hz, 8H), 2.39 (p, J=7.2 Hz, 4H), 1.75 (s, 3H), 1.70 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−139.76 (td, J=20.1, 8.6 Hz, 1F), −141.87 (td, J=20.1, 3.9 Hz, 1F),-143.57 (ddd, J=20.4, 18.0, 8.4 Hz, 1F), −152.12 (ddd, J=20.4, 18.6, 3.8 Hz, 1F); Analytical HPLC: tR=12.0 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C29H2 5F4N2O2[M+H]+ 509.1847, found 509.1839.
Via lithiation of tetrafluorobenzoic acid: A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 557 mg, 2.87 mmol, 6 eq) in THF (10 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 2.29 mL, 5.74 mmol, 12 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of 10,10−dimethyl-3,6−bis(pyrrolidin-1−yl-d8)anthracen-9(10H)-one (42; 180 mg, 0.478 mmol) in THE (15 mL) was added; the reaction was warmed to room temperature and stirred for 18 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel chromatography (0-10% MeOH (2 M NH3)/CH2Cl2, linear gradient) yielded 150 mg (57%) of 40 as a dark blue solid.
Via dibromide route: A solution of 1,1′-(propane-2,2−diylbis(4−bromo-3,1-phenylene))bis(pyrrolidine-2,2,3,3,4,4,5,5−d8) (39; 600 mg, 1.18 mmol) in THE (30 mL) was cooled to −78° C. under nitrogen. tert-Butyllithium (1.7 M in pentane, 3.05 mL, 5.19 mmol, 4.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. It was then warmed to −10° C. before adding a solution of MgBr2 OEt2 (670 mg, 2.60 mmol, 2.2 eq) in THE (20 mL). After an additional 30 min at −10° C., a solution of tetrafluorophthalic anhydride (4; 571 mg, 2.60 mmol, 2.2 eq) in THE (20 mL) was added dropwise over 30 min via addition funnel. The reaction was then allowed to warm to room temperature overnight (18 h). It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Silica gel chromatography (0-10% MeOH (2 M NH3)/CH2Cl2, linear gradient) afforded 257 mg (39%) of 40 as a deep blue solid.
1H NMR (CDCl3, 400 MHz) δ 6.694 (d, J=2.5 Hz, 2H), 6.691 (d, J=8.7 Hz, 2H), 6.41 (dd, J=8.7, 2.5 Hz, 2H), 1.81 (s, 3H), 1.75 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ-140.08 (td, J=20.1, 8.3 Hz, 1F), −141.94 (td, J=20.1, 3.8 Hz, 1F), −143.94-−144.24 (m, 1F),-152.52 (ddd, J=21.8, 18.5, 3.6 Hz, 1F); Analytical HPLC: tR=13.0 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C31H13D16F4N2O2[M+H]+ 553.3164, found 553.3154.
Step 1: A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 2.27 g, 11.70 mmol, 6 eq) in THE (40 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 9.36 mL, 23.41 mmol, 12 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of 1,11−dibenzyl-13,13−dimethyl-1,2,3,4,8,9,10,11−octahydrobenzo[1,2−g:5,4−g′]diquinolin-6(13H)-one (45; 1.00 g, 1.95 mmol) in THF (40 mL) was added via cannula; the reaction was immediately warmed to room temperature and stirred for 48 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The residue was purified by silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) to yield 145 mg (11%) of 2−(1,11−dibenzyl-13,13−dimethyl-2,3,4,8,9,10,11,13−octahydrobenzo[1,2−g:5,4−g′]diquinolin-6−ylium-6(1)-yl)-3,4,5,6-tetrafluorobenzoate (46) as a blue solid.
Step 2: A round-bottom flask was charged with Pd/C (10%, 44.8 mg, 42.1 mol, 0.2 eq) under nitrogen, and a solution of the intermediate from Step 1 (46; 145 mg, 0.211 mmol) in MeOH (15 mL) was added. The sealed flask was evacuated/backfilled with H2 from a balloon (4×) and then stirred under the H2 balloon at room temperature for 18 h. The reaction mixture was filtered through Celite with MeOH and EtOAc, and the filtrate was concentrated in vacuo. The blue residue was resuspended in 3:1 CH2Cl2/MeOH (8 mL), and p-chloranil (104 mg, 0.421 mmol, 2 eq) was added. After stirring the mixture at room temperature for 4 h, it was deposited onto Celite and concentrated to dryness. Silica gel chromatography (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient; dry load with Celite) yielded 54.5 mg (51%) of 47 as a dark blue solid. 1H NMR (CD3OD, 400 MHz) δ 6.96 (s, 2H), 6.82 (s, 2H), 3.53-3.46 (m, 4H), 2.67 (t, J=6.3 Hz, 4H), 1.91 (p, J=6.2 Hz, 4H), 1.69 (s, 3H), 1.57 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ -75.44 (s, 3F), −137.26 (ddd, J=19.9, 11.9, 6.9 Hz, 1F), −138.11 (ddd, J=22.2, 12.0, 4.4 Hz, 1F), −151.72-−151.90 (m, 1F), −153.58-−153.75 (m, 1F); Analytical HPLC: tR=12.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C29H2 5F4N2O2[M+H]+ 509.1847, found 509.1847.
Via tetrafluorobenzoic acid route: A solution of 2,3,4,5−tetrafluorobenzoic acid (6; 835 mg, 4.30 mmol, 6 eq) in THE (14 mL) was cooled to −78° C. under nitrogen. N-Butyllithium (2.5 M in hexanes, 3.44 mL, 8.61 mmol, 12 eq) was added, and the reaction was stirred at −78° C. for 3 h. A solution of 1,9,11,11−tetramethyl-2,3,7,8,9,11−hexahydrosilino[3,2-f5,6−f′]diindol-5(1H)-one31 (S26; 250 mg, 0.717 mmol) in THE (100 mL) was added via cannula; the reaction was immediately warmed to room temperature and stirred for 48 h. It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The residue was purified twice by silica gel chromatography (10-100% EtOAc/hexanes, linear gradient; then, 5-100% EtOAc/hexanes, linear gradient, with constant 20% v/v CH2Cl2 additive) to yield 45.9 mg (12%) of 108 as a pale blue solid.
Via dibromide route: A solution of bis(5−bromo-1−methylindolin-6-yl)dimethylsilane (S9; 500 mg, 1.04 mmol) in THF (25 mL) was cooled to −78° C. under nitrogen. tert-Butyllithium (1.7 M in pentane, 2.69 mL, 4.58 mmol, 4.4 eq) was added, and the reaction was stirred at −78° C. for 30 min. It was then warmed to −10° C. before adding a solution of MgBr2 OEt2 (591 mg, 2.29 mmol, 2.2 eq) in THF (10 mL). After an additional 30 min at −10° C., a solution of tetrafluorophthalic anhydride (4; 504 mg, 2.29 mmol, 2.2 eq) in THE (10 mL) was added dropwise over 30 min via addition funnel. The reaction was then allowed to warm to room temperature overnight (18 h). It was subsequently diluted with saturated NH4Cl and water and extracted with EtOAc (2×). The combined organic extracts were washed with saturated NaHCO3 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude material was redissolved in MeOH (10 mL); 1 M HCl (0.5 mL) was added, and the solution was aged 15 min. After adding 1 N NaOH (0.5 mL), the mixture was deposited onto Celite and concentrated to dryness. Silica gel chromatography (20-100% EtOAc/hexanes, linear gradient; dry load with Celite) afforded 232 mg (42%) of 108 as a light green solid.
1H NMR (CDCl3, 400 MHz) δ 6.63 (s, 2H), 6.60 (s, 2H), 3.33 (t, J=8.2 Hz, 4H), 2.94-2.84 (m, 4H), 2.82 (s, 6H), 0.52 (s, 3H), 0.51 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ-139.28 (td, J=20.1, 8.5 Hz, 1F), −140.87 (td, J=20.2, 3.8 Hz, 1F), −143.48 (ddd, J=21.0, 18.3, 8.6 Hz, 1F), −152.48 (ddd, J=21.6, 18.4, 3.7 Hz, 1F); Analytical HPLC: tR=12.3 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 700 nm); HRMS (ESI) calcd for C28H2 5F4N2O2Si [M+H]+ 525.1616, found 525.1614.
A solution of tetrafluorophthalic anhydride (4; 85.4 mg, 0.388 mmol, 1.5 eq) and AlCl3 (103 mg, 0.776 mmol, 3 eq) in 1,2−dichloroethane (5 mL) was added to a stirred solution of 8,8′-(propane-2,2−diyl)bis(2,3,6,7−tetrahydro-1H,5H-pyrido[3,2,1−ij]quinoline) (56; 100 mg, 0.259 mmol) in 1,2−dichloroethane (2 mL). After stirring the reaction at room temperature for 1 h, it was treated with Et3N (108 μL, 0.776 mmol, 3 eq). A second portion of tetrafluorophthalic anhydride (57.5 mg, 0.388 mmol, 1.5 eq) and AlCl3 (103 mg, 0.776 mmol, 3 eq) in 1,2-dichloroethane (5 mL) was added, and the reaction was stirred at room temperature an additional 1 h. It was then poured into ice water (50 mL), diluted with 1 M HCl (10 mL), and extracted with CH2Cl2 (2×). The organic extracts were washed with saturated NaHCO3, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) afforded 103 mg (68%) of 57 as a deep blue solid. 1H NMR (CD3OD, 400 MHz) δ 6.67 (s, 2H), 3.56 (t, J=6.2 Hz, 4H), 3.51 (t, J=5.9 Hz, 4H), 3.10-3.01 (m, 4H), 2.69 (dt, J=15.9, 6.2 Hz, 2H), 2.59 (dt, J=15.4, 6.3 Hz, 2H), 2.07-1.99 (m, 4H), 2.01 (s, 3H), 1.98 (s, 3H), 1.92 (p, J=6.2 Hz, 4H); 19F NMR (CD3OD, 376 MHz) δ−139.88 (ddd, J=21.8, 12.4, 3.2 Hz, 1F), −141.77 (ddd, J=22.4, 12.5, 3.1 Hz, 1F), −155.38 (ddd, J=22.4, 19.3, 3.1 Hz, 1F), −158.93 (ddd, J=22.2, 19.2, 3.2 Hz, 1F); Analytical HPLC: tR=13.4 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C35H33F4N2O2[M+H]+ 589.2473, found 589.2476.
A solution of phthalic anhydride (S15; 57.5 mg, 0.388 mmol, 1.5 eq) and AlCl3 (103 mg, 0.776 mmol, 3 eq) in 1,2−dichloroethane (5 mL) was added to a stirred solution of 8,8′-(propane-2,2−diyl)bis(2,3,6,7−tetrahydro-1H,5H-pyrido[3,2,1−ij]quinoline) (56; 100 mg, 0.259 mmol) in 1,2−dichloroethane (2 mL). After stirring the reaction at room temperature for 1 h, it was treated with Et3N (108 μL, 0.776 mmol, 3 eq). A second portion of phthalic anhydride (57.5 mg, 0.388 mmol, 1.5 eq) and AlCl3 (103 mg, 0.776 mmol, 3 eq) in 1,2−dichloroethane (5 mL) was added, and the reaction was stirred at room temperature an additional 1 h. It was then poured into ice water (50 mL), diluted with 1 M HCl (10 mL), and extracted with CH2Cl2 (2×). The organic extracts were washed with saturated NaHCO3, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) afforded 116 mg (87%) of 97 as a deep blue solid. 1H NMR (CDCl3, 400 MHz) δ 7.97-7.92 (m, 1H), 7.52 (td, J=7.4, 1.4 Hz, 1H), 7.47 (td, J=7.4, 1.2 Hz, 1H), 7.05-7.01 (m, 1H), 6.11 (s, 2H), 3.20 (t, J=6.7 Hz, 4H), 3.16 (t, J=5.8 Hz, 4H), 2.98-2.85 (m, 4H), 2.56-2.37 (m, 4H), 2.07 (s, 3H), 2.02 (s, 3H), 1.95 (p, J=6.4 Hz, 4H), 1.88-1.79 (m, 4H); 13C NMR (CDCl3, 101 MHz) δ 171.4 (C), 157.0 (C), 146.4 (C), 145.0 (C), 134.5 (CH), 128.4 (CH), 127.1 (C), 126.1 (CH), 124.7 (CH), 123.8 (CH), 121.3 (C), 119.6 (C), 116.4 (C), 50.8 (CH2), 50.1 (CH2), 37.0 (C), 34.6 (CH3), 33.3 (CH3), 28.4 (CH2), 28.2 (CH2), 22.3 (CH2), 21.8 (CH2); Analytical HPLC: tR=13.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C35H37N2O2 [M+H]+ 517.2850, found 517.2856.
A solution of tetrafluorophthalic anhydride (4; 79.2 mg, 0.360 mmol, 1.5 eq) and AlCl3 (96.0 mg, 0.720 mmol, 3 eq) in 1,2−dichloroethane (5 mL) was added to a stirred solution of 8-(2−(1-ethyl-2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7−yl)propan-2−yl)-2,3,6,7−tetrahydro-1H,5H-pyrido[3,2,1−ij]quinoline (58; 100 mg, 0.240 mmol) in 1,2−dichloroethane (4 mL). After stirring the reaction at room temperature for 1 h, it was treated with Et3N (100 μL, 0.720 mmol, 3 eq). A second portion of phthalic anhydride (79.2 mg, 0.360 mmol, 1.5 eq) and AlCl3 (96.0 mg, 0.720 mmol, 3 eq) in 1,2−dichloroethane (5 mL) was added, and the reaction was stirred at room temperature an additional 2 h. It was then poured into ice water (50 mL), diluted with 1 M HCl (10 mL), and extracted with CH2Cl2 (2×). The organic extracts were washed with saturated NaHCO3, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) afforded 119 mg (80%) of 59 as a deep blue solid (mixture of two diastereomers). 1H NMR (CD3OD, 400 MHz) δ 6.91 (s, 1H), 6.88-6.83 (m, 2H), 3.82 (dq, J=14.3, 7.1 Hz, 1H), 3.70-3.62 (m, 1H), 3.60 (t, J=6.0 Hz, 2H), 3.55 (t, J=5.9 Hz, 2H), 3.23-3.15 (m, 2H), 2.89-2.67 (m, 2H), 2.62 (dt, J=15.5, 6.2 Hz, 1H), 2.10-2.00 (m, 2H), 1.98-1.90 (m, 2H), 1.90-1.82 (m, 1H), 1.89 (s, 1.5H), 1.87 (s, 1.5H), 1.86 (s, 1.5H), 1.85 (s, 1.5H), 1.55 (t, J=13.3 Hz, 0.5H), 1.54 (t, J=13.4 Hz, 0.5H), 1.48 (s, 1.5H), 1.47 (s, 1.5H), 1.36 (s, 1.5H), 1.35 (t, J=7.1 Hz, 3H), 1.34 (s, 1.5H), 1.18 (d, J=6.5 Hz, 1.5H), 1.14 (d, J=6.5 Hz, 1.5H); 19F NMR (CD3OD, 376 MHz) δ−139.60 (ddd, J=21.9, 12.4, 3.3 Hz, 0.5F), −139.68 (ddd, J=21.6, 12.7, 3.2 Hz, 0.5F), −141.14 (ddd, J=22.4, 12.3, 3.4 Hz, 0.5F), −141.31 (ddd, J=22.5, 12.4, 3.2 Hz, 0.5F), −154.88 (ddd, J=22.4, 19.2, 3.2 Hz, 0.5F), −155.04 (ddd, J=22.5, 19.2, 3.0 Hz, 0.5F), −158.72 (ddd, J=22.5, 18.8, 3.3 Hz, 0.5F), −159.07 (ddd, J=22.0, 19.2, 3.2 Hz, 0.5F); Analytical HPLC: tR (two isomers)=14.1 min, 14.4 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C37H39F4N2O2[M+H]+ 619.2942, found 619.2948.
A portion of this material (60 mg) was further purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to separate the isomeric mixture. The pooled fractions of each isomer were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with CH2Cl2 (3×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to provide the two individual diastereomers as blue solids: 15.7 mg of the faster-eluting isomer (“diastereomer 1”) and 26.3 mg of the slower-eluting isomer (“diastereomer 2”).
Diastereomer 1: 1H NMR (CD3OD, 400 MHz) δ 6.91 (s, 1H), 6.86 (s, 1H), 6.85 (s, 1H), 3.82 (dq, J=14.2, 7.1 Hz, 1H), 3.66 (dq, J=14.1, 7.4 Hz, 1H), 3.60 (t, J=6.1 Hz, 2H), 3.55 (t, J=5.8 Hz, 2H), 3.23-3.15 (m, 2H), 2.82-2.67 (m, 2H), 2.62 (dt, J=15.4, 6.2 Hz, 1H), 2.10-2.00 (m, 2H), 1.98-1.90 (m, 2H), 1.90-1.82 (m, 1H), 1.89 (s, 3H), 1.85 (s, 3H), 1.55 (t, J=13.3 Hz, 1H), 1.47 (s, 3H), 1.36 (s, 3H), 1.35 (t, J=7.1 Hz, 3H), 1.18 (d, J=6.6 Hz, 3H); 19F NMR (CD3OD, 376 MHz) δ−139.61 (ddd, J=21.9, 12.4, 3.1 Hz, 1F), −141.17 (ddd, J=22.6, 12.3, 3.3 Hz, 1F), −155.05 (ddd, J=22.3, 19.0, 3.2 Hz, 1F), −158.78 (ddd, J=22.4, 19.3, 3.2 Hz, 1F); Analytical HPLC: tR=14.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C37H39F4N2O2[M+H]+ 619.2942, found 619.2945.
Diastereomer 2: 1H NMR (CD3OD, 400 MHz) δ 6.91 (s, 1H), 6.88-6.83 (m, 2H), 3.82 (dq, J=14.2, 7.0 Hz, 1H), 3.64 (dq, J=14.2, 7.4 Hz, 1H), 3.60 (t, J=5.9 Hz, 2H), 3.55 (t, J=5.9 Hz, 2H), 3.23-3.15 (m, 2H), 2.89-2.78 (m, 1H), 2.73 (dt, J=15.8, 6.1 Hz, 1H), 2.62 (dt, J=15.4, 6.2 Hz, 1H), 2.10-2.00 (m, 2H), 1.98-1.90 (m, 2H), 1.90-1.83 (m, 1H), 1.87 (s, 3H), 1.86 (s, 3H), 1.54 (t, J=13.4 Hz, 1H), 1.48 (s, 3H), 1.35 (t, J=7.1 Hz, 3H), 1.34 (s, 3H), 1.14 (d, J=6.5 Hz, 3H); 19F NMR (CD3OD, 376 MHz) δ−139.69 (ddd, J=21.8, 12.6, 3.3 Hz, 1F), −141.32 (ddd, J=22.5, 12.5, 3.1 Hz, 1F), −154.88 (ddd, J=22.5, 19.3, 3.2 Hz, 1F), −159.09 (ddd, J=21.7, 19.2, 3.1 Hz, 1F); Analytical HPLC: tR=14.4 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C37H39F4N2O2[M+H]+ 619.2942, found 619.2948.
A solution of phthalic anhydride (S15; 53.3 mg, 0.360 mmol, 1.5 eq) and AlCl3 (96.0 mg, 0.720 mmol, 3 eq) in 1,2−dichloroethane (5 mL) was added to a stirred solution of 8-(2−(1-ethyl-2,2,4−trimethyl-1,2,3,4−tetrahydroquinolin-7−yl)propan-2−yl)-2,3,6,7−tetrahydro-1H,5H-pyrido[3,2,1−ij]quinoline (58; 100 mg, 0.240 mmol) in 1,2−dichloroethane (4 mL). After stirring the reaction at room temperature for 1 h, it was treated with Et3N (100 μL, 0.720 mmol, 3 eq). A second portion of phthalic anhydride (53.3 mg, 0.360 mmol, 1.5 eq) and AlCl3 (96.0 mg, 0.720 mmol, 3 eq) in 1,2−dichloroethane (5 mL) was added, and the reaction was stirred at room temperature an additional 2 h. It was then poured into ice water (50 mL), diluted with 1 M HCl (10 mL), and extracted with CH2Cl2 (2×). The organic extracts were washed with saturated NaHCO3, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-20% MeOH (2 M NH3)/CH2Cl2, linear gradient) afforded 110 mg (84%) of S57 as a blue solid (mixture of two diastereomers). 1H NMR (CD3OD, 400 MHz) δ 8.10-8.01 (m, 1H), 7.61-7.52 (m, 2H), 7.13-7.07 (m, 1H), 6.881 (s, 0.5H), 6.876 (s, 0.5H), 6.85-6.78 (m, 2H), 3.78 (dq, J=14.5, 7.1 Hz, 1H), 3.65-3.56 (m, 1H), 3.56-3.51 (m, 2H), 3.51-3.45 (m, 2H), 3.23-3.14 (m, 2H), 2.80-2.63 (m, 1H), 2.62-2.45 (m, 2H), 2.04 (p, J=6.1 Hz, 2H), 1.93-1.85 (m, 2H), 1.910 (s, 1.5H), 1.901 (s, 1.5H), 1.892 (s, 1.5H), 1.885 (s, 1.5H), 1.85-1.78 (m, 1H), 1.52-1.45 (m, 1H), 1.45 (s, 1.5H), 1.44 (s, 1.5H), 1.36-1.30 (m, 3H), 1.31 (s, 1.5H), 1.30 (s, 1.5H), 1.01 (d, J=6.6 Hz, 1.5H), 0.98 (d, J=6.5 Hz, 1.5H); Analytical HPLC: tR (two isomers)=14.0 min, 14.3 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C37H43N2O2 [M+H]+ 547.3319, found 547.3325.
A portion of this material (80 mg) was further purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to separate the isomeric mixture. The pooled fractions of each isomer were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with CH2Cl2 (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to provide the two individual diastereomers as blue solids: 30.3 mg of the faster-eluting isomer (“diastereomer 1”) and 25.4 mg of the slower-eluting isomer (“diastereomer 2”).
Diastereomer 1: 1H NMR (CD3OD, 400 MHz) δ 8.10-8.05 (m, 1H), 7.57 (td, J=7.4, 1.6 Hz, 1H), 7.54 (td, J=7.4, 1.6 Hz, 1H), 7.11-7.07 (m, 1H), 6.87 (s, 1H), 6.82 (d, J=1.6 Hz, 1H), 6.81-6.78 (m, 1H), 3.78 (dq, J=14.1, 7.0 Hz, 1H), 3.59 (dq, J=14.2, 7.1 Hz, 1H), 3.53 (t, J=6.3 Hz, 2H), 3.47 (t, J=5.8 Hz, 2H), 3.22-3.14 (m, 2H), 2.74-2.63 (m, 1H), 2.62-2.45 (m, 2H), 2.03 (p, J=6.3 Hz, 2H), 1.92-1.85 (m, 2H), 1.91 (s, 3H), 1.89 (s, 3H), 1.80 (dd, J=13.2, 4.3 Hz, 1H), 1.49 (d, J=13.2 Hz, 1H), 1.44 (s, 3H), 1.33 (t, J=7.0 Hz, 3H), 1.31 (s, 3H), 1.01 (d, J=6.5 Hz, 3H); 13C NMR (CD3OD, 101 MHz) δ 173.3 (C), 165.2 (C), 158.7 (C), 153.5 (C), 152.8 (C), 151.0 (C), 140.5 (C), 139.8 (C), 135.6 (CH), 131.5 (CH), 130.6 (CH), 130.3 (CH), 130.1 (CH), 129.7 (CH), 129.3 (C), 123.7 (C), 123.4 (C), 122.2 (C), 120.5 (C), 111.8 (CH), 58.4 (C), 52.8 (CH2), 52.2 (CH2), 46.6 (CH2), 41.5 (C), 40.7 (CH2), 31.4 (CH3), 31.0 (CH3), 29.5 (CH3), 28.7 (CH2), 27.6 (CH), 26.2 (CH3), 22.0 (CH2), 21.9 (CH2), 19.1 (CH3), 14.7 (CH3); Analytical HPLC: tR=14.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C37H43N2O2 [M+H]+ 547.3319, found 547.3328.
Diastereomer 2: 1H NMR (CD3OD, 400 MHz) δ 8.06-8.01 (m, 1H), 7.57 (td, J=7.4, 1.6 Hz, 1H), 7.54 (td, J=7.4, 1.7 Hz, 1H), 7.13-7.09 (m, 1H), 6.88 (s, 1H), 6.84 (d, J=1.6 Hz, 1H), 6.83-6.80 (m, 1H), 3.78 (dq, J=14.2, 7.0 Hz, 1H), 3.60 (dq, J=14.2, 7.1 Hz, 1H), 3.54 (t, J=6.2 Hz, 2H), 3.48 (t, J=5.8 Hz, 2H), 3.23-3.15 (m, 2H), 2.80-2.68 (m, 1H), 2.62-2.45 (m, 2H), 2.04 (p, J=6.2 Hz, 2H), 1.93-1.85 (m, 2H), 1.90 (s, 3H), 1.89 (s, 3H), 1.82 (dd, J=13.3, 4.4 Hz, 1H), 1.46 (t, J=13.2 Hz, 1H), 1.45 (s, 3H), 1.34 (t, J=7.0 Hz, 3H), 1.30 (s, 3H), 0.98 (d, J=6.5 Hz, 3H); 13C NMR (CD3OD, 101 MHz) δ 173.8 (C), 166.4 (C), 158.9 (C), 153.6 (C), 153.0 (C), 151.2 (C), 140.9 (C), 139.1 (C), 135.8 (CH), 132.1 (CH), 130.5 (CH), 130.4 (CH), 130.1 (CH), 129.7 (CH), 129.4 (C), 123.8 (C), 123.5 (C), 122.3 (C), 120.6 (C), 111.9 (CH), 58.4 (C), 52.9 (CH2), 52.2 (CH2), 46.6 (CH2), 41.6 (C), 40.8 (CH2), 31.3 (CH3), 31.0 (CH3), 29.5 (CH3), 28.67 (CH2), 28.65 (CH2), 27.5 (CH), 26.1 (CH3), 22.0 (CH2), 21.9 (CH2), 19.4 (CH3), 14.7 (CH3); Analytical HPLC: tR=14.4 min, 98.7% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C37H43N2O2 [M+H]+ 547.3319, found 547.3319.
4,5,6,7−Tetrafluoro-fluorescein19 (60; 1.00 g, 2.47 mmol) was taken up in CH2Cl2 (25 mL) and cooled to 0° C. Pyridine (1.60 mL, 19.79 mmol, 8 eq) and trifluoromethanesulfonic anhydride (1.66 mL, 9.89 mmol, 4 eq) were added, and the reaction was allowed to warm to room temperature overnight (18 h). It was subsequently diluted with water and extracted with CH2Cl2 (2×). The combined organic extracts were washed with saturated CuSO4 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-40% EtOAc/hexanes, linear gradient) afforded 1.10 g (67%) of 61 as a white foam. 1H NMR (CDCl3, 400 MHz) δ 7.35-7.32 (m, 2H), 7.16-7.10 (m, 4H); 19F NMR (CDCl3, 376 MHz) δ-73.07 (s, 6F), −136.01 (td, J=19.8, 10.3 Hz, 1F), −139.59 (ddd, J=20.7, 18.0, 10.3 Hz, 1F),-141.78 (td, J=19.9, 5.1 Hz, 1F), −147.64 (ddd, J=20.2, 18.0, 5.1 Hz, 1F); Analytical HPLC: tR=16.2 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (ESI) calcd for C22H7F1009S2 [M+H]+ 668.9366, found 668.9361.
To a solution of 4,5,6,7−tetrafluoro-carbofluorescein (51; 445 mg, 1.03 mmol) in CH2Cl2 (10 mL) were added pyridine (669 μL, 8.27 mmol, 8 eq) and trifluoromethanesulfonic anhydride (696 μL, 4.14 mmol, 4 eq). The reaction was stirred at room temperature for 1 h. It was subsequently diluted with water and extracted with CH2Cl2 (2×). The combined organic extracts were washed with saturated CuSO4 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-30% EtOAc/hexanes, linear gradient) afforded 684 mg (95%) of 62 as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.56 (d, J=2.6 Hz, 2H), 7.19 (dd, J=8.8, 2.5 Hz, 2H), 7.02 (d, J=8.8 Hz, 2H), 1.84 (s, 3H), 1.79 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−73.10 (s, 6F), −136.52 (td, J=19.9, 10.1 Hz, 1F), −140.09 (ddd, J=20.4, 18.1, 10.1 Hz, 1F), −141.51 (td, J=19.9, 4.8 Hz, 1F), −148.41 (ddd, J=20.5, 18.2, 4.8 Hz, 1F); Analytical HPLC: tR=16.4 min, 97.7% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (EI) calcd for C25H12F10O8S2 [M·]+693.9808, found 693.9820.
To a solution of 4,5,6,7−tetrafluoro-Si-fluorescein (55; 170 mg, 0.381 mmol) in CH2Cl2 (5 mL) were added pyridine (246 μL, 3.05 mmol, 8 eq) and trifluoromethanesulfonic anhydride (256 μL, 1.52 mmol, 4 eq). The reaction was stirred at room temperature for 1 h. It was subsequently diluted with water and extracted with CH2Cl2 (2×). The combined organic extracts were washed with saturated CuSO4 and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-25% EtOAc/hexanes, linear gradient) afforded 261 mg (96%) of 63 as a white foam. 1H NMR (CDCl3, 400 MHz) δ 7.58 (d, J=2.7 Hz, 2H), 7.27 (dd, J=8.9, 2.7 Hz, 2H), 7.15 (dd, J=8.9, 1.4 Hz, 2H), 0.69 (s, 3H), 0.67 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−73.17 (s, 6F), −135.84 (td, J=19.8, 10.1 Hz, 1F), −137.58-−137.80 (m, 1F), −140.68 (ddd, J=21.0, 18.3, 10.1 Hz, 1F), −148.14 (ddd, J=20.5, 18.1, 4.9 Hz, 1F); Analytical HPLC: tR=16.9 min, 97.8% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (ESI) calcd for C24H13F10O8S2Si [M+H]+ 710.9656, found 710.9660.
A vial was charged with 4,5,6,7−tetrafluoro-fluorescein ditriflate (61; 90 mg, 0.135 mmol), Pd2dba3 (12.3 mg, 13.5 mol, 0.1 eq), XPhos (19.3 mg, 40.4 mol, 0.3 eq), and Cs2CO3 (123 mg, 0.377 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (1 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of N-methylaniline (32.1 μL, 0.296 mmol, 2.2 eq), the reaction was stirred at 80° C. for 4 h. It was then cooled to room temperature, diluted with CH2Cl2, deposited onto Celite, and concentrated to dryness. Purification by silica gel chromatography (10-100% EtOAc/hexanes, linear gradient; dry load with Celite) afforded 64 (70.7 mg, 90%) as a pale purple solid. 1H NMR (CDCl3, 400 MHz) δ 7.41-7.35 (m, 4H), 7.22-7.16 (m, 6H), 6.67 (d, J=8.8 Hz, 2H), 6.60 (d, J=2.4 Hz, 2H), 6.52 (dd, J=8.8, 2.5 Hz, 2H), 3.33 (s, 6H); 19F NMR (CDCl3, 376 MHz) δ−139.02 (td, J=20.0, 8.7 Hz, 1F), −141.95 (td, J=20.0, 4.0 Hz, 1F),-143.05 (ddd, J=20.4, 18.0, 8.6 Hz, 1F), −150.82-−151.01 (m, 1F); Analytical HPLC: tR=11.0 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C34H2 3F4N2O3[M+H]+ 583.1639, found 583.1631.
A vial was charged with 4,5,6,7−tetrafluoro-carbofluorescein ditriflate (62; 250 mg, 0.360 mmol), Pd2dba3 (33.0 mg, 36.0 mol, 0.1 eq), XPhos (51.5 mg, 0.108 mmol, 0.3 eq), and Cs2CO3 (328 mg, 1.01 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (2 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of N-methylaniline (85.8 μL, 0.792 mmol, 2.2 eq), the reaction was stirred at 80° C. for 8 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and concentrated to dryness. Purification by silica gel chromatography (0-25% EtOAc/hexanes, linear gradient) afforded 65 (167 mg, 76%) as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.37-7.31 (m, 4H), 7.17-7.06 (m, 8H), 6.74 (dd, J=8.8, 2.4 Hz, 2H), 6.69 (d, J=8.8 Hz, 2H), 3.36 (s, 6H), 1.65 (s, 3H), 1.63 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ-139.31 (td, J=20.0, 8.6 Hz, 1F), −141.79 (td, J=20.1, 3.9 Hz, 1F), −143.16 (ddd, J=21.0, 18.6, 8.7 Hz, 1F), −151.67 (ddd, J=21.2, 18.2, 3.7 Hz, 1F); Analytical HPLC: tR=16.4 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C37H29F4N2O2[M+H]+ 609.2160, found 609.2149.
A vial was charged with Si-fluorescein ditriflate17 (120 mg, 0.188 mmol), Pd2dba3 (17.2 mg, 18.8 mol, 0.1 eq), XPhos (26.9 mg, 56.4 mol, 0.3 eq), and Cs2CO3 (171 mg, 0.526 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (1.5 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of N-methylaniline (44.8 μL, 0.413 mmol, 2.2 eq), the reaction was stirred at 100° C. for 3 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and concentrated to dryness. Purification by silica gel chromatography (0-40% EtOAc/hexanes, linear gradient) afforded 92 (71.1 mg, 68%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.97 (dt, J=7.7, 1.0 Hz, 1H), 7.67 (td, J=7.5, 1.2 Hz, 1H), 7.56 (td, J=7.5, 0.9 Hz, 1H), 7.37 (dt, J=7.7, 1.0 Hz, 1H), 7.32-7.26 (m, 4H), 7.24 (d, J=2.6 Hz, 2H), 7.11-7.05 (m, 4H), 7.05-7.00 (m, 2H), 6.81 (d, J=8.7 Hz, 2H), 6.76 (dd, J=8.8, 2.6 Hz, 2H), 3.32 (s, 6H), 0.56 (s, 3H), 0.53 (s, 3H);
13C NMR (CDCl3, 101 MHz) δ 170.5 (C), 153.7 (C), 148.4 (C), 148.2 (C), 137.4 (C), 135.6 (C), 133.8 (CH), 129.5 (CH), 129.1 (CH), 128.1 (CH), 127.1 (C), 126.0 (CH), 124.8 (CH), 122.92 (CH), 122.89 (CH), 122.5 (CH), 119.3 (CH), 91.4 (C), 40.2 (CH3), 0.4 (CH3), −1.7 (CH3); Analytical HPLC: tR=15.3 min, >99% purity (50-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C36H33N2O2Si [M+H]+ 553.2306, found 553.2304.
A vial was charged with 4,5,6,7−tetrafluoro-Si-fluorescein ditriflate (63; 175 mg, 0.246 mmol), Pd2dba3 (22.6 mg, 24.6 mol, 0.1 eq), XPhos (35.2 mg, 73.9 mol, 0.3 eq), and Cs2CO3 (225 mg, 0.690 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (2 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of N-methylaniline (58.7 μL, 0.542 mmol, 2.2 eq), the reaction was stirred at 80° C. for 3 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and concentrated to dryness. Purification by silica gel chromatography (0-25% EtOAc/hexanes, linear gradient) afforded 66 (144 mg, 94%) as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.36-7.30 (m, 4H), 7.20-7.06 (m, 8H), 6.82-6.75 (m, 4H), 3.35 (s, 6H), 0.50 (s, 3H), 0.47 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−138.60 (td, J=19.8, 3.0 Hz, 1F),-138.76 (td, J=19.4, 7.8 Hz, 1F), −143.54-−143.71 (m, 1F), −151.30-−151.47 (m, 1F); Analytical HPLC: tR=16.3 min, >99% purity (50-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C36H29F4N2O2Si [M+H]+ 625.1929, found 625.1922.
A vial was charged with 4,5,6,7−tetrafluoro-fluorescein ditriflate (61; 200 mg, 0.299 mmol), tert-butyl carbamate (84.1 mg, 0.718 mmol, 2.4 eq), Pd2dba3 (27.4 mg, 29.9 μmol, 0.1 eq), XPhos (42.8 mg, 89.8 μmol, 0.3 eq), and Cs2CO3 (273 mg, 0.838 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (2 mL) was added; after flushing the reaction again with nitrogen (3×), it was stirred at 80° C. for 4 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and evaporated. The residue was purified by silica gel chromatography (0-30% EtOAc/hexanes, linear gradient) to afford 67 (172 mg, 95%) as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.49 (d, J=2.2 Hz, 2H), 7.01 (dd, J=8.7, 2.3 Hz, 2H), 6.82 (d, J=8.7 Hz, 2H), 6.61 (s, 2H), 1.53 (s, 18H); 19F NMR (CDCl3, 376 MHz) δ-138.19 (td, J=19.8, 9.4 Hz, 1F), −141.93 (ddd, J=20.5, 17.6, 9.2 Hz, 1F), −142.12 (td, J=19.8, 4.0 Hz, 1F), −149.98 (ddd, J=20.5, 17.7, 3.9 Hz, 1F); Analytical HPLC: tR=15.6 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C30H27F4N2O7[M+H]+ 603.1749, found 603.1750.
A vial was charged with 4,5,6,7−tetrafluoro-carbofluorescein ditriflate (62; 350 mg, 0.504 mmol), tert-butyl carbamate (142 mg, 1.21 mmol, 2.4 eq), Pd2dba3 (46.1 mg, 50.4 μmol, 0.1 eq), XPhos (72.1 mg, 0.151 mmol, 0.3 eq), and Cs2CO3 (460 mg, 1.41 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (3.5 mL) was added; after flushing the reaction again with nitrogen (3×), it was stirred at 80° C. for 4 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and evaporated. The residue was purified by silica gel chromatography (0-30% EtOAc/hexanes, linear gradient) to afford 68 (305 mg, 96%) as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.79 (d, J=2.2 Hz, 2H), 7.11 (dd, J=8.6, 2.2 Hz, 2H), 6.77 (d, J=8.6 Hz, 2H), 6.59 (s, 2H), 1.81 (s, 3H), 1.74 (s, 3H), 1.53 (s, 18H); 19F NMR (CDCl3, 376 MHz) δ−138.65 (td, J=20.0, 9.1 Hz), −141.98 (td, J=20.0, 4.0 Hz), −142.47 (td, J=19.5, 8.8 Hz), −150.82-−151.01 (m); Analytical HPLC: tR=15.7 min, 98.2% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C33H33F4N2O6[M+H]+ 629.2269, found 629.2280.
A vial was charged with 4,5,6,7−tetrafluoro-Si-fluorescein ditriflate (63; 245 mg, 0.345 mmol), tert-butyl carbamate (96.9 mg, 0.828 mmol, 2.4 eq), Pd2dba3 (31.6 mg, 34.5 μmol, 0.1 eq), XPhos (49.3 mg, 0.103 mmol, 0.3 eq), and Cs2CO3 (315 mg, 0.965 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (3 mL) was added; after flushing the reaction again with nitrogen (3×), it was stirred at 80° C. for 5 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and evaporated. The residue was purified by silica gel chromatography (0-30% EtOAc/hexanes, linear gradient) to afford 69 (212 mg, 95%) as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.70 (d, J=2.5 Hz, 2H), 7.30 (dd, J=8.7, 2.5 Hz, 2H), 6.90 (d, J=8.7 Hz, 2H), 6.56 (s, 2H), 1.52 (s, 18H), 0.60 (s, 3H), 0.56 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−138.04 (td, J=20.0, 8.8 Hz, 1F), −139.27-−139.47 (m, 1F), −142.79 (td, J=19.4, 8.8 Hz, 1F), −150.67-−150.88 (m, 1F); Analytical HPLC: tR=16.1 min, 98.4% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C32H33F4N2O6Si [M+H]+ 645.2039, found 645.2049.
4,5,6,7−Tetrafluoro-rhodamine 110 bis(tert-butyl carbamate) (67; 100 mg, 0.166 mmol) was taken up in CH2Cl2 (5 mL), and trifluoroacetic acid (1 mL) was added. The reaction was stirred at room temperature for 3 h. It was then diluted with toluene (5 mL) and concentrated to dryness. Purification by reverse phase HPLC (10-40% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) yielded 82.6 mg (96%, TFA salt) of 70 as a red solid. 1H NMR (CD3OD, 400 MHz) δ 7.29 (dd, J=9.2, 0.9 Hz, 2H), 6.90 (dd, J=9.2, 2.1 Hz, 2H), 6.83 (d, J=2.1 Hz, 2H); 19F NMR (CD3OD, 376 MHz) δ−75.77 (s, 3F), −135.40 (ddd, J=20.4, 11.9, 8.1 Hz, 1F), −137.30 (ddd, J=21.7, 11.9, 5.1 Hz, 1F), −150.52 (ddd, J=21.8, 18.9, 7.9 Hz, 1F), −151.93 (ddd, J=21.1, 19.0, 5.3 Hz, 1F); Analytical HPLC: tR=9.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 525 nm); HRMS (ESI) calcd for C20H11F4N2O3[M+H]+ 403.0700, found 403.0703.
4,5,6,7−Tetrafluoro-carborhodamine 110 bis(tert-butyl carbamate) (68; 90 mg, 0.143 mmol) was taken up in CH2Cl2 (5 mL), and trifluoroacetic acid (1 mL) was added. The reaction was stirred at room temperature for 4 h. It was then diluted with toluene (5 mL) and concentrated to dryness. The residue was taken up in saturated NaHCO3 and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, deposited onto Celite, and concentrated to dryness. Flash chromatography (10-100% EtOAc/hexanes, linear gradient; dry load with Celite) afforded 52.2 mg (85%) of 71 as a dark purple solid. 1H NMR (CD3OD, 400 MHz) δ 7.09 (d, J=2.2 Hz, 2H), 7.06 (dd, J=8.9, 0.8 Hz, 2H), 6.62 (dd, J=8.9, 2.2 Hz, 2H), 1.72 (s, 3H), 1.66 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ-140.30 (ddd, J=21.2, 13.8, 3.5 Hz, 1F), −141.26 (ddd, J=21.9, 13.9, 4.6 Hz, 1F), −154.43 (ddd, J=22.4, 18.8, 3.5 Hz, 1F), −155.33-−155.56 (m, 1F); Analytical HPLC: tR=9.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C23H17F4N2O2[M+H]+ 429.1221, found 429.1223.
4,5,6,7−Tetrafluoro-Si-rhodamine 110 bis(tert-butyl carbamate) (69; 50 mg, 77.6 μmol) was taken up in CH2Cl2 (4 mL), and trifluoroacetic acid (0.8 mL) was added. The reaction was stirred at room temperature for 4 h. It was then diluted with toluene (4 mL) and concentrated to dryness. The residue was taken up in saturated NaHCO3 and extracted with EtOAc (2×). The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, deposited onto Celite, and concentrated to dryness. Flash chromatography (10-100% EtOAc/hexanes, linear gradient; dry load with Celite) afforded 32.2 mg (93%) of 72 as a light blue solid. 1H NMR (CDCl3, 400 MHz) δ 6.94 (d, J=2.6 Hz, 2H), 6.72 (dd, J=8.5, 1.2 Hz, 2H), 6.58 (dd, J=8.5, 2.7 Hz, 2H), 3.82 (s, 4H), 0.54 (s, 3H), 0.52 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ-138.90 (td, J=19.8, 8.4 Hz, 1F), −139.14 (td, J=19.9, 3.4 Hz, 1F), −143.59 (ddd, J=20.5, 18.3, 8.3 Hz, 1F), −151.59 (ddd, J=20.2, 18.3, 3.8 Hz, 1F); Analytical HPLC: tR=9.9 min, 98.6% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C22H17F4N2O2Si [M+H]+ 445.0990, found 445.0998.
4,5,6,7−Tetrafluoro-fluorescein19 (60; 100 mg, 0.247 mmol) and 2-(methoxymethoxy)malononitrile (3; 31.2 mg, 0.247 mmol, 1 eq) were combined in DMF (5 mL), and DIEA (129 μL, 0.742 mmol, 3 eq) was added. After stirring the reaction at room temperature for 18 h, it was evaporated to dryness and purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled product fractions were partially concentrated to remove MeCN and extracted with CH2Cl2 (3×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to provide 60MAC (69 mg, 55%) as a yellow-orange solid. 1H NMR (DMSO-d6, 400 MHz) δ 10.26 (s, 2H), 7.05 (d, J=8.7 Hz, 2H), 6.70 (d, J=2.3 Hz, 2H), 6.60 (dd, J=8.7, 2.4 Hz, 2H), 5.11 (s, 2H), 3.34 (s, 3H); 19F NMR (DMSO-d6, 376 MHz) δ−118.57 (d, J=21.4 Hz, 1F), −129.27 (d, J=21.1 Hz, 1F),-140.99 (t, J=21.3 Hz, 1F); Analytical HPLC: tR=12.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C25H14F3N2O7[M+H]+ 511.0748, found 511.0746.
4,5,6,7−Tetrafluoro-carbofluorescein (51; 125 mg, 0.290 mmol) and 2-(methoxymethoxy)malononitrile (3; 36.6 mg, 0.290 mmol, 1 eq) were combined in DMF (4 mL), and DIEA (152 μL, 0.871 mmol, 3 eq) was added. After stirring the reaction at room temperature for 2 h, it was diluted with 10% citric acid and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-75% EtOAc/toluene, linear gradient) afforded 92 mg (59%) of 51MAC as an orange solid. 1H NMR (DMSO-d6, 400 MHz) δ 9.83 (s, 2H), 7.10 (d, J=2.5 Hz, 2H), 6.87 (d, J=8.6 Hz, 2H), 6.66 (dd, J=8.7, 2.4 Hz, 2H), 5.10 (s, 2H), 3.32 (s, 3H), 1.68 (s, 3H), 1.60 (s, 3H); 19F NMR (DMSO-d6, 376 MHz) δ−117.77 (d, J=21.4 Hz, 1F), −129.80 (d, J=21.4 Hz, 1F), −141.28 (t, J=21.5 Hz, 1F); Analytical HPLC: tR=13.1 min, 99.0% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C28H20F3N2O6[M+H]+ 537.1268, found 537.1268.
4,5,6,7−Tetrafluoro-Si-fluorescein (55; 45 mg, 0.101 mmol) and 2-(methoxymethoxy)malononitrile (3; 12.7 mg, 0.101 mmol, 1 eq) were combined in DMF (2 mL), and DIEA (52.7 μL, 0.302 mmol, 3 eq) was added. After stirring the reaction at room temperature for 3 h, it was diluted with 10% citric acid and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Flash chromatography on silica gel (0-60% EtOAc/toluene, linear gradient) afforded 31.6 mg (57%) of 55Mac as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.14 (d, J=2.6 Hz, 2H), 6.82 (d, J=8.8 Hz, 2H), 6.78 (dd, J=8.7, 2.6 Hz, 2H), 5.17 (s, 2H), 5.01 (s, 2H), 3.52 (s, 3H), 0.57 (s, 3H), 0.54 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−113.71 (d, J=22.6 Hz, 1F), −126.48 (d, J=19.9 Hz, 1F), −138.58 (dd, J=22.7, 20.1 Hz, 1F); Analytical HPLC: tR=13.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C27H20F3N2O6Si [M+H]+ 553.1037, found 553.1039.
4,5,6,7−Tetrafluoro-MGL (49; 300 mg, 0.675 mmol) and 2−(methoxymethoxy)-malononitrile (3; 85.1 mg, 0.675 mmol, 1 eq) were combined in DMF (10 mL), and DIEA (235 L, 1.35 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was concentrated in vacuo and purified by flash chromatography on silica gel (0-50% EtOAc/hexanes, linear gradient) to provide 49MAC (225 mg, 61%) as a yellow foam. 1H NMR (CDCl3, 400 MHz) δ 7.16-7.09 (m, 4H), 6.65 (d, J=9.0 Hz, 4H), 5.18 (s, 2H), 3.53 (s, 3H), 2.97 (s, 12H); 19F NMR (CDCl3, 376 MHz) δ−112.40 (d, J=22.4 Hz, 1F), −127.57 (d, J=20.4 Hz, 1F), −139.50 (dd, J=22.5, 20.3 Hz, 1F); Analytical HPLC: tR=13.3 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (ESI) calcd for C29H26F3N4O4 [M+H]+ 551.1901, found 551.1910.
4,5,6,7−Tetrafluoro-rhodamine 110 bis(tert-butyl carbamate) (67; 300 mg, 0.498 mmol) and 2−(methoxymethoxy)malononitrile (3; 62.8 mg, 0.498 mmol, 1 eq) were combined in DMF (5 mL), and DIEA (173 μL, 0.996 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was concentrated in vacuo and purified by silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) to yield 183 mg (52%) of 67MAC as an off-white solid.
1H NMR (CDCl3, 400 MHz) δ 7.48 (d, J=2.2 Hz, 2H), 7.06 (dd, J=8.7, 2.2 Hz, 2H), 6.82 (d, J=8.6 Hz, 2H), 6.63 (s, 2H), 5.13 (s, 2H), 3.51 (s, 3H), 1.53 (s, 18H); 19F NMR (CDCl3, 376 MHz) δ-116.95 (d, J=22.9 Hz, 1F), −125.48 (d, J=19.9 Hz, 1F), −138.65 (dd, J=23.0, 20.2 Hz, 1F); Analytical HPLC: tR=15.2 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C35H32F3N4O9[M+H]+ 709.2116, found 709.2130.
4,5,6,7−Tetrafluoro-carborhodamine 110 bis(tert-butyl carbamate) (68; 180 mg, 0.286 mmol) and 2−(methoxymethoxy)malononitrile (3; 36.1 mg, 0.286 mmol, 1 eq) were combined in DMF (3 mL), and DIEA (99.7 μL, 0.573 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was concentrated in vacuo and purified by silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) to yield 107 mg (51%) of 68MAC as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.78 (d, J=2.2 Hz, 2H), 7.16 (dd, J=8.6, 2.2 Hz, 2H), 6.75 (d, J=8.6 Hz, 2H), 6.61 (s, 2H), 5.12 (s, 2H), 3.50 (s, 3H), 1.81 (s, 3H), 1.75 (s, 3H), 1.53 (s, 18H); 19F NMR (CDCl3, 376 MHz) δ−116.84 (d, J=22.7 Hz, 1F), −126.32 (d, J=19.7 Hz, 1F), −139.19 (dd, J=22.9, 20.1 Hz, 1F); Analytical HPLC: tR=15.2 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C38H38F3N4O8 [M+H]+ 735.2636, found 735.2641.
4,5,6,7−Tetrafluoro-Si-rhodamine 110 bis(tert-butyl carbamate) (69; 150 mg, 0.233 mmol) and 2−(methoxymethoxy)malononitrile (3; 29.3 mg, 0.233 mmol, 1 eq) were combined in DMF (3 mL), and DIEA (81.1 μL, 0.465 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was concentrated in vacuo and purified by silica gel chromatography (0-50% EtOAc/hexanes, linear gradient) to yield 89 mg (51%) of 69MAC as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.68 (d, J=2.5 Hz, 2H), 7.36 (dd, J=8.8, 2.5 Hz, 2H), 6.88 (d, J=8.7 Hz, 2H), 6.58 (s, 2H), 5.16 (s, 2H), 3.52 (s, 3H), 1.52 (s, 18H), 0.60 (s, 3H), 0.56 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−114.17 (d, J=22.5 Hz, 1F), −126.44 (d, J=20.0 Hz, 1F), −138.55 (t, J=21.4 Hz, 1F); Analytical HPLC: tR=15.7 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C37H38F3N4O8Si [M+H]+ 751.2406, found 751.2413.
JF632 (44; 45.0 mg, 88.5 mol) and 2−(methoxymethoxy)malononitrile (3; 11.2 mg, 88.5 mol, 1 eq) were combined in DMF (2 mL), and DIEA (30.8 μL, 0.177 mmol, 2 eq) was added. After stirring the reaction at room temperature for 3 h, it was concentrated in vacuo and purified by reverse phase HPLC (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled HPLC product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with CH2Cl2 (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to yield 23.5 mg (43%) of 44MAC as a blue solid. 1H NMR (CDCl3, 400 MHz) δ 6.63 (d, J=8.6 Hz, 2H), 6.55 (d, J=2.3 Hz, 2H), 6.28 (dd, J=8.6, 2.4 Hz, 2H), 5.11 (s, 2H), 3.95 (t, J=7.3 Hz, 8H), 3.50 (s, 3H), 2.40 (p, J=7.2 Hz, 4H), 1.75 (s, 3H), 1.70 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−116.34 (d, J=22.7 Hz, 1F),-127.69 (d, J=20.0 Hz, 1F), −140.39 (dd, J=22.8, 20.1 Hz, 1F); Analytical HPLC: tR=12.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C34H30F3N4O4[M+H]+ 615.2214, found 615.2207.
JFX576 (8; 250 mg, 0.475 mmol) and 2−(methoxymethoxy)malononitrile (3; 59.9 mg, 0.475 mmol, 1 eq) were combined in DMF (9 mL), and DIEA (165 μL, 0.950 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was concentrated in vacuo and purified by silica gel chromatography (0-15% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive) to yield 8MAC as a dark purple solid (188 mg, 57%, acetate salt). 1H NMR (CD3OD, 400 MHz) δ 7.32 (dd, J=9.4, 0.8 Hz, 2H), 6.94 (dd, J=9.4, 2.3 Hz, 2H), 6.75 (d, J=2.3 Hz, 2H), 5.20 (s, 2H), 3.53 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−112.06 (d, J=14.9 Hz, 1F), −128.39 (d, J=21.8 Hz, 1F), −141.73 (dd, J=21.7, 14.9 Hz, 1F); Analytical HPLC: tR=12.7 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C33H12D16F3N4O5[M+H]+ 633.3011, found 633.3006.
JFX637 (40; 40 mg, 72.4 mol) and 2−(methoxymethoxy)malononitrile (3; 9.1 mg, 72.4 mol, 1 eq) were combined in DMF (2 mL), and DIEA (25.2 μL, 0.145 mmol, 2 eq) was added. After stirring the reaction at room temperature for 1 h, it was concentrated in vacuo and purified by reverse phase HPLC (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled HPLC product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with CH2Cl2 (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to yield 19.2 mg (40%) of 40MAC as a blue solid. 1H NMR (CD3OD, 400 MHz) δ 7.20 (dd, J=9.3, 0.9 Hz, 2H), 7.08 (d, J=2.4 Hz, 2H), 6.72 (dd, J=9.3, 2.4 Hz, 2H), 5.19 (s, 2H), 3.53 (s, 3H), 1.80 (s, 3H), 1.74 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−112.49 (d, J=14.6 Hz, 1F), −129.79 (d, J=22.3 Hz, 1F), −142.26 (dd, J=21.8, 14.9 Hz, 1F); Analytical HPLC: tR=13.0 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C36H18D16F3N4O4[M+H]+ 659.3531, found 659.3522.
JFX673 (25; 300 mg, 0.527 mmol) and 2−(methoxymethoxy)malononitrile (3; 66.5 mg, 0.527 mmol, 1 eq) were combined in DMF (7 mL), and DIEA (184 μL, 1.05 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was concentrated in vacuo and purified by silica gel chromatography (10-100% EtOAc/hexanes, linear gradient) to yield 166 mg (47%) of 25MAC as a blue-green solid. 1H NMR (CDCl3, 400 MHz) δ 6.77 (d, J=2.7 Hz, 2H), 6.73 (dd, J=8.8, 1.1 Hz, 2H), 6.46 (dd, J=8.8, 2.8 Hz, 2H), 5.16 (s, 2H), 3.53 (s, 3H), 0.57 (s, 3H), 0.55 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−113.90 (d, J=22.5 Hz, 1F), −128.13 (d, J=20.2 Hz, 1F), −140.21 (dd, J=22.7, 20.2 Hz, 1F); Analytical HPLC: tR=13.2 min, 97.5% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C35H18D16F3N4O4Si [M+H]+ 675.3300, found 675.3302.
Rhodamine 11 (100 mg, 0.169 mmol) and 2−(methoxymethoxy)malononitrile (3; 21.4 mg, 0.169 mmol, 1 eq) were combined in DMF (4 mL), and DIEA (59.0 μL, 0.339 mmol, 2 eq) was added. After stirring the reaction at room temperature for 4 h, it was evaporated to dryness. Flash chromatography on silica gel (0-10% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive) afforded 11MAC as a dark blue solid (93.8 mg, 73%, acetate salt). 1H NMR (CD3OD, 400 MHz) δ 6.94 (d, J=1.1 Hz, 2H), 6.81 (s, 2H), 5.68 (q, J=1.4 Hz, 2H), 5.19 (s, 2H), 3.51 (s, 3H), 3.20 (s, 6H), 1.94 (d, J=1.4 Hz, 6H), 1.52 (s, 6H), 1.51 (s, 6H); 19F NMR (CD3OD, 376 MHz) δ−111.06 (d, J=14.9 Hz, 1F), −127.94 (d, J=21.9 Hz, 1F),-140.94 (dd, J=21.8, 14.9 Hz, 1F); Analytical HPLC: tR=14.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C39H36F3N4O5 [M+H]+ 697.2632, found 697.2622.
JF563 (18; 50 mg, 88.2 μmol) and 2−(methoxymethoxy)malononitrile (3; 11.1 mg, 88.2 μmol, 1 eq) were combined in DMSO (5 mL), and DIEA (30.7 μL, 0.176 mmol, 2 eq) was added. The resulting dark red solution was stirred at room temperature for 4 h. A second portion of 2−(methoxymethoxy)malononitrile (3; 2.8 mg, 22.1 μmol, 0.25 eq) was added, and stirring was continued for an additional 2 h at room temperature. It was subsequently diluted with water and extracted with CH2Cl2 (2×). The combined organic extracts were dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel chromatography (0-20% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive) provided 30.5 mg (47%, acetate salt) of 18MAC as a dark red-purple solid (mixture of diastereomers). 1H NMR (CD3OD, 400 MHz) δ 7.16-7.09 (m, 2H), 6.64-6.59 (m, 2H), 5.21-5.18 (m, 2H), 3.55-3.50 (m, 3H), 3.00-2.85 (m, 2H), 1.91-1.84 (m, 2H), 1.49-1.23 (m, 20H); 19F NMR (CD3OD, 376 MHz) δ -111.22-−111.37 (m, 1F), −128.02-−128.46 (m, 1F), −140.92-−141.30 (m, 1F); Analytical HPLC: tR (three isomers)=13.2 min, 13.4 min, 13.6 min; 95.1% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C37H36F3N4O5[M+H]+ 673.2632, found 673.2623.
Si-rhodamine 38 (425 mg, 0.672 mmol) and 2−(methoxymethoxy)malononitrile (3; 84.7 mg, 0.672 mmol, 1 eq) were combined in DMF (13 mL); DIEA (234 μL, 1.34 mmol, 2 eq) was added, and the reaction was stirred at room temperature for 1 h. LC/MS analysis indicated that the reaction was incomplete, so additional 2−(methoxymethoxy)malononitrile (3; 25.4 mg, 0.201 mmol, 1 eq) was added. After stirring the reaction for another 1 h at room temperature, it was concentrated in vacuo and purified by silica gel chromatography (10-100% EtOAc/hexanes, linear gradient) to yield 152 mg (31%) of 38MAC as a green solid. 1H NMR (CDCl3, 400 MHz) δ 6.69 (s, 2H), 6.46 (s, 2H), 5.27 (q, J=1.4 Hz, 2H), 5.16 (s, 2H), 3.52 (s, 3H), 2.87 (s, 6H), 1.75 (d, J=1.5 Hz, 6H), 1.33 (s, 6H), 1.30 (s, 6H), 0.56 (s, 3H), 0.55 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−112.08 (d, J=22.4 Hz, 1F), −128.21 (d, J=19.7 Hz, 1F),-139.61 (dd, J=22.5, 20.3 Hz, 1F); Analytical HPLC: tR=11.5 min, 98.0% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 750 nm); HRMS (ESI) calcd for C41H42F3N4O4Si [M+H]+ 739.2922, found 739.2917.
Si-rhodamine 36 (150 mg, 0.248 mmol) and 2−(methoxymethoxy)malononitrile (3; 31.3 mg, 0.248 mmol, 1 eq) were combined in DMF (5 mL); DIEA (86.4 μL, 0.496 mmol, 2 eq) was added, and the reaction was stirred at room temperature for 1 h. A second portion of 2-(methoxymethoxy)malononitrile (3; 15.6 mg, 0.124 mmol, 0.5 eq) was added, and stirring was continued for an additional 1 h at room temperature. The reaction was then concentrated in vacuo and purified by silica gel chromatography (25-100% EtOAc/toluene, linear gradient) to yield 30 mg (17%) of 36MAC as a green solid. 1H NMR (CD3OD, 400 MHz) δ 6.94 (s, 2H), 6.83 (s, 2H), 5.51 (q, J=1.5 Hz, 2H), 5.19 (s, 2H), 3.53 (s, 3H), 1.77 (d, J=1.4 Hz, 6H), 1.40 (s, 6H), 1.39 (s, 6H), 0.52 (s, 3H), 0.48 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−112.09 (dd, J=14.6, 2.3 Hz, 1F), −130.38 (dd, J=21.9, 2.5 Hz, 1F), −141.65 (dd, J=21.9, 14.7 Hz, 1F); Analytical HPLC: tR=13.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 725 nm); HRMS (ESI) calcd for C39H38F3N4O4Si [M+H]+ 711.2609, found 711.2614.
SiRF712(108; 180 mg, 0.343 mmol) and 2−(methoxymethoxy)malononitrile (3; 43.3 mg, 0.343 mmol, 1 eq) were combined in DMF (5 mL), and DIEA (120 μL, 0.686 mmol, 2 eq) was added. After stirring the reaction at room temperature for 1 h, it was concentrated in vacuo and purified by silica gel chromatography (10-100% acetone/CH2Cl2, linear gradient) followed by reverse phase HPLC (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled HPLC product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with CH2Cl2 (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to yield 99 mg (46%) of 108MAC as a green solid. 1H NMR (CD3OD, 400 MHz) δ 7.09 (s, 2H), 6.81 (s, 2H), 5.18 (s, 2H), 3.83 (t, J=8.1 Hz, 4H), 3.51 (s, 3H), 3.21 (s, 6H), 3.06 (dt, J=16.3, 8.0 Hz, 2H), 2.95 (dt, J=16.8, 8.0 Hz, 2H), 0.54 (s, 3H), 0.53 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−112.97 (d, J=14.8 Hz, 1F),-130.78 (d, J=21.8 Hz, 1F), −142.67 (dd, J=21.7, 14.9 Hz, 1F); Analytical HPLC: tR=12.4 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 725 nm); HRMS (ESI) calcd for C33H30F3N4O4Si [M+H]+ 631.1983, found 631.1989.
JF698 (31; 150 mg, 0.248 mmol) and 2−(methoxymethoxy)malononitrile (3; 31.3 mg, 0.248 mmol, 1 eq) were combined in DMF (4 mL), and DIEA (86.4 μL, 0.496 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was concentrated in vacuo and purified by silica gel chromatography (0-15% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive) followed by reverse phase HPLC (40-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled HPLC product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with CH2Cl2 (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to yield 46 mg (26%) of 31MAC as a dark green solid. 1H NMR (CD3OD, 400 MHz) δ 6.70 (s, 2H), 5.15 (s, 2H), 3.56 (t, J=6.0 Hz, 4H), 3.53 (t, J=5.9 Hz, 4H), 3.50 (s, 3H), 3.00-2.92 (m, 4H), 2.72-2.46 (m, 4H), 2.10-2.01 (m, 4H), 1.96-1.88 (m, 4H), 0.68 (s, 3H), 0.68 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−112.34 (dd, J=14.3, 2.3 Hz, 1F), −130.94 (dd, J=22.0, 2.3 Hz, 1F), −142.74 (dd, J=22.0, 14.6 Hz, 1F); Analytical HPLC: tR=13.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 700 nm); HRMS (ESI) calcd for C39H38F3N4O4Si [M+H]+ 711.2609, found 711.2615.
FSiRhQ (29; 170 mg, 0.324 mmol) and 2−(methoxymethoxy)malononitrile (3; 40.9 mg, 0.324 mmol, 1 eq) were combined in DMF (5 mL), and DIEA (113 μL, 0.648 mmol, 2 eq) was added. After stirring the reaction at room temperature for 1 h, it was concentrated in vacuo and purified by silica gel chromatography (0-20% MeOH/CH2Cl2, linear gradient, with constant 1% v/v AcOH additive) followed by reverse phase HPLC (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled HPLC product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with 15% i-PrOH/CHCl3 (2×) followed by 20% MeOH/CH2Cl2 (3×). The combined organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to yield 86 mg (42%) of 29MAC as a dark blue solid. 1H NMR (CD3OD, 400 MHz) δ 6.95 (s, 2H), 6.84 (s, 2H), 5.17 (s, 2H), 3.51 (s, 3H), 3.50-3.45 (m, 4H), 2.68 (dt, J=16.2, 6.0 Hz, 2H), 2.56 (dt, J=16.1, 6.3 Hz, 2H), 1.89 (p, J=6.2 Hz, 4H), 0.47 (s, 3H), 0.44 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−112.41 (dd, J=15.0, 2.0 Hz, 1F), −130.57 (dd, J=21.8, 2.0 Hz, 1F), −142.51 (dd, J=21.9, 14.8 Hz, 1F); Analytical HPLC: tR=12.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C33H30F3N4O4Si [M+H]+ 631.1983, found 631.1988.
JF660 (57; 275 mg, 0.467 mmol) and 2−(methoxymethoxy)malononitrile (3; 58.9 mg, 0.467 mmol, 1 eq) were combined in DMF (8 mL), and DIEA (163 μL, 0.934 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was evaporated to dryness. Flash chromatography on silica gel (0-20% MeOH/CH2Cl2, linear gradient, with constant 0.1% v/v AcOH additive) afforded 57MAC as a dark blue solid (133 mg, 41%). 1H NMR (CD3OD, 400 MHz) δ 6.63 (s, 2H), 5.20 (s, 2H), 3.58 (t, J=6.1 Hz, 4H), 3.55-3.51 (m, 4H), 3.51 (s, 3H), 3.11-3.05 (m, 4H), 2.68-2.58 (m, 4H), 2.08-2.00 (m, 4H), 2.05 (s, 3H), 1.97 (s, 3H), 1.93 (p, J=6.1 Hz, 4H); 19F NMR (CD3OD, 376 MHz) δ−111.21 (d, J=14.7 Hz, 1F), −129.21 (d, J=20.6 Hz, 1F), −139.69 (dd, J=20.5, 14.5 Hz, 1F); Analytical HPLC: tR=13.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C40H38F3N4O4[M+H]+ 695.2840, found 695.2842.
JF657 (59; 150 mg, 0.242 mmol) and 2−(methoxymethoxy)malononitrile (3; 30.6 mg, 0.242 mmol, 1 eq) were combined in DMF (5 mL), and DIEA (84.5 μL, 0.485 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was concentrated in vacuo and purified by flash chromatography on silica gel (0-20% MeOH/CH2Cl2, linear gradient, with constant 0.1% v/v AcOH additive) to provide 83.8 mg (48%) of 59MAC as a dark blue solid (mixture of two diastereomers). 1H NMR (CD3OD, 400 MHz) δ 6.92 (s, 1H), 6.89-6.80 (m, 2H), 5.22-5.14 (m, 2H), 3.82 (dq, J=14.2, 7.0 Hz, 1H), 3.66 (dq, J=14.5, 7.3 Hz, 1H), 3.60 (t, J=5.8 Hz, 2H), 3.56 (t, J=6.0 Hz, 2H), 3.53 (s, 1.5H), 3.52 (s, 1.5H), 3.24-3.16 (m, 2H), 2.87-2.69 (m, 2H), 2.61 (dt, J=15.4, 6.2 Hz, 1H), 2.11-2.00 (m, 2H), 1.97-1.92 (m, 2H), 1.91-1.83 (m, 1H), 1.90 (s, 1.5H), 1.88 (s, 1.5H), 1.86 (s, 1.5H), 1.85 (s, 1.5H), 1.60-1.49 (m, 1H), 1.48 (s, 1.5H), 1.47 (s, 1.5H), 1.36 (s, 1.5H), 1.35 (t, J=7.1 Hz, 3H), 1.33 (s, 1.5H), 1.19 (d, J=6.6 Hz, 1.5H), 1.15 (d, J=6.5 Hz, 1.5H); 19F NMR (CD3OD, 376 MHz) δ−111.78 (d, J=14.7 Hz, 1F), −129.97 (dd, J=21.8, 2.0 Hz, 0.5F), −130.09 (dd, J=21.8, 2.0 Hz, 0.5F), −141.98 (dd, J=21.9, 14.5 Hz, 0.5F), −142.00 (dd, J=22.1, 14.6 Hz, 0.5F); Analytical HPLC: tR (two isomers)=13.8 min, 14.1 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C42H44F3N4O4[M+H]+ 725.3309, found 725.3310.
Rhodamine 64 (165 mg, 0.283 mmol) and 2−(methoxymethoxy)malononitrile (3; 35.7 mg, 0.283 mmol, 1 eq) were combined in DMF (6 mL), and DIEA (98.7 μL, 0.566 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was evaporated to dryness. Flash chromatography on silica gel (25-100% EtOAc/hexanes, linear gradient) afforded 64MAC (115 mg, 59%) as a dark purple solid. 1H NMR (CDCl3, 400 MHz) δ 7.45-7.37 (m, 4H), 7.26-7.19 (m, 6H), 6.78 (d, J=8.9 Hz, 2H), 6.61 (d, J=2.4 Hz, 2H), 6.58 (dd, J=8.9, 2.5 Hz, 2H), 5.14 (s, 2H), 3.53 (s, 3H), 3.38 (s, 6H); 19F NMR (CDCl3, 376 MHz) δ−116.29 (d, J=21.6 Hz, 1F), −126.47 (d, J=20.8 Hz, 1F), −139.41 (t, J=21.2 Hz, 1F); Analytical HPLC: tR=11.4 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C39H28F3N4O5[M+H]+ 689.2006, found 689.1999.
Carborhodamine 65 (150 mg, 0.246 mmol) and 2-(methoxymethoxy)malononitrile (3; 31.1 mg, 0.246 mmol, 1 eq) were combined in DMF (6 mL), and DIEA (85.8 μL, 0.493 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was evaporated to dryness. Flash chromatography on silica gel (0-75% EtOAc/hexanes, linear gradient) afforded 65MAC as a yellow-green solid (93.3 mg, 53%). 1H NMR (CDCl3, 400 MHz) δ 7.39-7.32 (m, 4H), 7.20-7.15 (m, 4H), 7.14-7.09 (m, 2H), 7.09 (d, J=2.5 Hz, 2H), 6.74 (dd, J=8.8, 2.5 Hz, 2H), 6.64 (d, J=8.8 Hz, 2H), 5.14 (s, 2H), 3.51 (s, 3H), 3.37 (s, 6H), 1.65 (s, 3H), 1.63 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−116.51 (d, J=22.7 Hz, 1F), −127.06 (d, J=20.5 Hz, 1F), −140.00 (dd, J=22.9, 20.3 Hz, 1F); Analytical HPLC: tR=14.1 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C42H34F3N4O4[M+H]+ 715.2527, found 715.2518.
Si-rhodamine 66 (125 mg, 0.200 mmol) and 2−(methoxymethoxy)malononitrile (3; 25.2 mg, 0.200 mmol, 1 eq) were combined in DMF (5 mL), and DIEA (69.7 μL, 0.400 mmol, 2 eq) was added. After stirring the reaction at room temperature for 2 h, it was evaporated to dryness. Flash chromatography on silica gel (0-40% EtOAc/hexanes, linear gradient) afforded 66MAC as an off-white solid (79.9 mg, 55%). 1H NMR (CDCl3, 400 MHz) δ 7.38-7.31 (m, 4H), 7.19-7.09 (m, 8H), 6.79 (dd, J=8.9, 2.7 Hz, 2H), 6.71 (dd, J=8.9, 0.7 Hz, 2H), 5.18 (s, 2H), 3.54 (s, 3H), 3.36 (s, 6H), 0.50 (s, 3H), 0.47 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−113.25 (d, J=22.4 Hz, 1F), −127.11 (d, J=20.2 Hz, 1F), −139.39 (dd, J=22.7, 20.2 Hz, 1F); Analytical HPLC: tR=15.0 min, >99% purity (50-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C41H34F3N4O4Si [M+H]+ 731.2296, found 731.2290.
4,5,7−Trifluoro-6−(MOM-MAC)-fluorescein (60MAC; 30 mg, 58.8 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 24 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 39.7 mg, 0.118 mmol, 2 eq) and DIEA (102 μL, 0.588 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 27.1 mg (72%) of 60HTL as an orange solid. 1H NMR (CD3OD, 400 MHz) δ 9.05 (t, J=5.1 Hz, 1H), 6.89 (d, J=8.7 Hz, 2H), 6.70 (d, J=2.4 Hz, 2H), 6.63 (dd, J=8.7, 2.4 Hz, 2H), 3.61-3.47 (m, 10H), 3.40 (t, J=6.5 Hz, 2H), 1.78-1.69 (m, 2H), 1.55-1.46 (m, 2H), 1.46-1.38 (m, 2H), 1.37-1.28 (m, 2H); 19F NMR (CD3OD, 376 MHz) δ−122.09-−122.44 (m, 1F), −133.85 (d, J=20.3 Hz, 1F), −142.82-−143.23 (m, 1F); Analytical HPLC: tR=13.7 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C31H30C1F3NO8 [M+H]+ 636.1607, found 636.1611.
4,5,7−Trifluoro-6−(MOM-MAC)-carbofluorescein (51MAC; 50 mg, 93.2 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 18 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 63.0 mg, 0.186 mmol, 2 eq) and DIEA (162 μL, 0.932 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 2 h. It was then diluted with 10% citric acid and extracted with EtOAc (2×). The combined organic extracts were dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by reverse phase HPLC (30-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) yielded 14.2 mg (23%) of 51HTL as a light pink solid. 1H NMR (CD3OD, 400 MHz) δ 9.07 (t, J=5.6 Hz, 1H), 7.09 (d, J=2.5 Hz, 2H), 6.77 (d, J=8.6 Hz, 2H), 6.67 (dd, J=8.6, 2.5 Hz, 2H), 3.60-3.46 (m, 10H), 3.40 (t, J=6.5 Hz, 2H), 1.78-1.68 (m, 2H), 1.74 (s, 3H), 1.69 (s, 3H), 1.56-1.46 (m, 2H), 1.46-1.38 (m, 2H), 1.38-1.28 (m, 2H); 19F NMR (CD3OD, 376 MHz) δ−122.22 (d, J=22.5 Hz, 1F), −134.87 (d, J=20.4 Hz, 1F), −143.66 (t, J=21.6 Hz, 1F); Analytical HPLC: tR=13.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C34H36C1F3NO7 [M+H]+ 662.2127, found 662.2129.
4,5,7−Trifluoro-6−(MOM-MAC)—Si-fluorescein (55MAC; 30 mg, 54.3 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 24 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 36.7 mg, 0.109 mmol, 2 eq) and DIEA (94.6 μL, 0.543 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 2 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 20.4 mg (55%) of 55HTL as a white solid. 1H NMR (CD3OD, 400 MHz) δ 9.15 (t, J=5.3 Hz, 1H), 7.14 (d, J=2.7 Hz, 2H), 6.87 (dd, J=8.7, 1.0 Hz, 2H), 6.74 (dd, J=8.7, 2.8 Hz, 2H), 3.65-3.52 (m, 8H), 3.50 (t, J=6.7 Hz, 2H), 3.42 (t, J=6.6 Hz, 2H), 1.74-1.65 (m, 2H), 1.55-1.46 (m, 2H), 1.44-1.26 (m, 4H), 0.56 (s, 3H), 0.52 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−118.77 (d, J=22.2 Hz, 1F), −134.57-−134.69 (m, 1F), −143.21 (t, J=21.6 Hz, 1F); Analytical HPLC: tR=14.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C33H36ClF3NO7Si [M+H]+ 678.1896, found 678.1907.
4,5,7−Trifluoro-6−(MOM-MAC)-MGL (49MAC; 75 mg, 0.136 mmol) was taken up in CH2Cl2 (5 mL); triethylsilane (500 μL) was added, followed by trifluoroacetic acid (1 mL). The reaction was stirred at room temperature for 18 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 92.0 mg, 0.272 mmol, 2 eq) and DIEA (237 μL, 1.36 mmol, 10 eq) in CH2Cl2 (4 mL), and the reaction was stirred at room temperature for 6 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-80% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 49.5 mg (46%, TFA salt) of 49HTL as a blue solid. 1H NMR (CD3OD, 400 MHz) δ 9.09 (t, J=5.4 Hz, 1H), 7.21 (d, J=9.0 Hz, 4H), 6.92 (d, J=8.9 Hz, 4H), 3.66-3.54 (m, 8H), 3.52 (t, J=6.7 Hz, 2H), 3.45 (t, J=6.5 Hz, 2H), 3.03 (s, 12H), 1.77-1.68 (m, 2H), 1.58-1.50 (m, 2H), 1.47-1.29 (m, 4H); 19F NMR (CD3OD, 376 MHz) δ−75.79 (s, 3F), −117.70 (d, J=22.0 Hz, 1F), −134.45 (d, J=21.0 Hz, 1F), −142.89 (t, J=21.5 Hz, 1F); Analytical HPLC: tR=13.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (ESI) calcd for C35H42C1F3N3O5 [M+H]+ 676.2760, found 676.2767.
4,5,7−Trifluoro-6−(MOM-MAC)-rhodamine 110 bis(tert-butyl carbamate) (67MAC; 90 mg, 0.127 mmol) was taken up in CH2Cl2 (5 mL); triethylsilane (500 μL) was added, followed by trifluoroacetic acid (1 mL). The reaction was stirred at room temperature for 8 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 85.8 mg, 0.254 mmol, 2 eq) and DIEA (221 μL, 1.27 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-40% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 70HTL as a red-orange solid (20.5 mg, 22%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.12 (t, J=5.5 Hz, 1H), 7.29 (dd, J=9.2, 0.9 Hz, 2H), 6.88 (dd, J=9.2, 2.1 Hz, 2H), 6.80 (d, J=2.1 Hz, 2H), 3.68-3.54 (m, 8H), 3.51 (t, J=6.6 Hz, 2H), 3.42 (t, J=6.5 Hz, 2H), 1.76-1.66 (m, 2H), 1.54-1.45 (m, 2H), 1.44-1.27 (m, 4H); 19F NMR (CD3OD, 376 MHz) δ−75.34 (s, 3F), −116.65 (d, J=15.3 Hz, 1F), −132.55 (d, J=21.7 Hz, 1F), −140.18-−140.53 (m, 1F); Analytical HPLC: tR=11.0 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 525 nm); HRMS (ESI) calcd for C31H32C1F3N3O6 [M+H]+ 634.1926, found 634.1926.
4,5,7−Trifluoro-6−(MOM-MAC)-carborhodamine 110 bis(tert-butyl carbamate) (68MAC; 90 mg, 0.122 mmol) was taken up in CH2Cl2 (5 mL); triethylsilane (500 μL) was added, followed by trifluoroacetic acid (1 mL). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 82.7 mg, 0.245 mmol, 2 eq) and DIEA (213 μL, 1.22 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to provide 71HTL as a purple solid (30.5 mg, 32%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.14 (t, J=5.4 Hz, 1H), 7.153 (dd, J=9.1, 0.9 Hz, 2H), 7.148 (d, J=2.2 Hz, 2H), 6.67 (dd, J=9.0, 2.2 Hz, 2H), 3.68-3.55 (m, 8H), 3.52 (t, J=6.6 Hz, 2H), 3.44 (t, J=6.5 Hz, 2H), 1.75 (s, 3H), 1.74-1.67 (m, 2H), 1.64 (s, 3H), 1.56-1.47 (m, 2H), 1.45-1.28 (m, 4H); 19F NMR (CD3OD, 376 MHz) δ−75.34 (s, 3F), −117.19 (d, J=15.3 Hz, 1F), −133.70 (d, J=22.2 Hz, 1F), −140.45 (dd, J=22.1, 15.6 Hz, 1F); Analytical HPLC: tR=11.3 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C34H38C1F3N3O5 [M+H]+ 660.2447, found 660.2459.
4,5,7−Trifluoro-6−(MOM-MAC)—Si-rhodamine 110 bis(tert-butyl carbamate) (69MAC; 75 mg, 0.100 mmol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 67.5 mg, 0.200 mmol, 2 eq) and DIEA (174 μL, 1.00 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to provide 72HTL as a bright blue solid (30.7 mg, 39%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.17 (t, J=5.0 Hz, 1H), 7.21 (d, J=2.5 Hz, 2H), 6.99 (dd, J=8.9, 1.3 Hz, 2H), 6.76 (dd, J=8.9, 2.5 Hz, 2H), 3.67-3.54 (m, 8H), 3.51 (t, J=6.6 Hz, 2H), 3.44 (t, J=6.5 Hz, 2H), 1.75-1.66 (m, 2H), 1.56-1.47 (m, 2H), 1.45-1.28 (m, 4H), 0.57 (s, 3H), 0.51 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.40 (s, 3F), −118.23 (d, J=19.4 Hz, 1F), −134.29 (d, J=21.2 Hz, 1F), −141.77-−142.06 (m, 1F); Analytical HPLC: tR=11.7 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C33H38C1F3N3O5Si [M+H]+ 676.2216, found 676.2222.
6−(MOM-MAC)-JF632 (44MAC; 20.0 mg, 32.5 mol) was taken up in CH2Cl2 (2 mL); triethylsilane (200 μL) was added, followed by trifluoroacetic acid (400 L). The reaction was stirred at room temperature for 6 h. Toluene (3 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 22.0 mg, 65.1 mol, 2 eq) and DIEA (56.7 μL, 0.325 mmol, 10 eq) in CH2Cl2 (2 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-80% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 20.2 mg (73%, TFA salt) of 44HTL as a deep blue solid. 1H NMR (CD3OD, 400 MHz) δ 9.09 (t, J=5.4 Hz, 1H), 7.15 (dd, J=9.1, 0.5 Hz, 2H), 6.81 (d, J=2.2 Hz, 2H), 6.45 (dd, J=9.1, 2.2 Hz, 2H), 4.37 (t, J=7.7 Hz, 8H), 3.67-3.55 (m, 8H), 3.52 (t, J=6.7 Hz, 2H), 3.44 (t, J=6.5 Hz, 2H), 2.56 (p, J=7.8 Hz, 4H), 1.77 (s, 3H), 1.75-1.68 (m, 2H), 1.66 (s, 3H), 1.56-1.48 (m, 2H), 1.44-1.30 (m, 4H); 19F NMR (CD3OD, 376 MHz) δ−75.31 (s, 3F), −117.35 (d, J=15.2 Hz, 1F), −133.92 (d, J=22.5 Hz, 1F), −140.91 (dd, J=22.1, 15.3 Hz, 1F); Analytical HPLC: tR=12.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C40H46C1F3N3O5 [M+H]+ 740.3073, found 740.3068.
6−(MOM-MAC)-JFX576 (8MAC; 60 mg, 86.6 mol) was taken up in CH2Cl2 (5 mL); triethylsilane (500 μL) was added, followed by trifluoroacetic acid (1 mL). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 58.5 mg, 0.173 mmol, 2 eq) and DIEA (151 L, 0.866 mmol, 10 eq) in CH2Cl2 (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 8HTL as a dark red-purple solid (49.2 mg, 65%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.13 (t, J=5.5 Hz, 1H), 7.33 (d, J=9.4 Hz, 2H), 6.97 (dd, J=9.4, 2.3 Hz, 2H), 6.82 (d, J=2.3 Hz, 2H), 3.67-3.55 (m, 8H), 3.51 (t, J=6.6 Hz, 2H), 3.42 (t, J=6.5 Hz, 2H), 1.74-1.66 (m, 2H), 1.50 (p, J=6.8 Hz, 2H), 1.43-1.26 (m, 4H); 19F NMR (CD3OD, 376 MHz) δ-75.36 (s, 3F), −116.57 (d, J=15.1 Hz, 1F), −132.50 (d, J=22.3 Hz, 1F), −140.03-−140.23 (m, 1F); Analytical HPLC: tR=13.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C39H28D16C1F3N3O6 [M+H]+ 758.3870, found 758.3861.
6−(MOM-MAC)-JFX637 (40MAC; 28.0 mg, 42.5 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 6 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 28.7 mg, 85.0 mol, 2 eq) and DIEA (74.0 μL, 0.425 mmol, 10 eq) in CH2Cl2 (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 18.9 mg (49%, TFA salt) of 40HTL as a deep blue solid. 1H NMR (CD3OD, 400 MHz) δ 9.15 (t, J=5.4 Hz, 1H), 7.21 (dd, J=9.3, 1.0 Hz, 2H), 7.10 (d, J=2.4 Hz, 2H), 6.74 (dd, J=9.3, 2.4 Hz, 2H), 3.68-3.55 (m, 8H), 3.51 (t, J=6.6 Hz, 2H), 3.43 (t, J=6.5 Hz, 2H), 1.83 (s, 3H), 1.75-1.66 (m, 2H), 1.71 (s, 3H), 1.55-1.47 (m, 2H), 1.44-1.26 (m, 4H); 19F NMR (CD3OD, 376 MHz) δ−75.29 (s, 3F), −117.12 (d, J=15.0 Hz, 1F), −133.84 (d, J=22.1 Hz, 1F),-140.64-−140.81 (m, 1F); Analytical HPLC: tR=13.4 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C42H34D16C1F3N3O5 [M+H]+ 784.4390, found 784.4385.
6−(MOM-MAC)-JFX673 (25MAC; 50 mg, 74.1 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 6 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 50.0 mg, 0.148 mmol, 2 eq) and DIEA (129 L, 0.741 mmol, 10 eq) in CH2Cl2 (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 25HTL as a blue solid (40.4 mg, 60%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.12 (t, J=5.4 Hz, 1H), 7.16 (dd, J=9.4, 1.0 Hz, 2H), 7.14 (d, J=2.7 Hz, 2H), 6.64 (dd, J=9.4, 2.7 Hz, 2H), 3.67-3.54 (m, 8H), 3.50 (t, J=6.6 Hz, 2H), 3.43 (t, J=6.5 Hz, 2H), 1.75-1.66 (m, 2H), 1.55-1.47 (m, 2H), 1.44-1.27 (m, 4H), 0.58 (s, 3H), 0.54 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.24 (s, 3F), −118.19 (d, J=16.4 Hz, 1F), −135.10 (d, J=22.6 Hz, 1F),-142.57-−142.90 (m, 1F); Analytical HPLC: tR=13.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C41H34D16ClF3N3O5Si [M+H]+ 800.4159, found 800.4167.
Rhodamine 11MAC (acetate salt; 60 mg, 79.3 μmol) was taken up in CH2Cl2 (5 mL), and trifluoroacetic acid (1 mL) was added. The reaction was stirred at room temperature for 18 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 53.6 mg, 0.159 mmol, 2 eq) and DIEA (138 μL, 0.793 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 2 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (40-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 11HTL as a purple solid (37.3 mg, 50%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.12 (t, J=5.4 Hz, 1H), 6.89 (s, 2H), 6.84 (s, 2H), 5.74-5.70 (m, 2H), 3.67-3.55 (m, 8H), 3.50 (t, J=6.7 Hz, 2H), 3.42 (t, J=6.5 Hz, 2H), 3.21 (s, 6H), 1.92 (d, J=1.4 Hz, 6H), 1.73-1.66 (m, 2H), 1.525 (s, 6H), 1.523 (s, 6H), 1.50-1.45 (m, 2H), 1.41-1.28 (m, 4H); 19F NMR (CD3OD, 376 MHz) δ−75.36 (s, 3F), −115.98 (d, J=15.4 Hz, 1F), −131.78 (d, J=22.2 Hz, 1F), −139.85-−140.17 (m, 1F); Analytical HPLC: tR=14.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C45H52C1F3N3O6 [M+H]+ 822.3491, found 822.3490.
6−(MOM-MAC)-JF563 (18MAC, acetate salt; 25 mg, 34.1 mol) was taken up in CH2Cl2 (2 mL); anisole (200 μL) was added, followed by trifluoroacetic acid (400 L). The reaction was stirred at room temperature for 24 h. Toluene (3 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 23.0 mg, 68.2 mol, 2 eq) and DIEA (59.4 μL, 0.341 mmol, 10 eq) in DMF (2 mL), and the reaction was stirred at room temperature for 3 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (35-65% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 17.3 mg (56%, TFA salt) of 18HTL as a purple solid (mixture of diastereomers). 1H NMR (CD3OD, 400 MHz) δ 9.19-9.08 (m, 1H), 7.15-7.05 (m, 2H), 6.67-6.61 (m, 2H), 3.70-3.52 (m, 8H), 3.53-3.47 (m, 2H), 3.45-3.40 (m, 2H), 2.98-2.87 (m, 2H), 1.95-1.86 (m, 2H), 1.75-1.66 (m, 2H), 1.54-1.19 (m, 26H); 19F NMR (CD3OD, 376 MHz) δ−75.35 (s, 3F),-116.07-−116.23 (m, 1F), −132.05-−132.22 (m, 1F), −139.69-−140.86 (m, 1F); Analytical HPLC: tR (three isomers)=13.7 min, 13.8 min, 14.0 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C43H52C1F3N3O6 [M+H]+ 798.3491, found 798.3488.
Si-rhodamine 38MAC (50 mg, 67.7 mol) was taken up in CH2Cl2 (4 mL), and trifluoroacetic acid (800 μL) was added. The reaction was stirred at room temperature for 18 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 45.7 mg, 0.135 mmol, 2 eq) and DIEA (118 μL, 0.677 mmol, 10 eq) in CH2Cl2 (4 mL), and the reaction was stirred at room temperature for 1 h. The solvent was removed by rotary evaporation, and the crude material was purified by flash chromatography on silica gel (10-100% EtOAc/hexanes, linear gradient) to afford 38HTL as a yellow-green solid (36.3 mg, 62%). 1H NMR (CDCl3, 400 MHz) δ 6.622 (s, 2H), 6.621 (s, 1H), 6.59 (s, 2H), 5.28 (q, J=1.3 Hz, 2H), 3.64-3.56 (m, 6H), 3.53-3.47 (m, 4H), 3.33 (t, J=6.6 Hz, 2H), 2.86 (s, 6H), 1.79 (d, J=1.4 Hz, 6H), 1.77-1.69 (m, 2H), 1.50-1.35 (m, 4H), 1.31 (s, 12H), 1.30-1.25 (m, 2H), 0.51 (s, 3H), 0.51 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−119.92 (d, J=22.8 Hz, 1F), −134.05 (d, J=21.5 Hz, 1F), −142.39 (t, J=22.2 Hz, 1F); Analytical HPLC: tR=11.9 min, 98.2% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 750 nm); HRMS (ESI) calcd for C47H58C1F3N3O5Si [M+H]+ 864.3781, found 864.3777.
Si-rhodamine 36MAC (20 mg, 28.1 mol) was taken up in CH2Cl2 (2 mL); anisole (200 μL) was added, followed by trifluoroacetic acid (400 L). The reaction was stirred at room temperature for 18 h. Toluene (2 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 19.0 mg, 56.3 mol, 2 eq) and DIEA (49.0 μL, 0.281 mmol, 10 eq) in DMF (2 mL), and the reaction was stirred at room temperature for 2 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 36HTL as a green solid (12.9 mg, 48%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.16 (t, J=5.5 Hz, 1H), 6.96 (s, 2H), 6.82 (s, 2H), 5.55 (q, J=1.2 Hz, 2H), 3.68-3.54 (m, 8H), 3.51 (t, J=6.6 Hz, 2H), 3.43 (t, J=6.5 Hz, 2H), 1.78 (d, J=1.4 Hz, 6H), 1.75-1.67 (m, 2H), 1.51 (p, J=6.8 Hz, 2H), 1.45-1.28 (m, 4H), 1.414 (s, 6H), 1.405 (s, 6H), 0.52 (s, 3H), 0.48 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ-75.33 (s, 3F), −116.54 (d, J=15.6 Hz, 1F), −133.68 (d, J=21.7 Hz, 1F), −141.14 (dd, J=22.1, 15.5 Hz, 1F); Analytical HPLC: tR=14.0 min, 99.0% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 725 nm); HRMS (ESI) calcd for C45H54C1F3N3O5Si [M+H]+ 836.3468, found 836.3472.
6−(MOM-MAC)—SiRF712(108MAC; 40 mg, 63.4 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 6 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 42.8 mg, 0.127 mmol, 2 eq) and DIEA (110 L, 0.634 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 108HTL as a blue-green solid (29.9 mg, 54%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 7.10 (s, 2H), 6.81 (s, 2H), 3.83 (t, J=8.0 Hz, 4H), 3.68-3.55 (m, 8H), 3.51 (t, J=6.7 Hz, 2H), 3.44 (t, J=6.5 Hz, 2H), 3.22 (s, 6H), 3.08-2.93 (m, 4H), 1.76-1.67 (m, 2H), 1.56-1.48 (m, 2H), 1.45-1.28 (m, 4H), 0.57 (s, 3H), 0.51 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ-75.29 (s, 3F), −118.27 (d, J=15.5 Hz, 1F), −135.07 (d, J=22.5 Hz, 1F), −141.70 (dd, J=22.3, 15.9 Hz, 1F); Analytical HPLC: tR=12.8 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 725 nm); HRMS (ESI) calcd for C39H46C1F3N3O5Si [M+H]+ 756.2842, found 756.2845.
6−(MOM-MAC)-JF698 (3MAC; 35 mg, 49.2 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 6 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 33.3 mg, 98.5 mol, 2 eq) and DIEA (85.8 μL, 0.492 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 31HTL as a blue-green solid (27.9 mg, 60%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.17 (t, J=5.3 Hz, 1H), 6.66 (s, 2H), 3.68-3.54 (m, 16H), 3.52 (t, J=6.7 Hz, 2H), 3.45 (t, J=6.5 Hz, 2H), 3.01-2.94 (m, 4H), 2.63-2.56 (m, 4H), 2.13-2.02 (m, 4H), 1.98-1.88 (m, 4H), 1.77-1.68 (m, 2H), 1.57-1.49 (m, 2H), 1.46-1.30 (m, 4H), 0.71 (s, 3H), 0.67 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.37 (s, 3F), −117.65 (dd, J=15.0, 2.0 Hz, 1F), −134.78 (dd, J=21.9, 2.0 Hz, 1F), −141.18 (dd, J=22.3, 15.1 Hz, 1F); Analytical HPLC: tR=13.6 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 700 nm); HRMS (ESI) calcd for C45H54C1F3N3O5Si [M+H]+ 836.3468, found 836.3476.
6−(MOM-MAC)—FSiRhQ (29MAC; 40 mg, 63.4 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 8 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 42.8 mg, 0.127 mmol, 2 eq) and DIEA (110 L, 0.634 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 29HTL as a deep blue solid (23.2 mg, 42%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.16 (t, J=5.3 Hz, 1H), 6.98 (s, 2H), 6.82 (s, 2H), 3.68-3.56 (m, 8H), 3.54-3.48 (m, 6H), 3.44 (t, J=6.5 Hz, 2H), 2.66-2.59 (m, 4H), 1.95-1.87 (m, 4H), 1.76-1.68 (m, 2H), 1.56-1.48 (m, 2H), 1.44-1.29 (m, 4H), 0.49 (s, 3H), 0.43 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ-75.32 (s, 3F), −117.66 (d, J=15.2 Hz, 1F), −134.57 (d, J=22.5 Hz, 1F), −141.14 (dd, J=22.3, 15.2 Hz, 1F); Analytical HPLC: tR=12.6 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C39H46C1F3N3O5Si [M+H]+ 756.2842, found 756.2849.
6−(MOM-MAC)-JF660 (57MAC; 60 mg, 86.4 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 8 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 58.3 mg, 0.173 mmol, 2 eq) and DIEA (150 L, 0.864 mmol, 10 eq) in CH2Cl2 (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 57HTL as a blue solid (33.0 mg, 41%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.15 (t, J=5.2 Hz, 1H), 6.64 (s, 2H), 3.68-3.50 (m, 18H), 3.44 (t, J=6.5 Hz, 2H), 3.13-3.02 (m, 4H), 2.67-2.60 (m, 4H), 2.10-1.99 (m, 4H), 2.04 (s, 3H), 1.98-1.90 (m, 4H), 1.96 (s, 3H), 1.76-1.68 (m, 2H), 1.57-1.49 (m, 2H), 1.45-1.30 (m, 4H); 19F NMR (CD3OD, 376 MHz) δ-75.36 (s, 3F), −117.34 (d, J=15.1 Hz, 1F), −134.31 (d, J=22.5 Hz, 1F), −140.92 (dd, J=22.2, 15.3 Hz, 1F); Analytical HPLC: tR=13.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C46H54C1F3N3O5 [M+H]+ 820.3699, found 820.3688.
6−(MOM-MAC)-JF657 (59MAC; 55 mg, 75.9 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 8 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 51.3 mg, 0.152 mmol, 2 eq) and DIEA (132 L, 0.759 mmol, 10 eq) in CH2Cl2 (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to provide 33.0 mg (45%, TFA salt) of 59HTL as a blue solid (mixture of two diastereomers). 1H NMR (CD3OD, 400 MHz) δ 9.18 (t, J=5.1 Hz, 0.5H), 9.12 (t, J=5.4 Hz, 0.5H), 6.95 (s, 1H), 6.86-6.79 (m, 2H), 3.84 (dq, J=14.4, 6.8 Hz, 1H), 3.71-3.56 (m, 13H), 3.51 (t, J=6.6 Hz, 2H), 3.45 (t, J=6.5 Hz, 1H), 3.44 (t, J=6.6 Hz, 1H), 3.25-3.17 (m, 2H), 2.86-2.75 (m, 1H), 2.72-2.63 (m, 2H), 2.14-2.02 (m, 2H), 1.96 (s, 2H), 1.93-1.86 (m, 1H), 1.92 (s, 1.5H), 1.91 (s, 1.5H), 1.84 (s, 1.5H), 1.83 (s, 1.5H), 1.72 (p, J=6.9 Hz, 2H), 1.59-1.47 (m, 3H), 1.49 (s, 3H), 1.46-1.28 (m, 4H), 1.362 (s, 1.5H), 1.361 (t, J=6.9 Hz, 3H), 1.35 (s, 1.5H), 1.174 (d, J=6.6 Hz, 1.5H), 1.165 (d, J=6.4 Hz, 1.5H); 19F NMR (CD3OD, 376 MHz) δ-75.38 (s, 3F), −116.63 (d, J=15.1 Hz, 0.5F), −116.78 (d, J=15.4 Hz, 0.5F), −133.56 (d, J=22.2 Hz, 0.5F), −133.70 (d, J=22.5 Hz, 0.5F), −140.50 (dd, J=22.0, 15.3 Hz, 0.5F), −140.72 (dd, J=22.0, 14.9 Hz, 0.5F); Analytical HPLC: tR (two isomers)=14.2 min, 14.4 min; >99% total purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C48H60C1F3N3O5 [M+H]+ 850.4168, found 850.4160.
2−(3,6−Bis(methyl(phenyl)amino)xanthylium-9−yl)-4−(dicyano(methoxymethoxy)-methyl)-3,5,6−trifluorobenzoate (64MAC; 100 mg, 0.145 mmol) was taken up in CH2Cl2 (10 mL); triethylsilane (1 mL) was added, followed by trifluoroacetic acid (2 mL). The reaction was stirred at room temperature for 6 h. Toluene (10 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 98.1 mg, 0.290 mmol, 2 eq) and DIEA (253 L, 1.45 mmol, 10 eq) in CH2Cl2 (7 mL), and the reaction was stirred at room temperature for 1 h. The solvent was removed by rotary evaporation, and the crude material was purified by silica gel chromatography (25-100% EtOAc/toluene, linear gradient) to yield 78.7 mg (67%) of 64HTL as a dark purple solid. 1H NMR (CDCl3, 400 MHz) δ 7.41-7.35 (m, 4H), 7.22-7.16 (m, 6H), 6.77 (s, 1H), 6.72 (d, J=8.9 Hz, 2H), 6.59 (d, J=2.4 Hz, 2H), 6.54 (dd, J=8.8, 2.5 Hz, 2H), 3.65-3.57 (m, 6H), 3.54-3.48 (m, 4H), 3.37 (t, J=6.7 Hz, 2H), 3.34 (s, 6H), 1.77-1.69 (m, 2H), 1.53-1.45 (m, 2H), 1.44-1.36 (m, 2H), 1.34-1.26 (m, 2H); 19F NMR (CDCl3, 376 MHz) δ-121.01 (d, J=22.5 Hz, 1F), −132.34 (d, J=21.6 Hz, 1F), −142.02 (t, J=22.0 Hz, 1F); Analytical HPLC: tR=11.5 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 550 nm); HRMS (ESI) calcd for C45H44C1F3N3O6 [M+H]+ 814.2865, found 814.2858.
4−(Dicyano(methoxymethoxy)methyl)-2−(10,10−dimethyl-3,6−bis(methyl(phenyl)-amino)anthracen-9−ylium-9(10H)-yl)-3,5,6−trifluorobenzoate (65MAC; 50 mg, 70.0 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 47.3 mg, 0.140 mmol, 2 eq) and DIEA (122 μL, 0.700 mmol, 10 eq) in CH2Cl2 (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by silica gel chromatography (5-75% EtOAc/hexanes, linear gradient) to yield 43.0 mg (73%) of 65HTL as a pale blue-green solid. 1H NMR (CDCl3, 400 MHz) δ 7.37-7.30 (m, 4H), 7.18-7.12 (m, 4H), 7.11-7.05 (m, 4H), 6.75 (dd, J=8.7, 2.4 Hz, 2H), 6.72 (bs, 1H), 6.71 (d, J=8.7 Hz, 2H), 3.65-3.57 (m, 6H), 3.54-3.47 (m, 4H), 3.37 (t, J=6.6 Hz, 2H), 3.36 (s, 6H), 1.78-1.69 (m, 2H), 1.63 (s, 6H), 1.54-1.46 (m, 2H), 1.45-1.37 (m, 2H), 1.34-1.27 (m, 2H); 19F NMR (CDCl3, 376 MHz) δ−120.93 (d, J=22.7 Hz, 1F), −133.20 (d, J=21.8 Hz, 1F),-142.37 (t, J=22.2 Hz, 1F); Analytical HPLC: tR=15.0 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C48H50ClF3N3O5 [M+H]+ 840.3386, found 840.3377.
4−(Dicyano(methoxymethoxy)methyl)-2−(5,5−dimethyl-3,7-bis(methyl(phenyl)amino)dibenzo[b,e]silin-10−ylium-10(5H)-yl)-3,5,6−trifluorobenzoate (66MAC; 40 mg, 54.7 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 6 h. Toluene (3 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 37.0 mg, 0.109 mmol, 2 eq) and DIEA (95.3 μL, 0.547 mmol, 10 eq) in CH2Cl2 (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by silica gel chromatography (5-75% EtOAc/hexanes, linear gradient) to yield 24.4 mg (52%) of 66HTL as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 7.36-7.29 (m, 4H), 7.19-7.11 (m, 6H), 7.11-7.05 (m, 2H), 6.86 (s, 1H), 6.84-6.77 (m, 4H), 3.67-3.58 (m, 6H), 3.55-3.51 (m, 2H), 3.49 (t, J=6.7 Hz, 2H), 3.37 (t, J=6.7 Hz, 2H), 3.35 (s, 6H), 1.76-1.68 (m, 2H), 1.52-1.44 (m, 2H), 1.43-1.35 (m, 2H), 1.32-1.25 (m, 2H), 0.49 (s, 3H), 0.45 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−118.19 (d, J=22.7 Hz, 1F), −133.12 (d, J=21.4 Hz, 1F), −141.91 (t, J=22.1 Hz, 1F); Analytical HPLC: tR=15.9 min, 98.8% purity (50-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C47H50ClF3N3O5Si [M+H]+ 856.3155, found 856.3150.
4−Carboxy-2−(1,2,2,4,8,10,10,11,13,13−decamethyl-2,10,11,13-tetrahydrosilino[3,2−g:5,6−g′]diquinolin-6−ylium-6(1H)-yl)benzoate (110; 40 mg, 66.1 mol) was combined with DSC (40.7 mg, 0.159 mmol, 2.4 eq) in DMF (3 mL). After adding Et3N (55.3 μL, 0.397 mmol, 6 eq) and DMAP (0.8 mg, 6.6 mol, 0.1 eq), the reaction was stirred at room temperature for 30 min. A solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 53.6 mg, 0.159 mmol, 2.4 eq) in DMF (200 μL) was then added. The reaction was stirred an additional 3 h at room temperature. Purification of the crude reaction mixture by reverse phase HPLC (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) afforded 39.4 mg (64%, TFA salt) of 104HTL as a green solid. 1H NMR (CD3OD, 400 MHz) δ 8.74 (t, J=5.5 Hz, 1H), 8.27 (d, J=8.1 Hz, 1H), 8.12 (dd, J=8.2, 1.7 Hz, 1H), 7.72 (d, J=1.6 Hz, 1H), 7.10 (s, 2H), 6.61 (s, 2H), 5.46 (q, J=1.2 Hz, 2H), 3.65 (t, J=5.5 Hz, 2H), 3.62-3.53 (m, 6H), 3.50 (t, J=6.6 Hz, 2H), 3.41 (t, J=6.5 Hz, 2H), 3.20 (s, 6H), 1.70 (dq, J=8.0, 6.7 Hz, 2H), 1.55 (d, J=1.4 Hz, 6H), 1.52-1.47 (m, 2H), 1.45 (s, 6H), 1.43 (s, 6H), 1.41-1.28 (m, 4H), 0.63 (s, 3H), 0.58 (s, 3H); Analytical HPLC: tR=11.5 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 725 nm); HRMS (ESI) calcd for C47H61ClN3O5Si [M+H]+ 810.4064, found 810.4046.
JFX612−NHS45 (25 mg, 40.2 mol) and 6−((4−(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 16.3 mg, 60.3 mol, 1.5 eq) were combined in DMF (1.5 mL), and DIEA (21.0 μL, 0.121 mmol, 3 eq) was added. After stirring the reaction at room temperature for 4 h, it was directly purified by reverse phase HPLC (10-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 33.6 mg (94%, TFA salt) of 88STL as a purple solid. 1H NMR (CD3OD, 400 MHz) δ 9.29 (t, J=6.1 Hz, 1H), 8.35 (d, J=8.2 Hz, 1H), 8.23 (s, 1H), 8.16 (dd, J=8.3, 1.8 Hz, 1H), 7.78 (d, J=1.7 Hz, 1H), 7.51 (d, J=8.2 Hz, 2H), 7.40 (d, J=8.2 Hz, 2H), 7.09 (d, J=2.4 Hz, 2H), 6.98 (d, J=9.2 Hz, 2H), 6.65 (dd, J=9.3, 2.4 Hz, 2H), 5.60 (s, 2H), 4.60 (d, J=6.0 Hz, 2H), 1.86 (s, 3H), 1.75 (s, 3H); Analytical HPLC: tR=10.3 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C45H29D16N8O4 [M+H]+ 777.4563, found 777.4567.
JFX650−NHS45 (75 mg, 0.118 mmol) and 6−((4−(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 47.7 mg, 0.176 mmol, 1.5 eq) were combined in DMF (5 mL), and DIEA (61.4 μL, 0.353 mmol, 3 eq) was added. After stirring the reaction at room temperature for 18 h, it was diluted with saturated NaHCO3 and extracted with 10% MeOH/CH2Cl2 (3×). The combined organic extracts were dried over anhydrous MgSO4, filtered, and evaporated. Flash chromatography on silica gel (0-10% MeOH/EtOAc, linear gradient) provided 89STL as a blue solid (73 mg, 78%). 1H NMR (CD3OD, 400 MHz) δ 8.02 (dd, J=8.0, 1.4 Hz, 1H), 7.98 (dd, J=8.0, 0.5 Hz, 1H), 7.81 (s, 1H), 7.69-7.67 (m, 1H), 7.42 (d, J=8.2 Hz, 2H), 7.29 (d, J=8.1 Hz, 2H), 6.84 (d, J=2.8 Hz, 2H), 6.67 (d, J=8.9 Hz, 2H), 6.40 (dd, J=8.9, 2.8 Hz, 2H), 5.47 (s, 2H), 4.50 (s, 2H), 0.60 (s, 3H), 0.53 (s, 3H); Analytical HPLC: tR=10.4 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C44H29D16N8O4Si [M+H]+ 793.4332, found 793.4341.
A vial was charged with 6−tert-butoxycarbonylcarbofluorescein ditriflate18 (S58; 200 mg, 0.277 mmol), Pd2dba3 (25.3 mg, 27.7 mol, 0.1 eq), XPhos (39.6 mg, 83.0 mol, 0.3 eq), and Cs2CO3 (252 mg, 0.775 mmol, 2.8 eq). The vial was sealed and evacuated/backfilled with nitrogen (3×). Dioxane (2 mL) was added, and the reaction was flushed again with nitrogen (3×). Following the addition of N-methylaniline (66.0 μL, 0.609 mmol, 2.2 eq), the reaction was stirred at 100° C. for 4 h. It was then cooled to room temperature, filtered through Celite with CH2Cl2, and concentrated to dryness. Purification by silica gel chromatography (0-30% EtOAc/hexanes, linear gradient) afforded S59 (150 mg, 85%) as an off-white solid. 1H NMR (CDCl3, 400 MHz) δ 8.15 (dd, J=8.0, 1.3 Hz, 1H), 8.04-7.99 (m, 1H), 7.71-7.68 (m, 1H), 7.35-7.28 (m, 4H), 7.16 (d, J=2.5 Hz, 2H), 7.14-7.09 (m, 4H), 7.08-7.01 (m, 2H), 6.70 (dd, J=8.7, 2.4 Hz, 2H), 6.57 (d, J=8.7 Hz, 2H), 3.35 (s, 6H), 1.73 (s, 3H), 1.67 (s, 3H), 1.55 (s, 9H); 13C NMR (CDCl3, 101 MHz) δ 170.0 (C), 164.6 (C), 155.3 (C), 149.6 (C), 148.4 (C), 146.6 (C), 137.9 (C), 130.2 (CH), 130.1 (C), 129.5 (CH), 128.9 (CH), 125.1 (CH), 125.0 (CH), 123.0 (CH), 122.7 (CH), 122.3 (C), 117.3 (CH), 115.5 (CH), 87.7 (C), 82.5 (C), 40.3 (CH3), 38.5 (C), 35.0 (CH3), 33.0 (CH3), 28.2 (CH3); Analytical HPLC: tR=12.7 min, >99% purity (50-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C42H41N2O4 [M+H]+ 637.3061, found 637.3061.
Ester S59 (120 mg, 0.188 mmol) was taken up in CH2Cl2 (5 mL), and trifluoroacetic acid (1 mL) was added. The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added; the reaction mixture was concentrated to dryness and then azeotroped with MeOH three times to provide S60 as a dark blue solid (128 mg, 98%, TFA salt). Analytical HPLC and NMR indicated that the material was >95% pure and did not require further purification prior to amide coupling. 1H NMR (CD3OD, 400 MHz) δ 8.34-8.28 (m, 2H), 7.87-7.82 (m, 1H), 7.56-7.48 (m, 4H), 7.43-7.36 (m, 2H), 7.34-7.29 (m, 4H), 7.15 (d, J=2.5 Hz, 2H), 6.94 (d, J=9.3 Hz, 2H), 6.71 (dd, J=9.3, 2.4 Hz, 2H), 3.57 (s, 6H), 1.67 (s, 3H), 1.59 (s, 3H); 13C NMR (CD3OD, 101 MHz) δ 168.0 (C), 167.8 (C), 156.9 (C), 146.8 (C), 136.7 (CH), 136.0 (C), 135.2 (C), 131.7 (C), 131.6 (CH), 131.5 (CH), 131.1 (CH), 128.7 (CH), 127.2 (CH), 123.0 (C), 116.0 (CH), 113.9 (CH), 42.5 (C), 41.6 (CH3), 35.3 (CH3), 32.1 (CH3); Analytical HPLC: tR=11.6 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C38H33N2O4 [M+H]+ 581.2435, found 581.2428.
Acid S60 (50 mg, 72.0 mol) was combined with DSC (44.2 mg, 0.173 mmol, 2.4 eq) in DMF (4 mL). After adding Et3N (60.2 μL, 0.432 mmol, 6 eq) and DMAP (0.9 mg, 7.2 mol, 0.1 eq), the reaction was stirred at room temperature for 30 min. A solution of HaloTag®(O2)amine (HTL-NH2, 111; TFA salt; 72.9 mg, 0.216 mmol, 3 eq) in DMF (500 L) was added; the reaction was then stirred for an additional 18 h at room temperature. It was subsequently diluted with saturated NaHCO3 and extracted with EtOAc (2×). The combined organic extracts were washed with water and brine, dried over anhydrous MgSO4, filtered, and evaporated. Purification of the crude product by silica gel chromatography (5-75% EtOAc/toluene, linear gradient) provided 91HTL as a pale blue solid (44 mg, 78%). 1H NMR (CDCl3, 400 MHz) δ 8.03 (d, J=7.9 Hz, 1H), 7.92 (dd, J=8.0, 1.4 Hz, 1H), 7.52 (s, 1H), 7.35-7.28 (m, 4H), 7.16 (d, J=2.4 Hz, 2H), 7.14-7.09 (m, 4H), 7.07-7.01 (m, 2H), 6.82 (t, J=5.1 Hz, 1H), 6.70 (dd, J=8.7, 2.4 Hz, 2H), 6.57 (d, J=8.7 Hz, 2H), 3.67-3.58 (m, 6H), 3.57-3.53 (m, 2H), 3.50 (t, J=6.6 Hz, 2H), 3.41 (t, J=6.7 Hz, 2H), 3.35 (s, 6H), 1.78-1.68 (m, 2H), 1.73 (s, 3H), 1.66 (s, 3H), 1.57-1.50 (m, 2H), 1.46-1.37 (m, 2H), 1.36-1.28 (m, 2H); Analytical HPLC: tR=14.9 min, >99% purity (30-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C48H53C1N3O5[M+H]+ 786.3668, found 786.3658.
4,5,7−Trifluoro-6−(MOM-MAC)—Si-fluorescein (55MAC; 60 mg, 0.109 mmol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 24 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4−(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 58.7 mg, 0.217 mmol, 2 eq) and DIEA (189 μL, 1.09 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 4 h. It was then acidified with 1 M HCl, diluted with water, and extracted with 15% i-PrOH/CHCl3 (2×). The combined organic extracts were dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by reverse phase HPLC (10-75% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) afforded 44.4 mg (49%, TFA salt) of 55STL as a pale pink solid. 1H NMR (CD3OD, 400 MHz) δ 9.44 (t, J=6.0 Hz, 1H), 8.21 (s, 1H), 7.43 (d, J=8.1 Hz, 2H), 7.29 (d, J=8.1 Hz, 2H), 7.03 (d, J=2.7 Hz, 2H), 6.76 (dd, J=8.7, 1.3 Hz, 2H), 6.63 (dd, J=8.7, 2.7 Hz, 2H), 5.54 (s, 2H), 4.52-4.45 (m, 2H), 0.45 (s, 3H), 0.41 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.49 (s, 3F), −118.89 (d, J=22.1 Hz, 1F),-134.74 (d, J=20.7 Hz, 1F), −143.01 (t, J=21.6 Hz, 1F); Analytical HPLC: tR=10.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 254 nm); HRMS (ESI) calcd for C36H28F3N6O6Si [M+H]+ 725.1786, found 725.1781
6−(MOM-MAC)-JF571 (85MAC16; acetate salt; 60 mg, 92.5 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4−(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (49.0 mg, 0.185 mmol, 2 eq) and DIEA (161 μL, 0.925 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 85CSTL as a dark red-purple solid (40.6 mg, 50%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.42 (t, J=5.8 Hz, 1H), 7.39 (AB quartet, vA=2963.2 Hz, vB=2947.9 Hz, JAB=8.3 Hz, 4H), 7.25 (dd, J=9.2, 0.8 Hz, 2H), 6.65 (dd, J=9.2, 2.2 Hz, 2H), 6.53 (d, J=2.1 Hz, 2H), 6.08 (s, 1H), 5.33 (s, 2H), 4.64-4.56 (m, 2H), 4.33 (t, J=7.7 Hz, 8H), 2.57 (p, J=7.7 Hz, 4H); 19F NMR (CD3OD, 376 MHz) δ−75.52 (s, 3F), −116.61 (d, J=15.4 Hz, 1F), −132.32 (d, J=22.5 Hz, 1F), −139.34 (dd, J=22.0, 14.8 Hz, 1F); Analytical HPLC: tR=12.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C39H31C1F3N6O5 [M+H]+ 755.1991, found 755.1986.
6−(MOM-MAC)-JF632 (44MAC; 14 mg, 0.0228 mmol) was taken up in CH2Cl2 (2 mL); triethylsilane (200 μL) was added, followed by trifluoroacetic acid (400 L). The reaction was stirred at room temperature for 6 h. Toluene (3 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4-(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 12.3 mg, 0.0456 mmol, 2 eq) and DIEA (39.7 μL, 0.228 mmol, 10 eq) in DMF (2 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (10-75% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with EtOAc (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to afford 44STL as a blue solid (7.1 mg, 39%). 1H NMR (CD3OD, 400 MHz) δ 7.83 (s, 1H), 7.51 (d, J=8.1 Hz, 2H), 7.38 (d, J=8.0 Hz, 2H), 7.18 (d, J=9.1 Hz, 2H), 6.77 (d, J=2.2 Hz, 2H), 6.40 (dd, J=9.1, 2.2 Hz, 2H), 5.53 (s, 2H), 4.59 (s, 2H), 4.33 (t, J=7.6 Hz, 8H), 2.54 (p, J=7.6 Hz, 4H), 1.73 (s, 3H), 1.67 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−118.52 (d, J=15.6 Hz, 1F), −135.08 (d, J=23.2 Hz, 1F), −143.94 (dd, J=22.8, 16.4 Hz, 1F); Analytical HPLC: tR=9.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C43H38F3N8O4[M+H]+ 787.2963, found 787.2950.
6−(MOM-MAC)-JF632 (44MAC; 16 mg, 0.0260 mmol) was taken up in CH2Cl2 (2 mL); triethylsilane (200 μL) was added, followed by trifluoroacetic acid (400 μL). The reaction was stirred at room temperature for 6 h. Toluene (3 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4-(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (13.8 mg, 0.0521 mmol, 2 eq) and DIEA (45.3 μL, 0.260 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with EtOAc (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to afford 44CSTL as a blue solid (6.4 mg, 32%). 1H NMR (CDCl3, 400 MHz) δ 7.34 (d, J=7.9 Hz, 2H), 7.28 (d, J=8.3 Hz, 2H), 6.67 (d, J=8.6 Hz, 2H), 6.52 (d, J=2.3 Hz, 2H), 6.25 (dd, J=8.6, 2.3 Hz, 2H), 6.19 (bs, 1H), 6.14 (s, 1H), 5.29 (s, 2H), 5.02 (s, 2H), 4.56 (d, J=5.8 Hz, 2H), 3.94 (t, J=7.3 Hz, 8H), 2.39 (p, J=7.2 Hz, 4H), 1.72 (s, 3H), 1.69 (s, 3H); 19F NMR (CDCl3, 376 MHz) δ−120.88 (d, J=20.2 Hz, 1F), −133.00 (d, J=21.6 Hz, 1F), −142.20 (t, J=22.0 Hz, 1F); Analytical HPLC: tR=12.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 625 nm); HRMS (ESI) calcd for C42H37C1F3N6O4 [M+H]+ 781.2511, found 781.2502.
6−(MOM-MAC)-JFX576 (8MAC; 60 mg, 86.6 mol) was taken up in CH2Cl2 (5 mL); triethylsilane (500 μL) was added, followed by trifluoroacetic acid (1 mL). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4-(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (45.9 mg, 0.173 mmol, 2 eq) and DIEA (151 μL, 0.866 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 8CSTL as a dark red-purple solid (52.8 mg, 67%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.46 (t, J=5.8 Hz, 1H), 7.39 (AB quartet, vA=2963.6 Hz, vB=2949.4 Hz, JAB=8.2 Hz, 4H), 7.30 (d, J=9.3 Hz, 2H), 6.95 (dd, J=9.4, 2.3 Hz, 2H), 6.81 (d, J=2.3 Hz, 2H), 6.08 (s, 1H), 5.33 (s, 2H), 4.63-4.58 (m, 2H); 19F NMR (CD3OD, 376 MHz) δ−75.41 (s, 3F),-116.58 (d, J=15.5 Hz, 1F), −132.40 (d, J=22.1 Hz, 1F), −139.51-−139.67 (m, 1F); Analytical HPLC: tR=12.8 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C41H19D16C1F3N6O5 [M+H]+ 799.3308, found 799.3299.
6−(MOM-MAC)-JFX637 (40MAC; 50 mg, 75.9 mol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 L). The reaction was stirred at room temperature for 6 h. Toluene (4 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4-(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 41.0 mg, 0.152 mmol, 2 eq) and DIEA (132 μL, 0.759 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (10-75% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 40STL as a deep blue solid (57.0 mg, 79%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 8.24 (s, 1H), 7.54 (d, J=8.2 Hz, 2H), 7.43 (d, J=8.1 Hz, 2H), 7.19 (dd, J=9.3, 1.0 Hz, 2H), 7.10 (d, J=2.4 Hz, 2H), 6.72 (dd, J=9.3, 2.4 Hz, 2H), 5.63 (s, 2H), 4.62 (s, 2H), 1.83 (s, 3H), 1.70 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.39 (s, 3F), −117.30 (d, J=15.2 Hz, 1F),-133.85 (dd, J=22.5, 2.3 Hz, 1F), −140.50 (dd, J=22.2, 15.3 Hz, 1F); Analytical HPLC: tR=10.4 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C45H26D16F3N8O4[M+H]+ 831.4280, found 831.4280.
6−(MOM-MAC)-JFX637 (40MAC; 15 mg, 0.0228 mmol) was taken up in CH2Cl2 (2 mL); triethylsilane (200 μL) was added, followed by trifluoroacetic acid (400 μL). The reaction was stirred at room temperature for 6 h. Toluene (3 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4-(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (12.1 mg, 0.0455 mmol, 2 eq) and DIEA (39.7 μL, 0.227 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 40CSTL as a blue solid (10 mg, 48%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.35 (t, J=5.7 Hz, 1H), 7.29 (AB quartet, vA=2926.6 Hz, vB=2911.2 Hz, JAB=8.1 Hz, 4H), 7.08 (d, J=9.3 Hz, 2H), 7.00 (d, J=2.4 Hz, 2H), 6.62 (dd, J=9.3, 2.4 Hz, 2H), 5.99 (s, 1H), 5.24 (s, 2H), 4.53-4.49 (m, 2H), 1.73 (s, 3H), 1.60 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ-75.38 (s, 3F), −117.16 (d, J=15.2 Hz, 1F), −133.75 (d, J=22.0 Hz, 1F), −140.25 (dd, J=21.4, 15.4 Hz, 1F); Analytical HPLC: tR=13.1 min, 98.2% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C44H2 5D16C1F3N6O4 [M+H]+ 825.3829, found 825.3816.
6−(MOM-MAC)-JFX673 (25MAC; 18 mg, 0.0267 mmol) was taken up in CH2Cl2 (2 mL); triethylsilane (200 μL) was added, followed by trifluoroacetic acid (400 L). The reaction was stirred at room temperature for 6 h. Toluene (3 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4-(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 14.4 mg, 0.0533 mmol, 2 eq) and DIEA (46.5 μL, 0.267 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 25STL as a blue solid (8.5 mg, 34%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.50 (t, J=5.9 Hz, 1H), 8.22 (s, 1H), 7.54 (d, J=8.1 Hz, 2H), 7.42 (d, J=8.0 Hz, 2H), 7.18 (d, J=2.7 Hz, 2H), 7.14 (d, J=9.5 Hz, 2H), 6.66 (dd, J=9.5, 2.7 Hz, 2H), 5.62 (s, 2H), 4.64-4.60 (m, 2H), 0.61 (s, 3H), 0.53 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.35 (s, 3F), −117.89 (d, J=15.4 Hz, 1F), −134.59 (d, J=22.1 Hz, 1F), −140.85-−141.01 (m, 1F); Analytical HPLC: tR=10.5 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C44H26D16F3N8O4Si [M+H]+ 847.4049, found 847.4038.
6−(MOM-MAC)-JFX673 (25MAC; 28 mg, 0.0415 mmol) was taken up in CH2Cl2 (3 mL); triethylsilane (300 μL) was added, followed by trifluoroacetic acid (600 μL). The reaction was stirred at room temperature for 6 h. Toluene (3 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4-(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (22.0 mg, 0.0830 mmol, 2 eq) and DIEA (72.3 μL, 0.415 mmol, 10 eq) in DMF (3 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 25CSTL as a blue solid (14 mg, 35%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.47 (t, J=5.7 Hz, 1H), 7.41 (AB quartet, vA=2974.9 Hz, vB=2958.5 Hz, JAB=8.1 Hz, 4H), 7.21 (d, J=2.7 Hz, 2H), 7.16 (d, J=9.5 Hz, 2H), 6.68 (dd, J=9.5, 2.7 Hz, 2H), 6.11 (s, 1H), 5.36 (s, 2H), 4.64-4.60 (m, 2H), 0.63 (s, 3H), 0.54 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ-75.39 (s, 3F), −117.71 (d, J=15.3 Hz, 1F), −134.44 (d, J=22.1 Hz, 1F), −140.57 (dd, J=21.6, 15.3 Hz, 1F); Analytical HPLC: tR=13.6 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 675 nm); HRMS (ESI) calcd for C43H2 5D16C1F3N6O4Si [M+H]+ 841.3598, found 841.3588.
6−(MOM-MAC)-JF563 (18MAC; acetate salt; 45 mg, 61.4 mol) was taken up in CH2Cl2 (4 mL); anisole (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 24 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6-((4−(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 33.2 mg, 0.123 mmol, 2 eq) and DIEA (107 μL, 0.614 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 34.4 mg (58%, TFA salt) of 18STL as a red-purple solid (mixture of diastereomers). 1H NMR (CD3OD, 400 MHz) δ 8.28-8.24 (m, 1H), 7.55 (d, J=8.1 Hz, 2H), 7.43 (d, J=7.9 Hz, 2H), 7.11-7.05 (m, 2H), 6.65-6.62 (m, 2H), 5.65-5.61 (m, 2H), 4.65-4.60 (m, 2H), 2.97-2.87 (m, 2H), 1.92-1.85 (m, 2H), 1.46-1.36 (m, 8H), 1.32-1.23 (m, 12H); 19F NMR (CD3OD, 376 MHz) δ−75.41 (s, 3F), −116.23-−116.40 (m, 1F), −132.06-−132.19 (m, 1F), −139.47-−140.58 (m, 1F); Analytical HPLC: tR=10.3 min, 98.1% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C46H44F3N8O5 [M+H]+ 845.3381, found 845.3366.
6−(MOM-MAC)-JF563 (18MAC; acetate salt; 45 mg, 61.4 mol) was taken up in CH2Cl2 (4 mL); anisole (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 24 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4-((4−(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (32.5 mg, 0.123 mmol, 2 eq) and DIEA (107 μL, 0.614 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 2 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to yield 46.7 mg (80%, TFA salt) of 18CSTL as a red-purple solid (mixture of diastereomers). 1H NMR (CDCl3, 400 MHz) δ 7.39 (AB quartet, vA=2965.0 Hz, vB=2950.7 Hz, JAB=8.3 Hz, 4H), 7.10-7.04 (m, 2H), 6.67-6.63 (m, 2H), 6.10-6.07 (m, 1H), 5.36-5.31 (m, 2H), 4.67-4.56 (m, 2H), 2.97-2.86 (m, 2H), 1.93-1.84 (m, 2H), 1.46-1.36 (m, 8H), 1.32-1.22 (m, 12H); 19F NMR (CDCl3, 376 MHz) δ−75.52 (s, 3F), −115.81-−116.06 (m, 1F), −131.65-−131.94 (m, 1F), −139.10-−139.65 (m, 1F); Analytical HPLC: tR=13.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C45H43C1F3N6O5 [M+H]+ 839.2930, found 839.2917.
Rhodamine 11MAC (acetate salt; 60 mg, 79.3 μmol) was taken up in CH2Cl2 (5 mL), and trifluoroacetic acid (1 mL) was added. The reaction was stirred at room temperature for 18 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4−(aminomethyl)benzyl)oxy)-9H-purin-2-amine (BG-NH2; 42.9 mg, 0.159 mmol, 2 eq) and DIEA (138 μL, 0.793 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 11STL as a purple solid (39.6 mg, 51%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 8.30 (s, 1H), 7.55 (d, J=8.0 Hz, 2H), 7.43 (d, J=7.9 Hz, 2H), 6.86 (s, 2H), 6.84 (s, 2H), 5.71 (s, 2H), 5.64 (s, 2H), 4.63 (s, 2H), 3.21 (s, 6H), 1.89 (s, 6H), 1.52 (s, 6H), 1.51 (s, 6H); 19F NMR (CD3OD, 376 MHz) δ−75.47 (s, 3F), −115.97 (d, J=15.4 Hz, 1F), −131.64 (d, J=23.1 Hz, 1F), −139.44 (dd, J=22.5, 15.3 Hz, 1F); Analytical HPLC: tR=11.1 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C48H44F3N8O5[M+H]+ 869.3381, found 869.3371.
Rhodamine 11MAC (acetate salt; 60 mg, 79.3 μmol) was taken up in CH2Cl2 (5 mL), and trifluoroacetic acid (1 mL) was added. The reaction was stirred at room temperature for 18 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4−(aminomethyl)benzyl)oxy)-6-chloropyrimidin-2−amine (42.0 mg, 0.159 mmol, 2 eq) and DIEA (138 μL, 0.793 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 11CSTL as a purple solid (40.4 mg, 52%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 7.39 (AB quartet, vA=2962.5 Hz, vB=2949.3 Hz, JAB=8.2 Hz, 4H), 6.85 (s, 2H), 6.84 (s, 2H), 6.08 (s, 1H), 5.71 (s, 2H), 5.33 (s, 2H), 4.61 (s, 2H), 3.21 (s, 6H), 1.88 (s, 6H), 1.52 (s, 6H), 1.52 (s, 6H); 19F NMR (CD3OD, 376 MHz) δ−75.57 (s, 3F), −115.71 (d, J=15.3 Hz, 1F), −131.42 (dd, J=22.4, 3.0 Hz, 1F), −139.04 (dd, J=22.3, 15.3 Hz, 1F); Analytical HPLC: tR=13.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 600 nm); HRMS (ESI) calcd for C47H43C1F3N6O5 [M+H]+ 863.2930, found 863.2924.
6−(MOM-MAC)-JF657 (59MAC; 40 mg, 55.2 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 8 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4-(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 29.8 mg, 0.110 mmol, 2 eq) and DIEA (96.1 μL, 0.552 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 37.9 mg (68%, TFA salt) of 59STL as a dark blue solid (mixture of two diastereomers). 1H NMR (CD3OD, 400 MHz) δ 8.23 (s, 0.5H), 8.22 (s, 0.5H), 7.54 (d, J=7.9 Hz, 2H), 7.43 (d, J=8.0 Hz, 2H), 6.94 (s, 1H), 6.84-6.78 (m, 2H), 5.63 (s, 1H), 5.62 (s, 1H), 4.62 (s, 2H), 3.83 (dq, J=14.1, 7.0 Hz, 1H), 3.71-3.55 (m, 5H), 3.25-3.14 (m, 2H), 2.85-2.74 (m, 1H), 2.65 (t, J=6.4 Hz, 2H), 2.12-2.01 (m, 2H), 1.97-1.85 (m, 3H), 1.91 (s, 1.5H), 1.90 (s, 1.5H), 1.84 (s, 1.5H), 1.83 (s, 1.5H), 1.58-1.50 (m, 1H), 1.482 (s, 1.5H), 1.477 (s, 1.5H), 1.39-1.32 (m, 6H), 1.16 (d, J=6.5 Hz, 1.5H), 1.14 (d, J=6.5 Hz, 1.5H); 19F NMR (CD3OD, 376 MHz) δ−75.39 (s, 3F), −116.89 (d, J=15.1 Hz, 0.5F), −116.99 (d, J=15.3 Hz, 0.5F), −133.73 (dd, J=22.4, 2.0 Hz, 0.5F), −133.85 (dd, J=22.0, 2.1 Hz, 0.5F), −140.51 (dd, J=22.1, 15.2 Hz, 0.5F), −140.80 (dd, J=22.3, 15.4 Hz, 0.5F); Analytical HPLC: tR (two isomers)=10.8 min, 10.9 min; >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C51H52F3N8O4[M+H]+ 897.4058, found 897.4046.
6−(MOM-MAC)-JF657 (59MAC; 40 mg, 55.2 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 8 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4-(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (29.2 mg, 0.110 mmol, 2 eq) and DIEA (96.1 μL, 0.552 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 34.0 mg (61%, TFA salt) of 59CSTL as a dark blue solid (mixture of two diastereomers). 1H NMR (CD3OD, 400 MHz) δ 7.39 (AB quartet, vA=2965.7 Hz, vB=2951.3 Hz, JAB=8.3 Hz, 4H), 6.944 (s, 0.5H), 6.939 (s, 0.5H), 6.83-6.77 (m, 2H), 6.085 (s, 0.5H), 6.080 (s, 0.5H), 5.340 (s, 1H), 5.336 (s, 1H), 4.61 (s, 2H), 3.83 (dq, J=14.1, 7.0 Hz, 1H), 3.70-3.54 (m, 5H), 3.26-3.14 (m, 2H), 2.84-2.74 (m, 1H), 2.64 (t, J=6.3 Hz, 2H), 2.12-2.02 (m, 2H), 1.98-1.85 (m, 3H), 1.915 (s, 1.5H), 1.906 (s, 1.5H), 1.84 (s, 1.5H), 1.83 (s, 1.5H), 1.58-1.50 (m, 1H), 1.48 (s, 3H), 1.39-1.33 (m, 6H), 1.15 (d, J=6.5 Hz, 1.5H), 1.13 (d, J=6.5 Hz, 1.5H); 19F NMR (CD3OD, 376 MHz) δ−75.43 (s, 3F), −116.65 (d, J=15.1 Hz, 0.5F), −116.82 (d, J=15.2 Hz, 0.5F), −133.54 (dd, J=22.5, 2.3 Hz, 0.5F), −133.73 (dd, J=22.6, 2.5 Hz, 0.5F),-140.30 (dd, J=22.1, 15.4 Hz, 0.5F), −140.44 (dd, J=22.3, 15.3 Hz, 0.5F); Analytical HPLC: tR(two isomers)=14.0 min, 14.2 min; 97.4% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C50H51C1F3N6O4 [M+H]+ 891.3607, found 891.3596.
6−(MOM-MAC)-JF698 (31MAC; 45 mg, 63.3 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4-(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 34.2 mg, 0.127 mmol, 2 eq) and DIEA (110 μL, 0.633 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-50% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 31STL as a blue-green solid (30.0 mg, 48%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 8.22 (s, 1H), 7.54 (d, J=8.1 Hz, 2H), 7.42 (d, J=8.2 Hz, 2H), 6.65 (s, 2H), 5.63 (s, 2H), 4.62 (s, 2H), 3.57 (t, J=6.2 Hz, 4H), 3.54 (t, J=6.2 Hz, 4H), 3.02-2.93 (m, 4H), 2.57 (t, J=6.2 Hz, 4H), 2.12-2.00 (m, 4H), 1.97-1.86 (m, 4H), 0.70 (s, 3H), 0.67 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.39 (s, 3F), −117.90 (d, J=15.2 Hz, 1F), −134.96 (d, J=22.1 Hz, 1F),-141.26 (dd, J=22.2, 15.2 Hz, 1F); Analytical HPLC: tR=10.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 700 nm); HRMS (ESI) calcd for C48H46F3N8O4Si [M+H]+ 883.3358, found 883.3346.
6−(MOM-MAC)-JF698 (3MAC; 45 mg, 63.3 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4-(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (33.5 mg, 0.127 mmol, 2 eq) and DIEA (110 μL, 0.633 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-60% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 31CSTL as a blue-green solid (29.0 mg, 46%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 7.40 (AB quartet, vA=2967.5 Hz, vB=2951.1 Hz, JAB=8.2 Hz, 4H), 6.65 (s, 2H), 6.09 (s, 1H), 5.34 (s, 2H), 4.61 (s, 2H), 3.58 (t, J=6.2 Hz, 4H), 3.54 (t, J=6.2 Hz, 4H), 2.97 (t, J=6.1 Hz, 4H), 2.56 (t, J=6.2 Hz, 4H), 2.12-2.01 (m, 4H), 1.97-1.86 (m, 4H), 0.71 (s, 3H), 0.67 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.44 (s, 3F), −117.74 (d, J=15.1 Hz, 1F),-134.86 (d, J=21.9 Hz, 1F), −141.05 (dd, J=22.1, 15.2 Hz, 1F); Analytical HPLC: tR=13.2 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 700 nm); HRMS (ESI) calcd for C47H45C1F3N6O4Si [M+H]+ 877.2907, found 877.2901.
Rhodamine 64MAC (50 mg, 72.6 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4-(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 39.3 mg, 0.145 mmol, 2 eq) and DIEA (126 μL, 0.726 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-80% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 64STL as a purple solid (53.6 mg, 76%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.45 (t, J=5.9 Hz, 1H), 8.30 (s, 1H), 7.61-7.45 (m, 8H), 7.44-7.35 (m, 6H), 7.32 (d, J=9.4 Hz, 2H), 6.99 (d, J=2.4 Hz, 2H), 6.92 (dd, J=9.5, 2.4 Hz, 2H), 5.64 (s, 2H), 4.63-4.57 (m, 2H), 3.62 (s, 6H); 19F NMR (CD3OD, 376 MHz) δ−75.50 (s, 3F), −116.67 (d, J=15.2 Hz, 1F), −132.09 (d, J=22.5 Hz, 1F), −139.29 (dd, J=22.3, 15.2 Hz, 1F); Analytical HPLC: tR=10.9 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C48H36F3N8O5[M+H]+ 861.2755, found 861.2742.
Rhodamine 64MAC (50 mg, 72.6 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4-(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (38.4 mg, 0.145 mmol, 2 eq) and DIEA (126 μL, 0.726 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (30-70% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 64CSTL as a purple solid (40.6 mg, 58%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.39 (t, J=5.8 Hz, 1H), 7.61-7.54 (m, 4H), 7.51-7.44 (m, 2H), 7.42-7.33 (m, 8H), 7.31 (d, J=9.4 Hz, 2H), 6.99 (d, J=2.4 Hz, 2H), 6.92 (dd, J=9.4, 2.4 Hz, 2H), 6.08 (s, 1H), 5.33 (s, 2H), 4.61-4.56 (m, 2H), 3.62 (s, 6H); 19F NMR (CD3OD, 376 MHz) δ−75.59 (s, 3F),-116.36 (d, J=14.8 Hz, 1F), −131.85 (d, J=22.4 Hz, 1F), −138.58 (dd, J=22.0, 15.3 Hz, 1F); Analytical HPLC: tR=13.7 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 575 nm); HRMS (ESI) calcd for C47H35C1F3N6O5 [M+H]+ 855.2304, found 855.2296.
6−(MOM-MAC)-JQ645 (65MAC; 50 mg, 70.0 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4-(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 37.8 mg, 0.140 mmol, 2 eq) and DIEA (122 μL, 0.700 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (20-80% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 65STL as a blue solid (37.8 mg, 54%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.46 (t, J=6.1 Hz, 1H), 8.30 (s, 1H), 7.53 (d, J=8.1 Hz, 2H), 7.50-7.43 (m, 4H), 7.39 (d, J=8.0 Hz, 2H), 7.33-7.23 (m, 6H), 7.15 (d, J=2.5 Hz, 2H), 7.00 (d, J=9.1 Hz, 2H), 6.75 (dd, J=9.1, 2.5 Hz, 2H), 5.63 (s, 2H), 4.60-4.55 (m, 2H), 3.51 (s, 6H), 1.63 (s, 3H), 1.58 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.53 (s, 3F), −119.50-−119.77 (m, 1F), −134.08 (d, J=21.3 Hz, 1F), −141.32-−141.60 (m, 1F); Analytical HPLC: tR=12.7 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C51H42F3NsO4 [M+H]+ 887.3276, found 887.3263.
6−(MOM-MAC)-JQ645 (65MAC; 50 mg, 70.0 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 6 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4-(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (37.0 mg, 0.140 mmol, 2 eq) and DIEA (122 μL, 0.700 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 18 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive) to afford 65CSTL as a blue solid (24.8 mg, 36%, TFA salt). 1H NMR (CD3OD, 400 MHz) δ 9.41 (t, J=5.8 Hz, 1H), 7.56-7.48 (m, 4H), 7.42-7.29 (m, 10H), 7.16 (d, J=2.5 Hz, 2H), 7.10 (d, J=9.2 Hz, 2H), 6.75 (dd, J=9.2, 2.5 Hz, 2H), 6.09 (s, 1H), 5.34 (s, 2H), 4.60-4.55 (m, 2H), 3.58 (s, 6H), 1.64 (s, 3H), 1.56 (s, 3H); 19F NMR (CD3OD, 376 MHz) δ−75.68 (s, 3F), −118.21 (d, J=16.2 Hz, 1F), −133.50 (d, J=21.8 Hz, 1F), −140.05 (m, 1F); Analytical HPLC: tR=16.0 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 650 nm); HRMS (ESI) calcd for C50H41C1F3N6O4 [M+H]+ 881.2824, found 881.2813.
4,5,7−Trifluoro-6−(MOM-MAC)-MGL (49MAC; 50 mg, 90.8 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 18 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 6−((4−(aminomethyl)benzyl)oxy)-9H-purin-2−amine (BG-NH2; 49.1 mg, 0.182 mmol, 2 eq) and DIEA (158 μL, 0.908 mmol, 10 eq) in DMF (4 mL), and the reaction was stirred at room temperature for 2 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (10-75% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with 10% MeOH/CH2Cl2 (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to provide 49STL (30.4 mg, 46%) as a light blue-green solid. 1H NMR (CD3OD with 1% TFA, 400 MHz) δ 8.39 (s, 1H), 7.56 (d, J=8.1 Hz, 2H), 7.42 (d, J=8.1 Hz, 2H), 7.33 (d, J=9.1 Hz, 4H), 7.18 (d, J=9.0 Hz, 4H), 5.67 (s, 2H), 4.59 (s, 2H), 3.13 (s, 12H); 19F NMR (CD3OD with 1% TFA, 376 MHz) δ-117.71 (d, J=21.8 Hz, 1F), −133.63 (d, J=20.9 Hz, 1F), −142.06 (t, J=21.4 Hz, 1F); Analytical HPLC: tR=10.0 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (ESI) calcd for C38H34F3N8O4[M+H]+ 723.2650, found 723.2640.
4,5,7−Trifluoro-6−(MOM-MAC)-MGL (49MAC; 50 mg, 90.8 mol) was taken up in CH2Cl2 (4 mL); triethylsilane (400 μL) was added, followed by trifluoroacetic acid (800 L). The reaction was stirred at room temperature for 18 h. Toluene (5 mL) was added, and the reaction mixture was concentrated to dryness. The residue was combined with a premixed solution of 4−((4−(aminomethyl)benzyl)oxy)-6−chloropyrimidin-2−amine (48.1 mg, 0.182 mmol, 2 eq) and DIEA (158 μL, 0.908 mmol, 10 eq) in DMF (5 mL), and the reaction was stirred at room temperature for 2 h. The solvent was removed by rotary evaporation, and the crude material was purified by reverse phase HPLC (10-75% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive). The pooled product fractions were partially concentrated to remove MeCN, diluted with saturated NaHCO3, and extracted with 10% MeOH/CH2Cl2 (2×). The organic extracts were dried over anhydrous MgSO4, filtered, and evaporated to provide 49CSTL (31.2 mg, 48%) as a blue-green solid. 1H NMR (CD3OD, 400 MHz) δ 7.38 (AB quartet, vA=2966.2 Hz, vB=2941.4 Hz, JAB=8.1 Hz, 4H), 7.10 (d, J=9.0 Hz, 4H), 6.71 (d, J=9.0 Hz, 4H), 6.10 (s, 1H), 5.34 (s, 2H), 4.56 (s, 2H), 2.94 (s, 12H); 19F NMR (CD3OD, 376 MHz) δ-117.92 (d, J=22.1 Hz, 1F), −135.20 (dd, J=20.9, 2.3 Hz, 1F), −143.30 (t, J=21.7 Hz, 1F); Analytical HPLC: tR=13.3 min, >99% purity (10-95% MeCN/H2O, linear gradient, with constant 0.1% v/v TFA additive; 20 min run; 1 mL/min flow; ESI; positive ion mode; detection at 280 nm); HRMS (ESI) calcd for C37H33C1F3N6O4 [M+H]+ 717.2198, found 717.2191.
Compound 81HTL was purchased from Promega. Compounds 1HTL, 84HTL, 84HST, 85HTL, 86HTL, 89HTL, 105HTL, 106HTL, and 107HTL were available from previous work. Data for dyes 1, 2, 22, 74, 75, 78-91, 93, and 95 were taken from published work of the inventors'; all spectral data was measured under identical conditions.
All dyes for spectroscopy were prepared as stock solutions in DMSO and diluted such that the final DMSO concentration did not exceed 1% v/v. Spectroscopy was performed using 1−cm path length, 3.5−mL quartz cuvettes or 1−cm path length, 1.4−mL semi-micro quartz cuvettes from Starna Cells. All measurements were taken at ambient temperature (22±2° C.). Absorption spectra were recorded on a Cary Model 100 spectrometer (Agilent), and fluorescence spectra were recorded on a Cary Eclipse fluorometer (Varian). The spectra, maximum absorption wavelength (labs), extinction coefficient at λabs (8), and maximum emission wavelength (em) were measured in 10 mM HEPES, pH 7.3 buffer (rhodamines and Malachite Green derivative 49) or 0.1 M NaOH (fluoresceins); the reported values for e are averages (n=3). Normalized spectra are shown for clarity.
All reported absolute fluorescence quantum yield values (Φf) were measured using a Quantaurus-QY spectrometer (model C11374, Hamamatsu). This instrument uses an integrating sphere to determine photons absorbed and emitted by a sample. Measurements were carried out using dilute samples (A<0.1), and self-absorption corrections were performed using the instrument software.81
The bacterial expression vector pRSET-A (Invitrogen) was used to recombinantly express HaloTag® (HT7; Promega).7 The soluble 6×His-Tagged HaloTag® protein was affinity purified by immobilized metal affinity chromatography (IMAC) on a 5−mL Fast Flow HiTrap Sepharose 6 column (Cytiva) with a 0-200 mM imidazole elution gradient using an ÄKTA Avant Protein Purification System (Cytiva). A280 peak fractions were pooled, concentrated by a spin concentrator, and dialyzed 3× into tris-buffered saline (TBS; 137 mM NaCl, 20 mM Tris-HCl, pH 7.4).
HaloTag® protein was used as a 100 M solution in 1× TBS. Absorption measurements were performed in 1.4−mL semi-micro quartz cuvettes. A 5 M solution of HaloTag® ligand 65HTL or 91HTL was prepared in 10 mM HEPES, pH 7.3 containing 0.1 mg mL-1 CHAPS. An aliquot of HaloTag® protein (2 equiv, 10 M final [HaloTag®]) was added. To examine chromogenicty (
KL-Z was calculated using the following equation:16, 18 KL-Z=(εdw/εmax)/(1−εdw/εmax). εdw is the extinction coefficient of the dyes in a 1:1 (v/v) dioxane/water solvent mixture; this dioxane/water mixture was chosen to give the maximum spread of KL-Z values across all classes of rhodamines.18 εmax refers to the maximal extinction coefficients measured in different solvent mixtures empirically determined depending on dye type: 0.1% v/v trifluoroacetic acid in ethanol for 18, 20, 29, 34, 36, 70-72, 81-83, 93-95, 99-102, and 104; 0.1% v/v trifluoroacetic acid in 2,2,2−trifluoroethanol for all other rhodamine variants. A accurate determination of low KL-Z values is complicated by the relatively poor sensitivity of absorbance measurements. No attempt was made to estimate KL-Z values when no measurable absorbance of the dye was observed in the dioxane/water solution.
The pKa values for compounds 51, 53, 60, 76, and 77 were determined by measuring the change in absorbance as a function of pH. For pH 2.0-4.0, the McIlvaine citrate/phosphate buffer system was used. For other pH ranges dye absorbance was measured in buffers containing 150 mM NaCl and 10 mM buffer using the following systems: citrate (pH 4.0-6.0), phosphate (pH 5.8-8.0); tris (pH 7.8-9.0); carbonate (pH 9.2-10.0). Buffer solutions containing 5 M of each fluorophore were prepared (36 samples in duplicate from pH 4.0-10.0 for 51, 53, and 60; 48 samples in duplicate from pH 2.0-10.0 for 76 and 77). Absorbance values were recorded on a Cary Model 100 spectrometer and plotted using GraphPad Prism software. The points were fitted to a sigmoidal dose response curve with a variable slope to determine the Hill coefficient (ηH).
U2OS cells (ATCC) and U2OS cells stably expressing an integrated HaloTag®-histone H2B fusion protein (U2OS·H2B·HaloTag®) were cultured in Dulbecco's modified Eagle medium (DMEM, phenol red-free; Life Technologies) supplemented with 10% (v/v) fetal bovine serum (FBS, Life Technologies), 1 mM GlutaMAX (Life Technologies) and maintained at 37° C. in a humidified 5% (v/v) CO2 environment. These cell lines undergo regular mycoplasma testing by the Janelia Cell Culture Facility. For mitochondrial imaging using the HaloTag® system, U2OS cells were transiently transfected using nucleofection (Lonza) with a plasmid constitutively expressing a HaloTag®-TOMM20 fusion protein, which is located on the outer mitochondrial membrane. For 4−color imaging, U2OS·H2B·HaloTag® stable cells were transiently transfected by nucleofection with plasmids constitutively expressing a SNAP-tag®-TOMM20 fusion protein, and a GFP-SKL (SKL: serine-lysine-leucine) fusion protein, a prototypical peroxisomal matrix targeting signal. All labeled cells were imaged 18-24 h post-transfection or post-plating.
The U2OS·H2B·HaloTag® stable cells were incubated with 100 nM HaloTag® ligand conjugated dyes (70HTL-70HTL) for 2 h at 37° C., washed 3× with dye-free media then imaged live. Confocal imaging was performed on a Leica SP8 using an HC PL APO 86×/1.20 water objective. Single plane images were processed using FIJI.82
For loading curve experiments (
For photostability experiments (
To achieve a 4−color image, live U2OS·H2B·HaloTag® stable cells that were transiently transfected with plasmids constitutively expressing a SNAP-tag®-TOMM20 fusion protein and an GFP-SKL fusion protein were incubated with 200 nM JF698-HaloTag® ligand (31HTL) and JFX650−SNAP-tag® ligand (89HTL) for 1 h at 37° C., washed 3× with dye-free media, and then fixed with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 for 15 min at 37° C. Fixed cells were then washed 3× in 1×phosphate buffered saline, pH 7.4 (PBS) and incubated with JF549−Hoechst (84HST; 3 μM) for 15 min at ambient temperature (22±2° C.) as a nuclear counterstain. Confocal imaging was performed on a Leica Stellaris with an HC PL APO CS2 86×/1.20 water objective using the tunable white light laser (WLL) to excite each dye or fluorescent protein at their λabs. Confocal image stacks were processed using FIJI and displayed as maximum intensity image projections.
For loading curve experiments, U2OS·H2B·HaloTag® stable cells were incubated with 200 nM 65HTL and 91HTL for 0-4 h at 37° C., washed 3× with dye-free media then chased with 200 nM JF552-HaloTag® ligand 15 for 30 min at 37° C., washed 3× with dye-free media and fixed with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 for 15 min at 37° C. Confocal imaging was performed on a Zeiss LSM 980 using a Plan-Apochromat 20×/0.8 M27 objective, and excited by a 561 nm laser. Fluorescence was quantified as the integrated density of nuclear signals from confocal image stack projections analyzed in FIJI;82 n=100 nuclear signals per compound.
U2OS cells transiently transfected with a plasmid constitutively expressing a HaloTag®-TOMM20 fusion protein were incubated with 200 nM JFX637-HaloTag® ligand (40HTL) for 1 h at 37° C., washed 3× with dye-free media then fixed with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 for 15 min at 37° C. Fixed cells were then washed 3× in 1×PBS and incubated with Hoechst 33342 (5 g/mL; nuclear co-stain) for 15 min at ambient temperature (22±2° C.) as a nuclear counterstain. High-resolution Airyscan imaging was performed on a Zeiss LSM 980 with Airyscan 2 confocal microscope using a Plan APO 63×/1.4 oil DIC M27 objective. Confocal image stacks were bulk processed in ZEN Blue (Zeiss) with automatic Airyscan settings; the final images were processed in FIJI.82
U2OS·H2B·HaloTag® stable cells were incubated with 200 nM of either JF657-HaloTag® ligand (59HTL) or ATTO 647N-HaloTag® ligand (105HTL) for 1 h at 37° C., washed 3× with dye-free media, stained with Hoechst 33342 (5 g/mL; nuclear co-stain) and MitoTracker Green FM (100 nM; mitochondrial stain) for 15 min at 37° C. then imaged live. Standard confocal imaging was performed on a Zeiss LSM 980 using a Plan APO 63×/1.4 oil DIC M27 objective. Confocal image stacks were processed using FIJI82 and displayed as maximum intensity image projections.
For loading curve experiments (
For photostability experiments (
To measure labeling rates a stopped-flow protocol was used where equimolar amounts of purified HaloTag® protein and HaloTag® ligand were mixed; the labeling was monitored by fluorescence polarization.83 HaloTag® protein and HaloTag® ligands were serially diluted in 50 mM HEPES buffer, pH 7.2 containing 50 mM NaCl, and 0.5 mg/mL bovine serum albumin (BSA) to yield final concentrations of 2 μM, 1 μM, 500 nM, 250 nM, and 125 nM. Sample concentrations were evaluated using a Cary Model 100 spectrometer (Agilent) using ε280 (64,430 M−1·cm−1) for the HaloTag® protein or the e values for the different fluorophores. Stopped-flow experiments were performed at 37° C. using an Applied Photophysics Stopped Flow Spectrometer, model SX20, in fluorescence polarization mode. Appropriate long-pass filters were used for each dye type. Five replicates of each concentration pair were collected (n=5). The plots of fluorescence polarization vs. time were fit using DynaFit (Biokin) to calculate k1, k−1, and k2; timepoints <3 ms were omitted from the analysis. The capture rate (kapp) was calculated using the following equation: kapp=k1(k2/k−1×k2). Reported values are averages of the kapp values measured for the different concentrations.
Purified HaloTag® protein was incubated with a 10-fold molar excess of “pulse” HaloTag® ligands in 1×PBS in LoBind microcentrifuge tubes (Eppendorf) and incubated for 2-4 h at 4° C. while protected from light. For displacement experiments, unbound pulse dye was removed by passing the reaction mixture through two successive Zeba Spin Desalting Column (ThermoFisher) using 1×PBS. These samples were then incubated with a 10-fold molar excess of JF646-HaloTag® ligand (1HTL) or a DMSO control for 1 h at 4° C. Reactions were stopped by adding 4× NuPAGE LDS buffer (ThermoFisher) with NuPAGE Sample Reducing Agent (ThermoFisher) and heated for 10 min at 90° C. Samples were run on NuPAGE 4-12% Bis-Tris 1.0-1.5 mm Mini Protein Gels (ThermoFisher) in NuPAGE MES SDS Running Buffer (ThermoFisher) for 60 min at 200 V. Gels were washed in Milli-Q water for 3 min then imaged on a black tray using a ChemiDoc MP Imaging system (Biorad) and 602/50 or 700/50 emission filter. Exposure times during imaging were set to avoid signal saturation. After fluorescence imaging, the gels were stained with Simply Blue Safe Stain (ThermoFisher) and reimaged using the white tray for calorimetric detection. ImageJ was used for signal quantification with background subtraction.
SPT experiments were carried out as previously described.84 JM8·N4 mouse embryonic stem cells (ESCs) stably expressing histone H2B-HaloTag® fusion proteins were generated by co-expressing the PiggyBac EF1a-H2B-HaloTag®-IRES-Neo vector with the super piggyBac transposase as described previously,85 followed by G418 selection (500 μg/mL) for 2 weeks and verified by FACS sorting/confocal imaging staining with JF549-HaloTag® ligand (84HTL; 100 nM, 30 min). Cells were seeded on 25 mm #1.5 coverglass pre-cleaned with KOH and ethanol and coated with iMatrix-511 (TaKaRa #T304) or rhLaminin-521 (Gibco™ #A29248) according to the manufacturers' instruction. All live-cell imaging experiments were conducted using an ESC imaging medium composed of FluoroBrite DMEM (ThermoFisher) plus 15% v/v ESC-qualified FBS, 1× GlutaMax, 1×NEAA, 0.1 mM 2−mercaptoethanol, and LIF. For comparison of 59HTL and 89HTL (
To quantify the brightness and photostability of the HaloTag® ligands, labeled cells were mounted onto a high speed motorized Nikon Eclipse Ti-E inverted microscope equipped with the following: 100× Apo TIRF 1.49 NA objective with a correction collar; four excitation laser lines (405/488/561/642 nm) and matching TIRF quad cube (405/488/561/640 nm reflection bands); automatic TIRF illuminator with motorized X axis and manual Y axis for beam positioning and focus: perfect focus 3 system; Triple DU-897 iXon Ultra EMCCD cameras on a Cairn Tri-cam emission splitter with filters 525/50 (GFP) 600/50 (RFP) and 705/72 (Cy5); humidified incubation chamber maintained at 37° C. with 5% v/v CO2 (Tokai Hit). SPT was performed at 100 Hz for the comparison of 59HTL and 89HTL (
The Epac-based cAMP sensor “Epac-SH189”, was obtained from Addgene (Plasmid #170348). This sensor consists of a mTurquoise fluorescent protein and a tdDark Venus protein linked via the Epac1 protein.
To construct the SNAP-tag®-Epac1-HaloTag® sensor, the sequence encoding the tdDark Venus domain in Epac-SH189 was first replaced with the HaloTag® sequence using Nhe1 and Asc1 fragment ligation (NEB), creating a construct with mTurquoise and HaloTag® flanking the Epac1 domain (i.e, mTurquoise-Epac1-HaloTag®).
A gene block encoding the SNAP-tag® self-labeling protein (IDT) was then used to replace the portion encoding the mTurquoise domain in the mTurquoise-Epac1-HaloTag® using HindIII and AgeI fragment ligation. The sequence of this final plasmid encoding ScAMPI (i.e, SNAP-tag®-Epac1-HaloTag®) was confirmed through sequence analysis (Genewiz).
To evaluate this semisynthetic system in cells, U2OS cells (ATCC) were maintained in DMEM (Corning) containing 10% v/v FBS (ATCC), 1% v/v L-glutamine (Gibco) and 1% v/v Pen/Strep (Gibco). Cells were transfected with plasmid DNA using nucleofection (Lonza) and labeled 48 h post-transfection with 100 nM of JFX612−SNAP-tag® (88STL) and 200 nM of the JQ645-HaloTag® ligand (65HTL) for 1 h. Cells were washed with 1×PBS (3×) and recovered in fresh medium for 30 min before imaging. Fluorescence lifetime imaging was performed with a Leica SP8 Falcon using LASX software for image acquisition and analysis. Excitation was achieved with a pulsed white light laser at 40 and 20 MHz using a 40× oil immersion objective at 1.3 NA. Fluorescence emission was collected by the HyD detector. The SNAP-tag® donor dye was excited at 610 nm and emission was collected at 620-720 nm. FLIM images were acquired before and 10 min after stimulation with 25 M forskolin. FLIM data were fitted with two-component exponential fitting function yielding quenched lifetime (τ1) and unquenched lifetime (τ2). Mean amplitude weighted lifetime image (τmean) was calculated by fixing the two lifetimes and performing an image fit for their respective amplitudes (a1 and a2). FRET efficiency was calculated using the mean lifetime obtained in absence (τmean,-forskolin) and (τmean,+forskolin) presence of forskolin as 1−(τmean,-forskolin/τmean,+forskolin).
All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference, including the references set forth in the following list:
It will be understood that various details of the presently disclosed subject matter can be changed without departing from the scope of the subject matter disclosed herein. Furthermore, the foregoing description is for the purpose of illustration only, and not for the purpose of limitation.
This application claims priority from U.S. Provisional Application Ser. No. 63/584,647 filed Sep. 22, 2023, the entire disclosure of which is incorporated herein by this reference.
| Number | Date | Country | |
|---|---|---|---|
| 63584647 | Sep 2023 | US |
